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Autophagy is a degradation pathway conserved in eukaryotes. Upon induction of au-
tophagy a double layered membrane is formed de novo and engulfs the cytosolic content.
After fusion of the membrane, an autophagosome vesicle is formed, which then fuses
with the vacuole (or lysosome) where its content is degraded. PROPPINs, β-propeller
proteins that bind polyphosphoinositides, play a role in autophagy and phosphoinosi-
tide binding depends on a conserved FRRG motif. The three yeast PROPPINs Atg18,
Atg21 and Hsv2 are involved in different subtypes of autophagy.
In this study, I purified different Atg18, Atg21 and Hsv2 PROPPIN homologs and
showed that they bind specifically to PI3P and PI(3,5)P2 using protein-liposome co-
flotation assays. Recently, we published the first structure of the PROPPIN Hsv2.
Based on our structure I performed mutagenesis studies to probe phosphoinositide bind-
ing of Hsv2. I analyzed phosphoinositide binding of the alaninine mutants with liposome
flotation assays. I identified conserved residues essential for binding right and left of
the FRRG motif, indicating the presence of two phosphoinositide binding sites, which
was an unexpected finding. Using ITC measurements I then confirmed the binding sto-
ichiometry of two phosphoinositides to one Hsv2 molecule and determined the binding
affinities of PROPPINs to both PI3P and PI(3,5)P2 incorporated in small unilamellar
vesicles. Phosphoinositide binding of S. cerevisiae Hsv2 is pH dependent. Acidic envi-
ronment increases and basic environment decreases the affinity. In addition, I showed
the involvement of loop 6CD in membrane binding. Mutagenesis analysis of loop 6CD
residues revealed that membrane insertion is dependent on both ionic and hydrophobic
interactions.
Two ubiquitin-like conjugation systems modifying Atg8 (in mammals MAP1LC3)
and Atg12 are essential for autophagy. Homologs of the canonical ubiquitin conjugation
system, E1- and E2-like enzymes, are involved in the conjugation of Atg8 and Atg12 to
their specific targets phosphatidylethanolamine and Atg5, respectively.
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XIV
A in vivo reconstitution system for the two human ubiquitin-like conjugation sys-
tems Atg12 and MAP1LC3 was established using the MultiBac baculovirus expression
system in insect cells. This allowed full length expression of the involved proteins and
purification of the Atg5-Atg12 conjugate and lipidated MAP1LC3 in small yields.
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1.1 Definition of autophagy
Metabolism is a widely studied field in the life sciences and of special interest because
all chemical reactions described under metabolism are important for life. Metabolism
is divided into two parts namely catabolism and anabolism. Anabolism includes all
pathways that use energy to build up components of the cell e.g. proteins, lipids and
storage substances. In contrast, catabolism generates energy through breakdown of cell
compounds.
One important pathway to degrade cell components and to restore energy is au-
tophagy (in greek ’self eating’). Autophagy is activated under nutrient starvation con-
ditions or other stresses and serves as adaptation of the cell to new circumstances.
Proteins, cytosolic material and even whole cell organelles are degraded through au-
tophagy. During autophagy a growing isolation membrane (or phagophore) engulfs
cytoplasmic content. The growing double layered membrane then fuses at its edges
and forms an autophagosome. Finally, the autophagosomes fuse with the lysosome (in
yeast: vacuole) and its content is degraded (see fig. 1.1) [1, 2].
This eukaryotic conserved pathway was discovered in 1950’s [3] and the term au-
tophagy was manifested by Christian De Duve, 1963. Yeast genetic screens in the 1990’s
led to the identification of the proteins involved in autophagy [4, 5, 6, 7]. Up to now 36
autophagy related (Atg) proteins have been described [8].
1.2 Types of autophagy
Different autophagic subtypes exist. Macroautophagy is a bulk degradation path-
way, which delivers cytoplasmic content to the lysosome/vacuole [1, 2, 9]. Also or-
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Figure 1.1: Scheme for autophagosome formation
During autophagosome formation a growing isolation membrane engulfs cytoplasmic content for degra-
dation. The formed autophagosome fuses finally with the lysosome, where its content gets hydrolyzed
in these so called autolysosomes. Different cargo like mitochondria, bacteria, etc. can be degraded in
autophagy.
ganelles can be degraded by macroautophagy. Specific autophagic subtypes where or-
ganelles are targeted for degradation are mitophagy [10], ribophagy [11] and pexophagy
[12]. Another non selective autophagy subtype is microautophagy. Through protrusion,
septation or incorporation of the membrane at the surface of the lysosome or vacuole,
cytoplasmic content is taken up and degraded [9, 13].
The cytoplasm to vacuole targeting (Cvt) pathway is highly selective and a biosyn-
thetic pathway. It delivers precursors of aminopeptidase I and α-mannosidase to the
vacuole where they are processed and activated. This process is restricted to yeast and
involves Atg19 as receptor for aminopeptidase I and α-mannosidase precursors [1, 14].
Chaperone mediated autophagy (CMA) has only been described in higher eukary-
otes. The target molecules carrying a KFERQ motif is bound by a chaperone complex
of Hsc70, Hsp90 and other co-chaperons in the cytoplasm. The protein is unfolded
followed by direct delivery across the lysosomal membrane via the Lamp2A receptor
[9, 15].
Autophagy plays also a role in defense against invading pathogens, which is then
called xenophagy [16].
Most of the proteins of the core autophagy machinery are shared in these autophagic
subtypes, but selective adapter proteins are employed to mediate cargo specificity [17].
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Initiation of macroautophagy (hereafter autophagy) is mediated by the Tor (target
of rapamycin) kinase. During nutrient starvation Tor is inhibited and Atg13 is dephos-
phorylated. Dephosphorylation of Atg13 allows it to bind Atg1. The Atg1 complex
(mammalian ULK1 complex) including Atg1, Atg11, Atg13, Atg17, Atg29 and Atg31
recruits downstream complexes to the PAS (pre-autophagosomal structure) [18]. One of
the first complexes recruited is the class III PI3 kinase complex I Vps34 which generates
phosphoinositol-3-phosphate (PI3P) at the PAS. This complex includes Vps34, Vps15,
Vps30/Atg6 and Atg14 [19, 20].
PI3P is important as a signaling factor in autophagy and functions as an anchor for
other proteins and protein complexes such as PROPPINs (β-propeller proteins that bind
phosphoinositides). One of the three yeast PROPPIN homologs Atg18 forms a complex
with Atg2 and is involved in the cycling of the only autophagic transmembrane protein
Atg9 [21].
Two ubiquitin-like conjugation systems are involved in autophagy, namely Atg8
and Atg12 [22, 23]. Atg8 is the ubiquitin-like protein, which gets conjugated to its
target phosphatidylethanolamine through action of the E1- and E2-like proteins Atg3
and Atg7, repectively. Atg7 is shared with the second conjugation system, where the
ubiquitin-like protein Atg12 is conjugated to Atg5. The involved E1-like enzyme is
Atg10. Atg5-Atg12 interacts via Atg5 with Atg16, which causes oligomerization of
the whole complex. These two ubiquitin-like conjugation systems are important for
membrane expansion (for review [1, 2]).
1.4 Structural characterization of autophagy proteins
Among the first determined structures of autophagy proteins were the two ubiquitin-
like proteins Atg12 and MAP1LC3 (LC3, in yeast: Atg8) (see table 1.1). During the
last years many other autophagy-related protein structures and structure improvements
were published. More than 60 determined structures including homologs from different
species can be found in the PDB (see suppl. table 5.1) .
Among the determined structures all the proteins part of the ubiquitin-like conju-
gation systems have been determined in the last years. Even some protein complexes
using truncated proteins were described. However, full length protein complexes of the
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conjugation systems are missing. In 2012, the first structure of a PROPPIN, namely
Hsv2, was published by us and others [24, 25, 26].
Up to now a range of structures of the autophagic core machinery proteins are
still missing. The determination of protein structures has become a growing field in
autophagy. It is important to understand the interplay of these molecules on a molecular
level which brings new insights into the understanding of the whole autophagy process.
Table 1.1: Structures of autophagy proteins in PDB
Protein Organism PDB entry Structure type Reference
MAP1A/1B
LC3 (4-120)
R. norvegicus 1UGM X-ray, 2.05 Å Sugawara et al., Genes Cell (2004) [27]
Atg4B H. sapiens 2CY7 X-ray, 1.90 Å Sugawara et al., JBC (2005) [28]
Atg3 S. cerevisiae 2DYT X-ray, 2.5 Å Yamada et al., JBC (2007) [29]
Atg7 (1-613) S. cerevisiae 3VH2 X-ray, 3.30 Å Noda et al., Mol Cell (2011) [30]
Atg12 (10-93) A. thaliana 1WZ3 X-ray, 1.80 Å Suzuki et al.,Autophagy (2005) [31]
Atg5 Kluyveromyces
marxianus
3VQI X-ray, 2.50 Å Yamaguchi et al., Structure (2012) [32]
Atg16 S. cerevisiae 3A7P X-ray, 2.80 Å Fujioka et al., JBC (2009) [33]
Atg10 Kluyveromyces
marxianus









H. sapiens 4DDP X-ray, 1.55 Å Huang et al., Cell Res (2012) [35]
Vps34 D. melanogaster 2X6H X-ray, 2.90 Å Miller et al., Science (2010) [36]
Hsv2 Kluyveromyces lac-
tis
4AV9 X-ray, 3.00 Å Krick et al., PNAS (2012) [24]
4EXV X-ray, 3.00 Å Baskaran et al., Mol Cell (2012) [25]
1.5 Involvement of autophagy in disease
Autophagy most likely evolved out of two reasons. First, to regain nutrients by
degradation of macromolecules and second to guard the cell against toxic or invading
components similar to a checkpoint of quality control. Therefore, impaired autophagy is
linked to diseases such as neurodegenerative diseases, Crohn‘s disease, type II diabetes,
cancer, heart disease and others. Autophagy is also linked to longevity and involved in
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cellular defense against pathogens [37, 38, 39, 40]. Neurodegenerative diseases such as
Parkinson, Alzheimer and Huntington’s disease are caused by accumulation of protein
aggregates in the cell, which are usually degraded via the autophagy pathway.
Deciphering the role of autophagy in disease is still at an early stage. Understanding
autophagy on a molecular level might provide novel targets to fight against diseases.

2 Materials & Methods
2.1 Materials
2.1.1 Chemicals
For this study I used reagent grade chemicals from the following companies: Fluka
(Buchs, Switzerland), Merck (Darmstadt, Germany), Sigma-Aldrich (Steinheim/Seelze,
Germany), Roth (Karlsruhe, Germany), Serva (Heidelberg, Germany), Roche (Basel,
Switzerland). Chemicals used were of analytical purity and chemicals for crystallization




complete EDTA-free, Protease inhibitor tablet Roche
IPTG




Gibco Sf900 III SFM (1x), Liquid Invitrogen
Gibco Express Five SFM (1x), Liquid Invitrogen
L-glutamine 100x Invitrogen
TMB substrate solution (3,3’,5,5’ - tetramethylbenzi-
dine)
Thermo Fisher Scientific
ADDit - Additive Screen Emerald BioSystems
pHat Buffer Block Hampton Research
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Enzymes were ordered from the companies stated in table 2.2. Enzymes were used









99 mg of Trombin was prepared in 7.5 ml Tris/EDTA buffer (10 mM Tris pH 7.4, 1
mM EDTA) and mixed with 7.5 ml glycerol.
2.1.3 Lipids
Lipids were ordered from the companies stated in table 2.3. Most lipids were shipped




Lipid Concentration Order No. Company
PC: L-α-phosphatidylcholine from egg, chicken 10/25 mg/ml 840051C/P Avanti Polar Lipids, Inc.
PE: L-α-phosphatidylethanolamine from brain,
porcine
25 mg/ml 840022P Avanti Polar Lipids, Inc.
PS: L-α-phosphatidylserine from brain, porcine 25 mg/ml 840032P Avanti Polar Lipids, Inc.
18:1 PI(3)P: 1,2-dioleoyl-sn-glycero-3-phospho-
(1’-myo-inositol-3’-phosphate)
1 mg/ml 850150P Avanti Polar Lipids, Inc.
PI(4)P: L-α-phosphatidylinositol-4-phosphate
ammonium salt from brain, porcine
1 mg/ml 840045P Avanti Polar Lipids, Inc.
18:1 PI(5)P: 1,2-dioleoyl-sn-glycero-3-phospho-
(1’-myo-inositol-5’-phosphate) ammonium salt
















1 mg/ml 850156P Avanti Polar Lipids, Inc.
TR-PE: 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt





All kits used in this study are summarized in table 2.4. All kits were used with the
supplied buffers following the manufacturers recommendation.
Table 2.4: Kits used in this study
Kit Company
Phusion High-Fidelity PCR Kit NEB
Gateway pENTR/D-TOPO cloning Invitrogen
Gateway LR Clonase enzyme mix, and re-
action buffer
Invitrogen
CloneJET PCR Cloning Kit Fermentas
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Kit Company
NucleoSpin Plasmid kit Macherey & Nagel
NucleoSpin Extract II kit Macherey & Nagel
NucleoBond PC100 Macherey & Nagel
NucleoBond Xtra Macherey & Nagel
QuickChange II Site-Directed Mutagene-
sis kit
Agilent Technologies (Stratagene)
QuickChange Ligthning Site-Directed Mu-
tagenesis kit
Agilent Technologies (Stratagene)
Western Lightening Plus-ECL Perkin Elmer
GST Spin Trap GE Healthcare
Proti-Ace Hampton Research
Proti-Ace II Hampton Research
Gel filtration molecular weight markers
(12,400 - 200,000)
Sigma
Ni-NTA Membrane Protein Kit Qiagen
2.1.5 Columns for chromatography
All columns listed below in table 2.5 where used in combination with an Äkta
Purifier FPLC system (RT) or with the Äkta Prime FPLC (4 ◦C). The manufacturers
recommendations were followed for handling of the columns, including storage, cleaning
and equilibration.
Table 2.5: Chromatography columns
Column Company
5 ml HiTrap SP FF column GE Healthcare
5 ml HiTrap Q FF column GE Healthcare
1 ml/5 ml His-Trap FF column GE Healthcare
5 ml Strep-Trap column GE Healthcare
5 ml GSTrap column GE Healthcare
Superdex 200 10/300 GL GE Healthcare
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Column Company
HiLoad 16/60 Superdex 200 prep grade GE Healthcare
HiLoad 16/60 Superdex 75 prep grade GE Healthcare
2.1.6 Antibodies




Ms mAb to GST Abcam
Hsv2 (CGEPTRWELVRESWREL) gift from Prof. M. Thumm
Hexa-Histidine tag (DIA900) Dianova
murine Strep-tag II IBA GmbH
Ubiquitin antibody [10C2-2] Abcam
Penta His HRP conjugate Qiagen GmbH
StrepMAB-Classic HRP conjugate IBA GmbH
goat polyclonal mouse IgG (HRP labeled) BioRad Laboratories GmbH
goat polyclonal rabbit IgG (HRP labeled) BioRad Laboratories GmbH
2.1.7 Buffers and media
Luria Bertani (LB) media and plates
10 g/l (w/v) tryptone, 5 g/l (w/v) yeast extract, 10 g/l (w/v) NaCl
for plates: 18 g/l (w/v) Agar were added
TYE low salt plates
15 g/l (w/v) Agar, 10 g/l (w/v) tryptone, 5 g/l (w/v) yeast extract
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SOB/SOC-media
2 % tryptone, 0.5 % yeast extract, 10 mM NaCl, 2.5 mM KCl,
after autoclaving 10 mM MgCl2, 10 mM Mg2SO4 were added
SOC: + 20 mM glucose
ZYM-5052 media (Autoinducible media) [41]
950 ml ZY (10 g/l (w/v) N-Z-Amine AS (Sigma) and 5 g/l (w/v) yeast extract-B
(QBIOgene))
20 ml 50x5052 (250 g/l (w/v) glycerol, 25 g/l (w/v) glucose, 100 g/l (w/v) α-lactose
monohydrate, 730 ml H2O)
20 ml 50xM (222.5 g/l (w/v) Na2HPO4 x 2 H2O, 170 g/l (w/v) KH2PO4, 134 g/l (w/v)
NH4Cl, 35.5 g/l (w/v) Na2SO4, 800 ml H2O)
1 ml 2 M MgSO4
200 µl 1000x trace metals mixture (50 mM Fe, 20 mM Ca, 10 mM Mn, 10 mM Zn, 2
mM Co, 2 mM Cu, 2 mM Ni, 2 mM Mo, 2 mM Se, 2 mM B; further details in [41])
Terrific broth (TB) media
12 g/l (w/v) tryptone, 24 g/l (w/v) yeast extract, 0.4 % (v/v) glycerol, 2.31 g/l (w/v)
KH2PO4, 12.54 g/l (w/v) K2HPO4
Minimal media with selenomethionine
1 l culture consists of:
200 ml 5x M9 stock solution (15 g/l (w/v) KH2PO4, 5 g/l (w/v) NH4Cl, 2.5 g/l (w/v)
NaCl)
800 ml autoclaved water
1 ml of 1 M MgSO4 (autoclaved)
20 ml 20 % glucose (w/v) (sterile filtered)
100 µl of 0.5 % (w/v) thiamine vitamin (sterile filtered)
1 ml of 4.2 g/l (w/v) FeIISO4 (sterile filtered)
For inoculation an over night culture was harvested and spun down at low speed and
washed with in M9 media to remove all full media components. The culture in minimal
media was grown until an OD of 0.3 at 600 nm. At this point solid amino acids were
added:
100 mg/l (w/v) L-Lysine
100 mg/l (w/v) L-Phenylalanine
100 mg/l (w/v) L-Threonine
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50 mg/l (w/v) L-Isoleucine
50 mg/l (w/v) L-Leucine
50 mg/l (w/v) L-Valine
50 mg/l (w/v) L-Selenomethionine
About 15 min after amino acid addition the expression was started with 1 mM IPTG.
This protocol was adopted from [42].
1x PBS
150 mM NaCl, 20 mM Na2PO4 pH 7.4
for PBS-T add 0.1 % (v/v) Tween 20
1x TBS
50 mM Tris, 150 mM NaCl, pH 7.5
for TBS-T add 0.1 % (v/v) Tween 20
2.1.8 Antibiotics
The following antibiotics were prepared as 1000x stock solutions. Ampicillin, gen-
tamycin and kanamycin were prepared in deionized water, tetracyclin powder was re-
suspended in 70 % ethanol. All solutions were filter sterilized and stored at -20 ◦C.
Ampicillin (100 µg/ml (w/v))
Gentamycin (7 µg/ml (w/v))
Kanamycin (30 µg/ml (w/v))
Streptomycin sulfate salt (2 % (w/v))
Tetracycline (10 µg/ml (w/v))
2.1.9 Insect cell lines and bacterial strains
Sf9 insect cells (Invitrogen) - virus generation
Sf21 insect cells (Invitrogen) - virus generation
High5 insect cells (Invitrogen) - expression cell line
E. coli DH10MultiBac (Imre Berger) - generation of bacmid with genes of interest
E. coli BW23474 - cloning strain for plasmids with R6Kγ origin
E. coli DH5α - standard cloning strain
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E. coli XL1-blue - standard cloning strain
E. coli BL21(DE3) - expression strain
E. coli Rosetta(DE3) - expression strain
2.1.10 DNA constructs
In the following table 2.7 all plasmids are stated, which were used in this study.
Table 2.7: DNA constructs generated and used in this study
Vector Gene Affinity Cleavage Cloning Resistance Source
tag sites sites
pFL AmpR, GentaR I. Berger
pFL MAP1LC3 10x His TEV XmaI/NheI AmpR, GentaR R. Busse
pFL MAP1LC3/hatg3/hatg7 10x His TEV Cre/loxP AmpR, GentaR R. Busse
pFL hatg5 StrepII TEV XmaI/NheI AmpR, GentaR R. Busse
pFL hatg5/hatg12 10x His TEV BamH I/SalI AmpR, GentaR R. Busse
pFL hatg5/hatg12/hatg10/hatg7 10x His, StrepII TEV Cre/loxP AmpR, GentaR R. Busse
pFL-His 6x His TEV AmpR, GentaR K. dos Santos
pFL-His Scatg18 6x His TEV EcoRI/HindIII AmpR, GentaR R. Busse
pFL-His Scatg18/Schsv2 StrepII TEV XmaI/XhoI AmpR, GentaR R. Busse
pFL-His Scatg21 6x His TEV SalI/HindIII AmpR, GentaR R. Busse
pFL-His Scatg21/Schsv2 StrepII TEV XmaI/XhoI AmpR, GentaR R. Busse
pFL-His Scatg21/Scatg8 StrepII TEV XmaI/NcoI AmpR, GentaR R. Busse
pFL-His Scatg21/Scatg8 StrepII XmaI/NcoI AmpR, GentaR R. Busse
pFL-His hatg16 6x His TEV EcoRI/SalI AmpR, GentaR R. Busse
pFL-Strep StrepII TEV AmpR, GentaR K. dos Santos
pFL-Strep Scatg18 6x StrepII TEV EcoRI/HindIII AmpR, GentaR R. Busse
pFL-Strep Scatg21 6x StrepII TEV SalI/HindIII AmpR, GentaR R. Busse
pFL-Strep hatg16 6x StrepII TEV EcoRI/SalI AmpR, GentaR R. Busse
pUCDM CmR I. Berger
pUCDM hatg3 BamH I/SalI CmR R. Busse
pUCDM hatg3/hatg7 XmaI/NheI CmR M. Druminski
pUCDM hatg10 BamH I/SalI CmR R. Busse
pUCDM hatg10/hatg7 XmaI/NheI CmR M. Druminski
pENTR attL1/attL2 KanR Invitrogen
pENTR Scatg18 10x His TEV attL1/attL2 KanR R. Busse
pENTR Scatg21 10x His TEV attL1/attL2 KanR R. Busse
pDEST8 attR1/attR2 AmpR, GentaR Invitrogen
pDEST8 Scatg18 10x His TEV attR1/attR2 AmpR, GentaR R. Busse
pDEST8 Scatg21 10x His TEV attR1/attR2 AmpR, GentaR R. Busse
pETDuet-1 6x His, S-Tag AmpR Novagen
pETDuet-1 SpHsv2/SpAtg18 StrepII TEV AmpR R. Busse
pETDuet-1 SpAtg18/SpAtg21 StrepII TEV AmpR R. Busse
pETDuet-1 SpHsv2/SpAtg21 StrepII TEV AmpR R. Busse
pET-28a 6x His, T7 KanR Novagen
pET-28a Spatg18 6x His NdeI/XhoI KanR R. Busse
pET-28a Spatg21 6x His NdeI/XhoI KanR R. Busse
pET-28a Paatg18 6x His NdeI/XhoI KanR R. Busse
pET-28a Ceatg18 6x His NdeI/XhoI KanR R. Busse
pET-28a Dmatg18 6x His NdeI/XhoI KanR R. Busse
pET-28a Paatg21 6x His NdeI/XhoI KanR R. Busse
pET-28a Klatg21 6x His NdeI/XhoI KanR R. Busse
pET-28a Klhsv2 6x His NdeI/XhoI KanR K. Kühnel
pET-28a Klhsv2 GS linker 6x His NdeI/XhoI KanR K. Kühnel
pET-28a Klhsv2 272A/273A 6x His NdeI/XhoI KanR K. Kühnel
pET-28a Klhsv2 K260E/R261D/H262D 6x His NdeI/XhoI KanR R. Busse
pET-28a Klhsv2 loop chimera 6x His NdeI/XhoI KanR R. Busse
pET-28a Schsv2 loop chimera 6x His NdeI/XhoI KanR R. Busse
pACE AmpR I. Berger
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Vector Gene Affinity Cleavage Cloning Resistance Source
tag sites sites
pACE-His AmpR A. Scacioc
pACE-His Klhsv2 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2 FTTG 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2 K260E/R261D/H262D 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2 Y272D/F273D 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2 Y272D 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2 F273D 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2 loop chimera 10x His NdeI/XhoI AmpR R. Busse
pACE-His Schsv2 loop chimera 10x His NdeI/XhoI AmpR R. Busse
pACE-His Paatg18 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klatg21 10x His NdeI/XhoI AmpR R. Busse
pACE-His Klhsv2/Klatg8 10x His, OneSTrEP Cre/loxP AmpR R. Busse
pACE-His Klatg21/Klatg8 10x His, OneSTrEP Cre/loxP AmpR R. Busse
pACE-His Paatg18/Paatg8 10x His, OneSTrEP Cre/loxP AmpR R. Busse
pDK CmR I. Berger
pDK Klatg8 OneSTrEP NdeI/XhoI CmR R. Busse
pDK Paatg8 OneSTrEP NdeI/XhoI CmR R. Busse
pGEX-4T3 Schsv2 GST Thrombin AmpR R. Krick
pGEX-4T3 Schsv2 FTTG GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 FAAG GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 R123A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 H223A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 S243A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 T247A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 R250A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 E262A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 R264A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 R265A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 K290A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 T292A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 H294A GST Thrombin AmpR R. Busse
pGEX-4T3 Schsv2 K269A GST Thrombin AmpR R. Busse
2.1.11 Oligonucleotides
Oligonucleotides were ordered from Sigma-Genosys and purchased through Sigma
Aldrich Chemie GmbH (Steinheim, Germany). Mutagenesis primer were designed with
the software QuickChange primer design from Agilent Technologies
(https://www.genomics.agilent.com). All oligonucleotides used in this study are listed
in table 2.8.
Table 2.8: Oligonucleotides ordered especially for this study





Kozak, 10x His tag,
TEV cleavage site
52 ◦C forward primer to
amplify ScAtg18 for
pENTR/pDEST8 cloning





Kozak, 10x His tag,
TEV cleavage site
52 ◦C forward primer to
amplify ScAtg21 for
pENTR/pDEST8 cloning
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Name Sequence 5’-3’ Properties Tm Aim




60 ◦C generation of hatg7 iso-





62 ◦C generation of hatg7 iso-
form 1, include 27 missing
aa, bp 38-81
RB7 GTGGCCTTATGGCTATGTCTCCT 60 ◦C sequencing primer for
Scatg18, aligns at position
450 bp, fwd
RB8 GATAGCCAGTACTTGGCGGTTAC 60 ◦C sequencing primer for
Scatg18, aligns at position
900 bp, fwd
RB9 CTATTTGTGAAATAGTTTTCCCACAT 58 ◦C sequencing primer for
Scatg21, aligns at position
450 bp, fwd
RB10 TGTTTAGCAGTAAGTCACGATGGTA 60 ◦C sequencing primer for






XmaI, 10x His tag,
TEV cleavage site
59 ◦C fwd primer to amplify
MAP1LC3
RB12 tataaGCTAGCTCAGCCGAAGGTTTCCTGGGAG NheI, C-terminal Gly,
stop codon
60 ◦C reverse primer for RB11




NheI, stop codon 60 ◦C rev primer for RB13
RB15 tataaGGATCCATGCAGAATGTGATTAATACT
GTGAAGGGAAAG









BamHI, 10x His tag,
TEV cleavage site
60 ◦C fwd primer to amplify
hatg12











NheI, stop codon 61 ◦C rev primer for RB19
RB21 tataaGGATCCATGGAAGAAGATGAGTTCATT
GGAGAAAAAACATTC




SalI, stop codon 60 ◦C rev primer for RB21
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Name Sequence 5’-3’ Properties Tm Aim
RB30 ttatGAATTCATGTCTGATTCATCACCTACTAT
CAACTTTATTAATTTCAAT




HindIII, stop codon 60 ◦C rev primer for RB30
RB33 ataaAAGCTTTTATGTAAATTTATTATTTT
TAGTCAGCACACATTCACCAG





61 ◦C generation of full length
hatg16, include missing N-




61 ◦C generation of full length
hatg16, include missing N-
terminus, fwd primer 2
RB41 TCAGTACTGTGCCCACAGCACAGC 61 ◦C rev primer for RB39 and
RB40
RB42 ACTCTCGCAGCCTGCTGGAGG 60 ◦C sequencing primer for
hAtg16, anneals at posi-
tion 801-821 bp
RB43 GCATTACTGCCAGATAGGGAACCCTT 60 ◦C rev sequencing primer for



















60 ◦C fwd primer to amplify
Sphsv2











XhoI, stop codon 60 ◦C rev primer for RB67
RB69 CCATTAAAGACGTGTTTTTATCTgcGATTC
ATATTGTGGTAGTCCTGG












78.52 ◦C mutagenesis primer,
Schsv2 H223A
RB73 CACCATGGTAGCAACATGTgCCGTCCAGGG 78.9 ◦C mutagenesis primer,
Schsv2 S243A
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Name Sequence 5’-3’ Properties Tm Aim








































































78.08 ◦C mutagenesis primer,
Schsv2 K269A












78.31 ◦C mutagenesis primer,
Schsv2 FAAG
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Name Sequence 5’-3’ Properties Tm Aim
RB97 CCTTGTCCACCCCTgcTGCAAATTCTTTGA
TTAAAGTACCGTT











61 ◦C rev primer for RB98, sec-





60 ◦C rev primer for RB98, first
















60 ◦C fwd primer to amplify




XhoI 60 ◦C rev primer for RB104 and
RB105




XhoI 60 ◦C rev primer for RB109
RB117 ACGGAGTACTGGTCCGTGAATTTGCTGCTG
GACTGGACCG






































78.97 ◦C mutagenesis primer for
Klhsv2 Y272D
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Name Sequence 5’-3’ Properties Tm Aim
RB127 GTGCTGAAAGATTGGATCAACATCAAATAT
GACCAAAGTGAATGGAGC




78.65 ◦C mutagenesis primer for
Klhsv2 F273D








Standard methods were used for molecular cloning. PCR’s were done with the
Phusion High-Fidelity PCR kit and the provided manual was followed. Elongation
time was adjusted to template length (30 sec per 1 kb). Furthermore the annealing
temperature was chosen according to the melting temperature of the primers (see table
2.9).







water 36.5 µl 1 - initial denaturation 95 ◦C, 30 sec
5x HF or GC buffer 10 µl 2 - denaturation 95 ◦C, 30 sec
10 mM dNTP 1 µl 3 - annealing 55− 60 ◦C, 30 sec
10 µM Pfwd 0.5 µl 4 - elongation 72 ◦C, 30 sec/kb
10 µM Prev 0.5 µl jump to step 2 for 30 cycles
template DNA 1 µl (10 ng) 5 - final extension 72 ◦C, 10 min
Phusion DNA
polymerase
0.5 µl 6 - hold 4 ◦C, ∞
PCR products where extracted from 1 % (w/v) agarose gels using the NucleoSpin
Extract II kit. Agarose gel check of Bacmids prior transfection was done on 0.8 %
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(w/v) agarose gels. Before loading, samples for agarose gels were supplemented with
reasonable amounts of 6x loading dye (0.25 % (w/v) bromphenol blue, 0.25 % (w/v)
xylene cyano, 30 % (v/v) glycerol in H2O). TBE (10x: 108 g/l (w/v) Tris, 55 g/l (w/v)
boric acid, 40 ml/l (v/v) of a 5.5 M EDTA stock) or TAE (50x: 242 g/l (w/v) Tris,
57,1 ml/l (v/v) glacial acetic acid, 100 ml/l (v/v) of a 0.5 M EDTA stock) buffer was
used for agarose gel electrophoresis.
In a next step, restriction digestion was carried out with restriction enzymes from
NEB. PCR products were usually resuspended in a total of 50 µl. To this 5 µl buffer
(0.5 µl BSA) and 1 µl of each enzyme were added. For control digestions after cloning
a reaction of 30 µl volume were set up containing 5 µl purified plasmid, 3 µl buffer, 1
µl of each enzyme, 0.3 µl BSA, if required, and 25 µl water.
T4 DNA ligase was used for ligation reactions. For this purpose, usually 50 ng of
vector was used. Amount of insert was calculated in a way that insert was available in
a three times molar excess. A final volume of 20 µl was set up with 2 µl 10x buffer and
1 µl T4 DNA ligase. The reaction was incubated for 30 min at RT.
Mutagenesis of ScHsv2 was done using the QuickChange II site-directed mutage-
nesis kit and for KlHsv2 the QuickChange Ligthning site-directed mutagenesis kit was
used. The PCR mix contained 5 µl 10x reaction buffer, 2 µl of 10 ng/µl dsDNA tem-
plate, 1 µl oligonucleotide primer 1 (125 ng), 1 µl oligonucleotide primer 2 (125 ng), 1
µl dNTP mix, 40 µl H2O and 1 µl PfuUltra HF DNA polymerase (2.5 U/µl). The PCR
reaction was run with the following program 95 ◦C for 30 sec as initial denaturation
step, then 16 cycles of 95 ◦C for 30 sec, 55 ◦C for 1 min and 68 ◦C for 6 min and 30 sec
(1 min/kb) was done. The temperature was held at 16 ◦C. Afterwards, template DNA
was degraded by DpnI-treatment. Finally the PCR product was transformed with E.
coli XL1-blue supercompetent cells.
Recombination was used for insect cell vectors like pFL and pUCDM as well as
ACEMBL vectors (pACE, pDK) contain a loxP site. Here, a total of 2 µg per vector was
mixed with 1 µl Cre recombinase and 2 µl of its supplied buffer. The total volume
of these reactions were 20 µl and they were incubated for 2 hours at 37 ◦C.
Heat shock transformation was done with 100 µl chemocompetent E. coli XL1-
blue or DH5α cells. They were incubated with plasmid for 20 min on ice, then heat
shock was done at 42 ◦C for 1 min. Cells were incubated for a few minutes on ice again,
before 900 µl of pre-warmed LB or SOC media was added and the culture was incubated
at 37 ◦C for 1 hour. After this the culture was centrifuged for 3 min at 7,000 rpm and
plated on LB plates with the appropriate antibiotics. Heat competent E. coli cells were
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prepared according to Hanahan [43] and high efficiency electro competent E. coli DH10
MultiBac were prepared following the protocol from Dower [44].
Plasmid preparation was done using the NucleoSpin Plasmid kit. Afterwards a
control restriction digestion or colony-PCR was performed. For colony-PCR a PCR
reaction as described in table 2.9 was pipetted and then a colony was touched with a
pipette tip and swirled in the PCR reaction.
2.2.2 Methods for insect cell culture
2.2.2.1 Insect cell culture
Insect cells were cultured in a room kept at a constant temperature of 27 ◦C since
insect cells are highly sensitive to temperature changes. These cells can be cultured as
suspension culture in autoclaved glass flasks with screw cap or as adherent culture in
6-well plates. When the insect cells are cultivated in flasks their densities should be
kept at 1x 106 cells/ml.
For this study Spodoptera frugiperda (Sf21 and Sf9) cells were used to generate virus
(virus generation v0) through transfection with bacmid (2.2.2.3) and to increase virus
titer (virus generations v1 and v2). These cells were cultivated in Sf900 media. Tri-
choplusia ni (High5) cells were used for protein expression and cultured in ExpressFive
media supplemented with 20 mM final concentration of glutamine.
Media containing the budded virus can be stored in sterile plastic bottles for a few
weeks at 4 ◦C. For insect cell culture no antibiotics are used therefore special care and
sterile handling is necessary and all work was done in a sterile hood.
2.2.2.2 Bacmid extraction from E. coli DH10
In order to prepare bacmid for transfection of insect cells, 7 ml LB media supple-
mented with kanamycin, tetracyclin and gentamycin were inoculated with E. coli DH10
MultiBac and incubated over night. Cells were harvested by spinning the culture at
4,500 rpm for 10 min at 4 ◦C. Pellet was resuspended in 250 µl buffer A1 from Nucle-
ospin plasmid kit. 250 µl buffer A2 were added and the tubes inverted for mixing. After
adding 300 µl buffer A3 tubes were inverted again and centrifuged at 4,500 rpm for 10
min at 4 ◦C. Supernatant is transferred into a new 2 ml tube and spun again at 13,000
rpm for 10 min at 4 ◦C. For precipitation of the bacmid the supernatant is again trans-
ferred into a new 2 ml test tube, 800 µl 2-propanol are added to the supernatant and
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mixed very well by inverting. Precipitated bacmid is pelleted through centrifugation at
13,000 rpm for 30 min at 4 ◦C. Pellet is washed twice with 1 ml of 70 % ethanol. Dry
the pellet with open lid at room temperature. The dried pellet is resuspended in 20 µl
sterile MilliQ water. The bacmid can be stored at 4 ◦C for a few days [45].
2.2.2.3 Transfection of insect cells
Cells were plated into a 6-well plate at a concentration of 0.25 x 106 cells per ml in
a total of 3 ml and kept for 30 min until cells settled. In the mean time, 18 µl bacmid
was mixed with 200 µl Sf900 media through gentle bubble generation with pipette (no
up and down pipetting). In an additional test tube 20 µl Fugene was mixed in the same
way with 200 µl media. Both test tubes were incubated for 5 min at RT (here: RT =
27 ◦C). Afterwards Fugene-mix was added to the bacmid-mix by slowly releasing the
mix starting at the bottom and go up in circles with the pipette. Additional bubbles
can be created for mixing. After 1 hour 200 µl of this mix can be added per well to the
insect cells. Usually as control one well was not transfected and in a second well only
media was plated as contamination control.
2.2.2.4 Pull down of infected insect cells
A pull down of infected insect cells was routinely performed after transfection of
insect cells, when the first virus generation (v0) was harvested. This method was used
as first to test the expression level of the protein and its solubility.
Therefore adherent insect cells were washed with PBS and resuspended in 0.5 ml
PBS per well. Supernatant of wells with same conditions were pooled to increase pro-
tein amounts. Then cells were lyzed using a Branson Sonifier 450 sonicator with an
amplitude of 20 % for some seconds. From this whole cell extract 50 µl were taken for
SDS-PAGE analysis. Whole cell extract was centrifuged for 3 min at full speed and
from the supernatant another 50 µl were taken for analysis.
In order to perform the pull down 20 µl Ni-NTA beads are taken and washed with
water and buffer (spin 1 - 2 min, 2,000 rpm). Afterwards the supernatant is put on
the beads and incubated for 30 min at 4 ◦C. Unbound protein in the supernatant is
removed by spinning at low speed.
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The samples with whole cell extract, supernatant and bead fraction are supple-
mented with 25 µl 3x sample buffer, heated for 3 min at 95 ◦C and analyzed on SDS-
PAGE (2.2.6.1).
The same procedure applies for streptactin beads.
2.2.2.5 Measuring YFP in infected insect cells
YFP is encoded by the bacmid and is therefore expressed at the same time as protein
necessary for virus budding. Comparable to YFP expression is the expression of the
gene of interest, since both are regulated by a late stage virus expression promoter.
Therefore YFP levels are a direct indicator for virus gene expression and is generally
measured from infected High5 insect cells in order to determine the maximum protein
level.
Supernatant from 1 x 106 insect cells was prepared in the same way as described
in 2.2.2.4. From this a dilution series of 200 µl undiluted supernatant, 1:5 dilution and
1:25 dilution was prepared in a black flat bottom 96-well plate (Greiner). As a control
200 µl PBS was used. Fluorescence was measured with a Victor 3V (Perkin Elmer) at
495 nm excitation and 520 nm emission wavelength.
2.2.3 Purification protocols of protein complexes from insect cells
2.2.3.1 MAP1LC3
Human MAP1LC3 (1-120) was expressed together with full length human Atg3 and
Atg7 in insect cells. Sf21 and Sf9 cells were used for virus generation, High5 insect cells
were infected for large scale expression of 1 l culture divided into 5 flasks.
Best purification results were achieved for LC3 purification, when freshly harvested
High5 insect cells were used, harvested 48 hours after day of proliferation arrest (DPA).
Cells were harvested by centrifugation at 1,000 rpm for 20 min, 4 ◦C and resuspended
in buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 30 mM imidazole). Cell lysis was
induced using a Branson Sonifier 450 sonicator with an amplitude of 20 % for 30 sec,
followed by addition of 1 mM final concentration of MgCl2, a protease inhibitor pill,
lysozyme, DNaseI and 2 % Triton X-100. The sample was incubated for 20 min on a
head-over rotator, 4 ◦C and then spun in a Sigma centrifuge at 4,000 rpm, 30 min, 4 ◦C.
In the mean time Ni2+-sepharose beads were prepared by washing two times with
water and equilibration twice with buffer. Beads were only spun at low speed (2,000
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rpm, 1 min). 1 ml Ni2+-sepharose beads were added to the supernatant and incubated
for 2 hours, rotating at 4 ◦C. 5 ml resuspension buffer was used for washing the beads
and this step was four times repeated. For elution of the protein the same buffer with
500 mM imidazole was used. Four times 1 ml elution buffer was subjected onto the
beads. Elution fractions were snap frozen and stored at -80 ◦C.
The purification efficiency was analyzed by SDS-PAGE of whole cell extract, super-
natant, pellet, flow through, washing steps and elution fractions.
2.2.3.2 Atg5-Atg12
Full length Atg5, Atg12, Atg7 and Atg10 from human were co-expressed using the
MultiBac baculovirus system. Sf9 and Sf21 insect cells were used for virus production.
High5 insect cells were infected for large scale protein expression. Usually a 1 l culture
was grown subdivided into five 2 l flasks.
Atg5-Atg12 conjugate was purified from freshly harvested High5 insect cells, 48
hours after DPA. After centrifugation of these cells at 1,000 rpm for 20 min, 4 ◦C,
the pellet was resuspended in buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 30
mM imidazole). Insect cells were lyzed using a Branson Sonifier 450 sonicator with
an amplitude of 20 % for 30 sec. Then one tablet of protease inhibitors, 1 mM final
concentration of MgCl2, lysozyme and DNaseI as well as 2 % Triton X-100 were added.
The cell suspension was incubated for 20 min, 4 ◦C in a head-over rotating wheel. Then
soluble and insoluble fractions were divided by centrifugation in a Sigma centrifuge at
4,000 rpm, 30 min, 4 ◦C.
The obtained supernatant was incubated with 1 ml Ni2+-sepharose beads for 2 hours
on a rotator, 4 ◦C. Preparation of Ni2+-sepharose beads was done by washing first twice
with water and then twice with buffer. In between beads were spun at 2,000 rpm for 1
min. After the incubation time the bead-supernatant suspension was spun at 2,000 rpm,
for 2 min, 4 ◦C. Thereafter beads were washed four times with 5 ml buffer, followed by
protein elution in buffer supplemented with 500 mM imidazole. Five times 1 ml elution
buffer was added. Afterwards elution fractions were snap frozen in liquid nitrogen and
stored at -80 ◦C.
Samples taken during the purification process were analyzed by SDS-PAGE.
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2.2.3.3 Increase of solubility of Atg5-Atg12 using a detergent screen
A Ni-NTA membrane protein kit (Qiagen) containing seven different detergents was
employed to test if higher amounts of soluble protein can be obtained. This kit com-
prises the detergents octyl-b-D-glucopyranoside (DG), n-dodecyl-β-D-maltopyranoside
(DM), N, N-Dimethyldodecylamine-N-oxide (lauryldimethylamine-N-oxide, LDAO), n-
dodecyl-β-D-maltoside (DDM), Cymal 6 (Cy6), n-Nonyl-β-D-glucopyranoside (NG) and
FOS-choline-16 (FOS).
High5 insect cells expressing Atg5-Atg12 were prepared by resuspension of the cells
in TS-buffer provided in the kit and and incubated on ice for 30 min with DNaseI. Cell
extract was divided into seven 200 µl aliquots and spun (Fresco centrifuge, maximum
speed, 1 hour, 4 ◦C) to obtain the insoluble membrane fraction (pellet). The obtained
pellet was resuspended in the provided NTI-10-G-buffer (volumes can be taken from
table 2.10) and detergent was added. The samples were incubated in an end-over-end
shaker for 1 hour at RT. Afterwards 10 µl samples were taken for immunoblotting.
Another sample was taken after centrifugation for 1 hour, full speed, at 4 ◦C in a fresco
centrifuge.
Samples of cell extract and supernatant were analyzed by SDS-PAGE and Western
blotting.
Table 2.10: Buffer and detergent stock solution volumes for screening
Detergent Vol. Buffer
NTI-10-G
Vol. detergent Final detergent
concentration
OG 457 µl 43 µl 51 mM
DM 430 µl 70 µl 21 mM
LDAO 432 µl 68 µl 30 mM
DDM 421 µl 79 µl 20 mM
Cy6 424 µl 76 µl 20 mM
NG 441 µl 59 µl 33 mM
FOS 421 µl 79 µl 1.3 mM
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2.2.4 Purification protocols for PROPPINs
2.2.4.1 Batch purification for test expression
For this purpose, 2 ml of expression culture were spun in a centrifuge for 2 min at
13,000 rpm. The pellet was resuspended in buffer (50 mM NaH2PO4 pH 7.5, 300 mM
NaCl, 30 mM imidazole). Then cells were lyzed using a sonicator at low intensity for a
few seconds. Afterwards soluble and insoluble fractions were separated by centrifugation
for 10 min at 13,000 rpm. The supernatant was transferred into a new Eppendorf tube.
20 µl beads per sample were prepared by spinning at low speed (2,000 rpm, 1 min).
Then beads were washed with water and equilibrated with buffer. Supernatant was
added to beads and incubated for 30 min on a rotating wheel at 4 ◦C. Afterwards beads
were washed two times with buffer. Finally 20 µl of 3x sample buffer were added and
heated for 3 min at 95 ◦C. SDS-PAGE was performed with cell extract, supernatant,
pellet and bead fraction.
2.2.4.2 Purification protocol for ScAtg18
Synthetic genes for ScAtg18 and ScAtg21 were ordered from Mr. Gene GmbH
and codon usage was optimized for insect cell expression. As transfer vector for bacmid
integration pFL was used. Virus was generated using Sf21 insect cells, protein expression
and purification was done using High5 insect cells. After infection of High5 cells it took
48 hours for optimal protein expression (see also 4.2.1.1). At this time point High5
insect cells were harvested.
After harvesting through spinning of the cell suspension at 1,000 rpm for 20 min,
4 ◦C, the pellet is resuspended in 80 ml buffer A (see table 2.11). One protease inhibitor
tablet, 1 mM final concentration of MgCl2 and DNaseI was added to the resuspended
cells. Cells were opened by sonication with a Biorupter for 3 times 5 min at a duration
of 30 sec ultrasound and 30 sec pause. After sonication 1 % final concentration of Triton
X-100 was added and everything incubated stirring for 25 min, at 4 ◦C. Cell extract was
spun for 1 hour at 14,000 rpm, 4 ◦C in a Du Pont Sorvall centrifuge with a SS-34 rotor.
Phytic acid powder at a final concentration of 2 mM was added to the supernatant.
In the same time 4 ml Ni2+-sepharose beads were prepared by washing once with
water and twice with buffer A for equilibration. Beads were spun at 2,000 rpm for 1 min
at RT. Supernatant was incubated with beads for 2 hours at 4 ◦C, rotating. Then beads
were separated from unbound solution by spinning in a Sigma centrifuge for 10 min,
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2,000 rpm at 4 ◦C. Using 3 times 30 ml buffer A the beads were washed, incubated for
10 min at 4 ◦C, rotating in between and then spun in the centrifuge. Next, beads were
resuspended with 5 ml buffer A and put in a membrane column. For elution 3 times
5 ml buffer B (see table 2.11) were applied onto the beads and carefully resuspended.
After beads settled again, the column was opened for buffer B to run through. Fractions
were checked with SDS-PAGE.
Table 2.11: Buffers for purification of ScAtg18 from insect cells
His-Trap purification gel filtration
Buffer A Buffer B
50 mM NaH2PO4 50 mM 50 mM NaH2PO4
500 mM NaCl 500 mM NaCl 500 mM NaCl
30 mM imidazole 500 mM imidazole
pH 8.5 pH 8.5 pH 8.5
Buffers used for protein purification were filtered and degased.
Elution fractions 1 to 3 were pooled and diluted in gel filtration buffer to decrease
the imidazole concentration. Then batch purified protein was loaded on an 1 ml His-
Trap FF column (GE Healthcare) for further purification. Protein was loaded with a 50
ml Superloop and then the column was washed with buffer A for 10 CV before protein
was eluted with an imidazole gradient over 10 CV to a final concentration of 100 % B.
Column was run at 1 ml/min.
After another SDS-PAGE check fractions containing the protein were pooled and
concentrated to 500 µl final volume. The sample was loaded on a Superdex 200 10/300
GL (GE Healthcare) column. Size exclusion chromatography was done at 0.5 ml/min
and 500 µl fractions were collected. Afterwards SDS-PAGE check was performed.
His-tagged ScHsv2 was concentrated with a Vivaspin 2, 30,000 MWCO (Sartorius)
concentrator to a final concentration of 5 mg/ml and directly subjected to crystallization
screens.
2.2.4.3 Purification of PaAtg18, DmAtg18, CeAtg18, KlAtg21 and PaAtg21
DmAtg18 was ordered from the Drosophila Genomics Resource Center (No. CG7986)
and cloned into pET-28a vector. The other proteins were ordered from GeneArt (In-
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vitrogen) as synthetic genes and the codon sequence was optimized for expression in
bacteria. The genes were cloned into pET-28a vector for expression with a 6x His-tag.
Additionally PaAtg18, PaAtg21 and KlAtg21 were cloned into pACE-His vector for
later co-expression experiments with PaAtg8 and KlAtg8 [46].
For each construct 9 l autoinducible media were inoculated from a LB over night
culture and incubated for 3 hours at 37 ◦C. Afterwards the temperature was shifted to
22 ◦C for 20 to 24 hours. The culture was harvested using the JS-4.2 rotor in a Beckman
J6-MI centrifuge for 20 min at 4,000 rpm at 4 ◦C. Resuspension of the cell pellet was
done in 150 ml buffer A (see table 2.12) on a horizontal shaker. After this 1 mM final
concentration MgCl2, a protease inhibitor tablet, DNaseI and lysozyme were added.
The cell suspension was incubated with a stir bar on a magnetic-stirrer device. Then
sonication with a Branson Sonifier 450 sonicator using a duty cycle of 70, the output
control set to the microtip limit which yielded an output of 20 - 30 % for 5 cycles of
30 sec sonication and 30 sec break on ice was performed. Or a microfluidizer M-110L
(Microfluidics Corporation) was used with 3 repetitions. Afterwards 1 % Triton X-100
was added to DmAtg18 and CeAtg18 cell lysate. Lyzed cells were incubated stirring for
another 10 min and then spun at 14,000 rpm for 1 h at 4 ◦C in a SS-34 rotor in a Du
Pont Survall centrifuge to remove cell debris.
Cleared cell lysate was subjected to a 5 ml His-Trap FF column (GE Healthcare)
with 1 ml/min. Loading the supernatant was done with a 150 ml Superloop (GE
Healthcare), then the column was washed with buffer A for 20 CV with 2 ml/min,
followed by an elution gradient over 20 CV with 1 ml/min from buffer A to buffer B.
A final elution step with 5 CV buffer B was applied. Elution fractions were checked
with SDS-PAGE and purified protein containing fractions were pooled. Over night the
protein was dialyzed with gel filtration buffer (see table 2.12). The purified protein
sample was concentrated to a final volume of 5 ml with Vivaspin 20, 30,000 MWCO
(Sartorius) concentrators.
In addition to the affinity purification of this proteins size exclusion chromatography
was done. For this a HiLoad 16/60 Superdex 200 prep grade or HiLoad 16/60 Superdex
75 prep grade was employed connected to an Äkta Prime or Äkta Purifier FPLC system.
Here dialyzed protein was loaded with a 5 ml loop and the gel filtration run was done
for 1.1 CV at 1 ml/min. After 0.3 CV the fraction collector was started and 2 ml
fractions were collected. Fractions containing protein indicated by UV280 detection
were checked with SDS-PAGE. Fractions containing the protein of interest were pooled
and concentrated to a concentration of approximately 30 mg/ml, then aliquoted, snap
frozen in liquid nitrogen and stored at -80 ◦C.
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Table 2.12: Buffers for purification of PaAtg18, DmAtg18, CeAtg18, KlAtg21 and PaAtg21
PROPPIN His-Trap purification gel filtration
Buffer A Buffer B
PaAtg18 30 mM Hepes 30 mM Hepes 30 mM Na-lactate
300 mM NaCl 300 mM NaCl 300 mM NaCl
30 mM imidazole 500 mM imidazole 1 mM DTT
pH 7.0 pH 7.0 pH 4.0
DmAtg18 30 mM MES 30 mM MES 30 mM Na-lactate
300 mM NaCl 300 mM NaCl 300 mM NaCl
30 mM imidazole 500 mM imidazole 1 mM DTT
pH 5.8 pH 5.8 pH 5.2
CeAtg18 30 mM Tris 30 mM Tris 30 CHES
300 mM NaCl 300 mM NaCl 300 mM NaCl
30 mM imidazole 500 mM imidazole 1 mM DTT
pH 8.0 pH 8.0 pH 8.0
KlAtg21 30 mM MES 30 mM MES 30 mM MES
300 mM NaCl 300 mM NaCl 300 mM NaCl
30 mM imidazole 500 mM imidazole 1 mM DTT
pH 5.8 pH 5.8 pH 5.8
PaAtg21 30 mM MES 30 mM MES 30 mM MES
300 mM NaCl 300 mM NaCl 300 mM NaCl
30 mM imidazole 500 mM imidazole 1 mM DTT
pH 5.8 pH 5.8 pH 5.8
Buffers used for protein purification were filtered and degased.
2.2.4.4 Purification protocol for SpHsv2
SpHsv2 was expressed with an N-terminal 6x His-tag from the pET-28a expression
vector in E. coli BL21(DE3). 9 l culture of LB media with kanamycin was inoculated
1:100 with an over night pre-culture. The culture was incubated at 37 ◦C, shaking until
it reached an OD of 0.6. At this time point 1 mM final concentration of IPTG was added
to induce expression of Sphsv2 from the vector. IPTG is a molecular mimic of allolactose
and activates the lac-UV promoter of T7-RNA polymerase which then activates the T7
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promoter present in pET-28a vector. When IPTG was added temperature was shifted
to 25 ◦C and the culture was incubated over night.
After approximately 20 hours the culture was harvested using the JS-4.2 rotor in a
Beckman J6-MI centrifuge for 20 min at 4,000 rpm, 4 ◦C. The pellet was resuspended
in 90 ml buffer A (see table 2.13). Then 1 mM final concentration of MgCl2, DNaseI
powder, lysozyme powder and a protease inhibitor tablet were added and mixed on a
stirring device for 15 min. Cells were lyzed using the Branson Sonifier 450 with the same
settings as above mentioned for 5 times 30 sec sonication and 30 sec break in between.
The lysate was kept on ice during sonication. Further incubation of the lysate provided
time for DNaseI and lysozyme activity. Finally, cell debris and soluble protein fraction
were separated during centrifugation using the SS-34 rotor.
Table 2.13: Buffers for purification of SpHsv2 from E. coli BL21(DE3) cells
His-Trap purification gel filtration
Buffer A Buffer B
50 mM NaH2PO4 50 mM NaH2PO4 30 mM Citric acid
500 mM NaCl 500 mM NaCl 500 mM NaCl
30 mM imidazole 500 mM imidazole
pH 7.5 pH 7.5 pH 5.5
Buffers used for protein purification were filtered and degased.
In a next step, supernatant was applied to a 5 ml His-Trap FF column (GE Health-
care) using a 150 ml Superloop. After loading the column was washed with buffer A
for 20 CV to remove unspecific bound protein. Then a gradient of imidazole for elution
was run over the column using buffer A and B (see table 2.13). A final elution step of 5
CV 100 % buffer B was applied to remove all remaining protein from the column. All
steps were done at a flow rate of 1 ml/min.
The protein was then dialyzed over night into gel filtration buffer and concentrated
(Vivaspin 20, cut off 30,000 MW; Sartorius) to a final volume of 5 ml. Either of the
two HiLoad Superdex 200 or 75 prep grade columns were used and run at 1 ml/min for
1.1 CV, 0.3 CV without fraction collection and 0.8 CV with collection of 2 ml fractions.
Fractions containing protein were pooled and concentrated to 30 mg/ml, then aliquoted,
snap frozen in liquid nitrogen and stored at -80 ◦C.
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DTT was added to the gel filtration buffer to avoid dimerization of the protein
(compare section 4.2.1.3).
2.2.4.5 Purification protocol for ScHsv2 and mutants
ScHsv2 and mutants were expressed from the pGEX-4T3 vector with an N-terminal
GST-tag and a thrombin cleavage site between the tag and ScHsv2. E. coli BL21(DE3)
carrying the respective vector was cultivated in 1.5 l autoinducible media and inoculated
with 10 ml from an over night LB pre-culture. The culture was incubated for 3 hours
at 37 ◦C and then shifted for 20 to 24 hours to 22 ◦C. Harvesting was done for 20 min
at 4,000 rpm at 4 ◦C using the JS-4.2 rotor in a Beckman J6-MI centrifuge.
Pellets were resuspended each in 15 ml buffer A (see table 2.14) by incubation on a
horizontal shaker for 20 min. Afterwards DNaseI, lysozyme, a protease inhibitor tablet
and MgCl2 at a final concentration of 1 mM were added and everything incubated
stirring for 15 min. Then a Branson Sonifier 450 sonicator using a duty cycle of 70 and
the output control set to the microtip limit which yielded an output of 20 - 30 % was
used for cell opening, while cells were kept on ice during sonication. Or a microfluidizer
M-110L (Microfluidics Corporation) was used with 3 repetitions. The lyzed cells were
incubated on a stirrer for 10 min. Following this the cell lysate was spun in a centrifuge
(Du Pont Sorvall) with a SS-34 rotor for 1 hour, 14,000 rpm, at 4 ◦C.
Table 2.14: Buffers for purification of ScHsv2 from E. coli BL21(DE3) cells
GSTrap purification gel filtration
Buffer A Buffer B
30 mM Hepes 30 mM Hepes 30 mM Hepes
300 mM NaCl 300 mM NaCl 300 mM NaCl
20 mM Glutathione
pH 7.0 pH 7.0 pH 7.0
Buffers used for protein purification were filtered and degased.
Using a 50 ml Superloop (GE Healthcare) the supernatant was applied to a 5 ml
GSTrap FF column (GE Healthcare) connected to the Äkta Prime FPLC system or
Äkta Purifier FPLC system. After loading the supernatant with 2 ml/min, the column
was washed with 20 CV buffer A and then bound protein was eluted with 5 CV buffer
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B containing glutathione (see table 2.14) with 2 ml/min. Elution fractions containing
the protein were collected and pooled.
Over night the affinity purified protein was dialyzed with buffer A and 200 µl throm-
bin (1 U/µl) were added for cleavage of the GST-tag. On the next day thrombin activity
was blocked by adding Pefabloc (0.4 mM final concentration), the protein was loaded
on the GSTrap column and flow through was collected, which contained the cleaved
protein. Uncleaved protein and free GST bound to the column. Flowthrough fractions
were pooled and concentrated to a final volume of 5 ml (Vivaspin 20, cut off 30,000
MW; Sartorius).
An additional purification step was implemented. Here, size exclusion chromatogra-
phy (HiLoad 16/60 Superdex S200 or S75 prep grade) was used to improve purity. For
this, the same buffer as buffer A was used at 1 ml/min. After each purification step the
protein fractions were checked with SDS-PAGE. Finally purified protein fractions were
pooled, aliquoted and snap frozen in liquid nitrogen. The purified protein was stored
at -80 ◦C.
2.2.4.6 GST SpinTrap purification of ScHsv2 and mutants
GST SpinTrap purification was performed for wild type ScHsv2 and ScHsv2 mutants
in order to obtain freshly purified protein for PIPstrip analyses.
20 ml cultures of E. coli BL21(DE3) carrying the respective plasmids were grown
in 50 ml autoinducable media. Cultures were incubated 3 hours at 37 ◦C and then for
another 20 hours at 22 ◦C. From each culture 12 ml were harvested in a Sigma centrifuge
at 4,000 rpm, 10 min, 4 ◦C. Then the pellet was resuspended in 2 ml Hepes buffer (20
mM Hepes pH 7.0, 300 mM NaCl). Since the same buffer was used for several cultures
at a time it was supplemented with a protease inhibitor tablet, 1 mM MgCl2, DNaseI
and lysozyme before resuspension. After 10 min incubation cells were sonicated using
a Branson Sonifier 450 sonicator with a duty cycle of 70, the output control set to the
microtip limit which yielded an output of 20 - 30 % for one cycle of 30 sec sonication
on ice. After another 10 min incubation on ice cells were spun in a Du Pont Sorvall
centrifuge with a SS-34 rotor for 30 min at 14,000 rpm, 4 ◦C.
In the mean time GST SpinTrap columns were prepared by first shaking the column
to resuspend the resin. Then the column was opened at the bottom and spun to remove
the storage liquid (1500 rpm, 30 sec). Afterwards the top cap was removed and the
column equilibrated with 600 µl Hepes buffer. Column was spun at 1,500 rpm for 30
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sec. Then in three steps of 600 µl supernatant was subjected onto the column and
spun in between. Two washing steps were performed with 600 µl Hepes buffer. Bound
protein was then eluted in two steps with Hepes buffer containing 20 mM glutathione.
Elution fractions were pooled for each protein and 5 µl thrombin was added. The
purified protein was transferred into a Slide-A-Lyzer G2 Dialysis Cassette 3.5K MWCO
(Pierce Protein Biology Products; Thermo Fischer Scientific) for dialysis with Hepes
buffer over night at 4 ◦C.
Next day a second GST SpinTrap purification was performed for each protein to
remove uncleaved protein and free GST. Thrombin activity was blocked by adding 5 µl
Pefabloc.
2.2.4.7 Purification protocol for KlHsv2 and mutants
The pET-28a or pACE-His expression vector was used for expression of KlHsv2 and
mutants in E. coli BL21(DE3) (see table of plasmids 2.7). Particularly, KlHsv2loopchimera
construct and KlHsv2EDD mutant could only be purified, when expressed from pET-28a
vector. pACE is lacking the lacI gene in its vector, the repressor of IPTG/allolactose
activated promoters. The expression of the gene in the molecular cloning site is therefore
active in low amounts all the time from this vector.
10 ml over night culture in LB was used to inoculate 1.5 l of autoinducible media.
The culture was incubated, shaking for 3 hours at 37 ◦C and then shifted to 22 ◦C for
20 hours. To harvest the culture it was spun in a Beckman J6-MI centrifuge with the
JS-4.2 rotor, for 20 min, 4,000 rpm and at 4 ◦C. Resuspension of the pellet was done
with 15 ml buffer A (see table 2.15). Next, a protease inhibitor tablet was added, as
well as DNaseI, lysozyme and MgCl2 to a final concentration of 1 mM. The mixture was
incubated with a magnetic stir bar on an electric device for 10 min. Afterwards cells were
opened with a microfluidizer M-110L (Microfluidics Corporation) with 3 repetitions.
During sonication the cell lysate was kept on ice. Another incubation for 10 min on
a stirring device followed before soluble and insoluble cell components were separated
while spinning in a Du Pont Sorvall centrifuge with a SS-34 rotor for 1 hour at 14,000
rpm, 4 ◦C.
The clear lysate was then loaded onto an 1 ml His-Trap FF column (GE Healthcare)
applying 1 ml/min on the column in all steps. When supernatant has passed the column
it was washed with 20 CV buffer A. After this an imidazole gradient was created on the
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column from 0 % to 100 % buffer B for elution (see table 2.15). A final elution step of
5 CV buffer B was applied.
Table 2.15: Buffers for purification of KlHsv2 from E. coli BL21(DE3) cells
His-Trap purification gel filtration
Buffer A Buffer B
30 mM Hepes 30 mM Hepes 30 mM Hepes
300 mM NaCl 300 mM NaCl 300 mM NaCl
30 mM imidazole 300 mM imidazole
pH 7.0 pH 7.0 pH 7.0
Buffers used for protein purification were filtered and degased.
After SDS-PAGE for checking elution fractions, fractions containing the protein
were pooled and concentrated to a final volume of 5 ml. Then the affinity purified
protein was loaded on a HiLoad 16/60 Superdex column with a flow rate of 1 ml/min.
The first 0.3 CV representing the void volume of the column were run without fraction
collection followed by 0.8 CV with collecting 2 ml fractions. An additional SDS-PAGE
check was done to check purity. Fractions with pure protein were pooled, aliquoted and
snap frozen in liquid nitrogen. The purified protein was stored at -80 ◦C.
2.2.5 Purification protocol for PaAtg8 and KlAtg8
Synthetic genes of PaAtg8 and KlAtg8 were ordered from Gene Art (Invitrogen).
The codon usage was optimized for bacterial expression and a C-terminal OneSTrEP-
tag was added to the gene. The genes were cloned into the pACE expression vector and
expressed in E. coli BL21(DE3). E. coli cells containing the plasmid were grown in 3
l autoinducible media for 3 hours at 37 ◦C and then shifted for additional 20 hours to
22 ◦C. The cells were harvested in a Beckman J6-MI centrifuge with the JS-4.2 rotor, for
20 min, 4,000 rpm and at 4 ◦C. The cell pellet was resuspended in 30 mM Hepes pH 7.0
and 300 mM NaCl. After addition of a protease inhibitor tablet, 1 mM MgCl2, DNaseI
and lysozyme the cells were incubated for 10 min stirring and then a microfluidizer
M-110L (Microfluidics Corporation) was used for lysis with 3 repetitions. Another
incubation of 10 min was performed followed by centrifugation with a SS-34 rotor in a
Du Pont Sorvall centrifuge for 1 hour at 14,000 rpm, 4 ◦C. The obtained supernatant
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was loaded to a 5 ml Strep-Trap column (GE Healthcare). Loading and washing of the
column was done with the Hepes buffer, for elution 2.5 mM desthiobiotin was added to
the Hepes buffer. Washing was done for 10 CV, elution for 3 CV. Samples were taken
from cell extract, supernatant, pellet, flow through and peak fractions and analyzed
with SDS-PAGE. The protein containing peak fractions were pooled, concentrated and
subjected to a Superdex S75 gel filtration column using Hepes buffer. With SDS gels
protein purity was confirmed. The peak fractions were pooled, concentrated if necessary,
aliquoted, snap frozen in liquid nitrogen and stored at -80 ◦C.
2.2.6 Biochemical methods
2.2.6.1 SDS-PAGE and Western Blotting
Denaturing protein gels for SDS-PAGE were done using an adapted protocol from
Laemmli [47]. The gels generally consist of resolving and separation parts. Samples
were mixed with 3x SDS sample buffer (9 g SDS, 30 g glycerol, 0.02 g bromphenol blue,
18.75 ml of 1 M Tris pH 6.8, 90 ml water; for use mix: 9 parts of premix and 1 part
beta-mercaptothanol (end concentration 3.3 %)) and heated for 3 to 5 min at 95 ◦C. A
10x protein running buffer (2 l: 60.6 g Tris, 285.2 g Glycine, 20 g SDS, pH 8.4) was
diluted to 1x concentration and gels were applied to a current of 120 V until the blue
protein running front completely run through.
For Coomassie staining the SDS gel is placed in a microwave container, overlaid
with staining solution A (500 mg Coomassie R, 650 ml H2O, 250 ml 2-propanol, 100
ml acetic acid) and heated for one minute at maximum temperature in the microwave.
Afterwards the staining solution was drained and the procedure was repeated with
solution B (50 mg Coomassie R, 800 ml H2O, 100 ml 2-propanol, 100 ml acetic acid),
solution C (20 mg Coomassie R, 900 ml H2O, 100 ml acetic acid) and with destaining
solution D (900 ml H2O, 100 ml acetic acid). If necessary solution D was replaced again
for further destaining.
In another Coomassie staining method applied in this study gels were stained in
Coomassie Brilliant Blue solution (0.1 % (w/v) Coomassie R250 Brilliant Blue, 10 %
(v/v) acetic acid, 40 % (v/v) ethanol) for 20 - 30 min and then left in destaining solution
(10 % (v/v) acetic acid, 40 % (v/v) ethanol) until bands became visible.
Analysis of SDS gels by Western blotting [48, 49] was performed by blotting the
gel on either Immobilon-FL Transfer PVDF membrane (Millipore) (generally used for
protein-lipid co-flotation assays, section 2.2.6.6) or nitrocellulose (Whatman, Schleicher
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& Schüll). The blotting was performed on a semi-dry apparatus. For this purpose,
the gel, Whatman paper (Whatman) and nitrocellulose membrane were preincubated
in transfer buffer (2.9 g/l (w/v) Glycine, 5.8 g/l (w/v) Tris, 0.37 g/l (w/v) SDS, 20 %
(v/v) Methanol). When a PVDF membrane was used it was first incubated in methanol
for approx. 15 - 20 sec and then put into transfer buffer. The transfer was performed at
45 mA per gel for nitrocellulose membranes in the apparatus for 45 min and for PVDF
membranes at 25 V for 90 - 120 min at RT. After blotting the membrane was blocked
in blocking solution (PBS-T or TBS-T supplemented with 1 % (w/v) milk powder) for
30 min. Next, the membrane was incubated with a primary antibody for 1 hour at RT
or over night at 4 ◦C. When an antibody labeled with HRP was used incubation time
was 1 hour. Unbound antibody was washed off in three repeated steps with PBS-T
or TBS-T. Subsequently a secondary antibody was added on the membrane for 1 hour
at RT. Washing the membrane was repeated before detection using the ECL solution
(Perkin Elmer) with a Imageready LAS-1000 CCD camera (Fujifilm). Visualization and
editing of the images was performed with the AIDA software (Fujifilm).
2.2.6.2 Protein stability assay
Thermofluor experiments were performed to test protein stability after the first
purification of a protein [50]. The influence of buffers on protein stability were tested.
A first run of Thermofluor experiment was done after affinity purification of the protein.
The found optimal buffer conditions were used to run the size exclusion column.
In order to perform this assay, purified protein was diluted to 3 - 10 µM in affinitiy
purification buffer without imidazole. 16 µl of protein were pipetted per well in a white
96-well plate (Biozym Scientific GmbH) leaving out the last four rows of column 12 for
controls. Column 12, row E+F were filled with 18 µl buffer and row G+H with 18 µl
water. In addition, 2 µl of buffer from the pHat screen (Hampton Research) were added
to the protein in columns 1 - 11. On top, 2 µl of 50x diluted Sypro Orange (5000x stock
solution, Invitrogen) were added to all wells. The plate was closed with transparent
caps (Biozym Scientific GmbH) and then spun at 1,000 rpm, for 1 min, at 4 ◦C.
For the thermal shift and read out of Sypro Orange fluorescence a CFX96 Real-Time
System (C1000 Thermal Cycler, BioRad) was used. Here the plate was heated starting
from 25 ◦C up to 95 ◦C. At the beginning of the thermal shift protein is folded and
Sypro Orange in aqueous environment is quenched. Therefore the measured fluores-
cence signal is low. While temperature is increasing the protein unfolds and presents
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hydrophobic patches, which Sypro Orange binds and becomes dequenched. Sypro Or-
ange fluorescence increases until it reaches a plateau. The melting temperature Tm of
a protein is defined as half way of the linear increase of the Sypro Orange fluorescence.
A second thermofluor run using the ADDit screen (Emerald BioSystems) was carried
out after gel filtration. In the same way as described for the pHat screen.
Analysis of Thermofluor experiments were done using the DSF analysis sheet, ver-
sion 2.5 (available from: ftp://ftp.sgc.ox.ac.uk/pub/biophysics). Before, data of the
HEX channel were exported from the Real-Time System to an excel-sheet. After in-
cluding the data into the DSF analysis sheet a special Excel-file containing macros
(minNormMacro.xlsm) was run.
2.2.6.3 Circular dichroism spectroscopy
Circular dichroism spectroscopy (CD) was used to analyse the secondary structure of
a protein. In order to get good CD spectra with a low background purified protein was
dialyzed in NaF buffer (30 mM NaH2PO4 pH 7.5, 300 mM NaF), because NaF shows no
absorbance in far UV (for summary read [51]). Chloride ions and imidazole should be
avoided, since they show a high absorbance in the far UV region. Dialyzed protein was
used at a concentration of 40 µM and pipetted into a 1 mm glas cuvette. For measuring
CD spectra a Chirascan Circular Dichroism Spectrometer (Applied Photophysics) was
used and set to 20 ◦C. CD spectra were recorded from 190 nm to 260 nm with a
bandwidth of 2 nm and in 0.5 nm steps. Each time point was recorded for 3 sec and a
total of 3 repetitions were measured. First a buffer run was taken as baseline.
The minimum at 216 nm characteristic for β-strands was used to measure the melting
temperature of the protein. For this purpose, the wavelength was set to 216 nm and
a temperature shift from 20 ◦C to 90 ◦C was applied to the sample chamber. Here, 4
sec per time point were recorded, for 3 repetitions with a bandwidth of 1.5 nm. The
temperature was increased in steps of 0.5 ◦C and at a rate of 0.25 ◦C/min.
For analysis data were exported. Therefore, the three repetitions of baseline and
protein run were each averaged, baseline subtracted from the protein spectrum and
the resulting curve smoothed. CD spectra data were converted to mean residual molar
ellipticity by including concentration, molecular weight and path length. Final figures
were prepared with the software Kaleidagraph.
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2.2.6.4 Limited proteolysis
Generation of stable protein fragments for crystallization was done with limited
proteolysis [52] using the Proti-Ace kit I + II (Hampton Research). Each of these kits
provides a set of 6 commonly used proteases.
• Kit I: α-Chymotrypsin, Trypsin, Elastase, Papain, Subtilisin, Endoproteinase Glu-C
• Kit II: Proteinase K, Endoproteinase Arg-C, Pepsin, Thermolysin, Bromelain, Actinase
Proteases were prepared at a concentration of 1 mg/ml by resuspending the powder
in 100 µl deionized water. These were further diluted 1:100 with supplied dilution
buffer (10 mM Hepes pH 7.5, 500 mM NaCl). From this 10 µl were mixed with 10
µl of protein (approximately 10 mg/ml). Samples were incubated at 37 ◦C and the
reaction was stopped at defined time points by adding 3x SDS sample buffer (9 g (w/v)
SDS, 30 g (w/v) glycerol, 0.02 g (w/v) bromphenol blue, 18.75 ml of 1 M Tris pH
6.8, 90 ml water; for use mix: 9 parts of premix and 1 part beta-mercaptothanol (end
concentration 3.3 %)) and heated for 3 to 5 min at 95 ◦C. Afterwards samples were
checked with SDS-PAGE.
Identified stable fragments were analyzed by N-terminal sequencing or mass spec-
trometry.
2.2.6.5 N-terminal protein sequencing
Samples for N-terminal sequencing of the first five amino acids were sent to SeqLab
(Sequence Laboratories Göttingen GmbH). Sequencing results were used to identify the
cleavage site of stable fragments. SeqLab provides this service according to Edman’s
degradation [53]. Sample preparation was performed analog to the protocol given by
SeqLab.
This requires SDS-PAGE separation and immobilization of the fragment on a PVDF-
membrane (see caption 2.2.6.1). For transfer to the membrane a special CAPS buffer
(10 mM CAPS pH 11, 10 % (v/v) methanol) was used.
Then the membrane was washed with water, moistened in 100 % (v/v) methanol,
stained with Coomassie Brilliant Blue (0.1 % (w/v) Coomassie Blue R-250 in 1 % (v/v)
acetic acid and 40 % (v/v) methanol) and destained in 50 % (v/v) methanol. Again the
membrane was washed with water, dried and the protein band cut with a clean razor
blade.
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Finally the membrane was transfered in a polypropylen cup for shipping.
2.2.6.6 Protein-lipid co-flotation assay and liposome preparation
Flotation assays with small unilamellar vesicles (SUV) were used to study membrane
binding and lipid binding specificity of proteins.
Liposome preparation was done with lipids stated in table 2.3, which were dis-
solved in chloroform at indicated concentrations. Lipids were added in their respective
(w/w) volumes to a total of 1 mg lipids in 2 ml test tubes and dried. Addition of Texas-
Red conjugated PE served as visible marker of dried lipids and later liposomes. After
chloroform evaporation the lipids were resuspended in HP150 buffer (20 mM Hepes pH
7.4, 150 mM KCl) supplemented with 3 % cholate. Liposome formation and cholate
removal was done by size exclusion chromatorgaphy on a column of 0.7 cm in diameter
and 15 cm in length (BioRad) containing Sephadex G-50 as matrix. The purple colored
fraction was collected. Typical liposome compositions are listed in table 2.16.
Table 2.16: Liposome lipid compositions
Control 2 % PIP 1 % PIP 20 % PS 10 % PS
75 % (w/w) PC 73 % (w/w) PC 74 % (w/w) PC 55 % (w/w) PC 65 % (w/w) PC
23 % (w/w) PE 23 % (w/w) PE 23 % (w/w) PE 23 % (w/w) PE 23 % (w/w) PE
2 % (w/w) TR-
PE
2 % (w/w) TR-
PE
2 % (w/w) TR-
PE
2 % (w/w) TR-
PE
2 % (w/w) TR-
PE
2 % (w/w) PIP 1 % (w/w) PIP
20 % (w/w) PS 10 % (w/w) PS
Large unilamellar vesicles (LUV) were used for ITC measurements and prepared
with a Mini-extruder (Avanti Polar Lipids). Polycarbonate membranes with a pore
sizes of 0.4 µm and 0.1 µm were used for extrusion. Lipids were mixed and dried in
the same way as described above for SUVs. Then lipids were directly resuspended in
1 ml HP150 buffer and subjected to the Mini-extruder with a 0.4 µm membrane for
approximately 25 strokes. In a second step the membrane was exchanged with a 0.1 µm
pore size membrane and another 25 strokes were done. Hereby the lipids were pushed
through the membrane and form liposomes of a defined size with approximately 100 nm
diameter.
Protein-lipid co-flotation assays were investigated as previously described in
[54, 55]. 5 µl of 2 µM protein was incubated with 45 µl of liposomes for 10 min, RT
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in 7 x 20 mm PC tubes (Beckman). Then the protein liposome sample was gently
mixed with 50 µl of 80 % Nycodenz (w/v in HP150 buffer) and overlayed with 50
µl of 30 % Nycodenz. The gradient was covered with 30 µl HP150 buffer. Samples
were spun at 55000 rpm (275000 g) for 1.5 hours at 4 ◦C in a Sorvall Discovery M150
SE analytical ultracentrifuge (Thermo Scientific) using a S55-S swinging bucket rotor
(Thermo Scientific). Six 30 µl aliquots were taken afterwards and separated in 12 %
SDS-PAGE and analyzed by Western blotting. ScHsv2 proteins were detected with an
polyclonal rabbit antibody against ScHsv2 C-terminus. KlHsv2 and other His-tagged
proteins were detected with a Penta His HRP conjugated antibody.
Calculation of accessible PI3P and PI(3,5)P2 in liposomes for ITC analysis
was through measurement of the total phosphate concentration of the liposomes with
the phosphomolybdate method [56]. For this liposomes were diluted 1:10 with water.
20 µl of 70 % HClO and 100 µl of 7.2 M H2SO4 were added and the sample heated
at 300 ◦C for 2 hours. In this step, bound organic phosphates were released. Then the
sample was cooled to RT and formed phosphate was disolved in 1 ml H2O. Further, 100
µl molybdate solution (3 % (w/v) ammonium molybdate, 0.12 % (w/v) Triton X-100)
were added and the absorbance at 660 nm was measured exactly after 20 min after
molybdate solution was added. A calibration curve from NaH2PO4 (0.2 mM) was used
to calculate phosphate concentrations.
Liposome size distribution was determined by field-flow fractionation coupled to
multi-angle laser light scattering (FFF-MALLS) [57, 58]. In this experimental set up
50 µl 1:50 diluted liposomes were first separated by their size (Eclips 2 system, Wyatt
Technology) with a 0.1 µm filtered buffer (20 mM Hepes pH 7.4, 150 mM KCl, 0.02 %
(w/v) NaN3). Absolute size determination occured in the next step using a conventional
multi angle light scattering device (DAWN EOS) in combination with an Agilent 1100
series HPLC pump and autosampler. A channel flow of 1 ml/min was applied and
sample was injected at 0.2 ml/min. The sample was concentrated by the system with a
focus flow of 3 ml/min for 3 min. Right after concentration the liposomes were separated
with a cross flow of 0.75 ml/min which was linearly decreased to zero in a time frame
of 35 min. Detection and analysis was done with the manufacturers ASTRA software.
Fitting of the data were performed with the coated-sphere model.
Knowing the size distribution of SUVs, the total phospholipid amount, weight ratio
and molecular weight of the individual lipids as well as the number of phosphorus atoms
in each phospholipid the concentration of phosphoinositide was determined. For this,
an equal incorporation of all lipids was assumed. Further, the bilayer thickness was
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considered to be 4 nm in SUVs with an average radius of 20 nm. The outer surface of
the SUVs contain 60 % of total lipids.
2.2.6.7 Isothermal titration calorimetry
ITC measurements were done to determine binding affinities and stochiometry of
protein-protein or protein-liposome interactions. Further enthalpy and entropy of bind-
ing can be determined with this method.
The Microcal VP-ITC or ITC200 were used for measurements. The two machines
differ in their cell and syringe volume. The VP-ITC has a cell size of 1.4 ml and a syringe
volume of 300 µl, whereas the volumes for the ITC200 are much smaller, the cell holds
200 µl and the syringe 40 µl. For measurements the concentration of the component in
syringe was approximately 7 - 10 times higher than that of the interaction partner in
the sample cell.
Buffer typically used for ITC was HP150 buffer (20 mM Hepes pH 7.4, 150 mM
KCl). Otherwise the buffer composition is specified in the results section. Protein was
dialyzed to HP150 buffer using Slide-A-Lyzer G2 Dialysis Cassette 3.5K MWCO (Pierce
Protein Biology Products; Thermo Fischer Scientific). Liposomes were prepared in the
same buffer as used for dialysis of the protein.
Settings of the machine for measurements are listed in table 2.17. For fitting of the
data a single-site binding model was used and the MicroCal Origin 7.0 software was
employed for analysis.
Table 2.17: Settings for isothermal calorimeters
VP-ITC ITC200
total injections 20 20
pre-injection volume 3 µl 0.1 µl
volume of injection 15 µl 2 µl
reference power 10 µcal/sec 7 µcal/sec
temperature 25 ◦C 20 ◦C
delay 120 120 sec
spacing 250/500 sec 90 sec
stirring speed 250 rpm 300 rpm
duration time 30 sec 4sec
filter period 3 sec 2 sec
2.2 Methods 43
2.2.6.8 Protein-lipid overlay assay (PIP strip, PIP array, membrane lipid
strip)
PIP strips, PIP arrays and membrane lipid strips were ordered directly from Echelon
Biosciences Inc. or its distributor MoBiTec GmbH. These nitrocellulose membranes
are spotted with pure lipids and used for determination of protein-lipid interaction.
PIP strips are spotted with 100 pmol of all seven phosphoinositides and eight other
biological important lipids. PIP arrays are spotted with a concentration gradient of
phosphoinositol and seven phosphoinositides (per spot 100 pmol, 50 pmol, 25 pmol,
12.5 pmol, 6.25 pmol, 3.13 pmol and 1.56 pmol). Membrane lipid strips contain 15
biologically important lipids at a concentration of 100 pmol each.
In order to perform these protein-lipid overlay assays, membranes were incubated
in blocking buffer for 30 min at RT, then protein was diluted in blocking buffer and
added onto the membrane for 1 hour. Afterwards the membrane was washed 3 times
with buffer. Bound protein was detected by primary and secondary antibody diluted in
blocking buffer and incubated for 1 hour each. In between the nitrocellulose membrane
was washed 3 times in buffer. Finally the HRP-conjugated antibody was detected using
ECL solution in a Luminescence detector (also see Western blotting, section 2.2.6.1)
In order to test different conditions PBS or TBS were used as buffers and were
supplemented with different concentrations of milk, BSA, Tween 20, MgCl2 as specified
in section 4.2.2.1. Also different protein concentrations were tested, here concentrations
between 0.1 µg/ml and 1 µg/ml were used.
2.2.6.9 Cova PIP specificity plate
Cova PIP specificity plates were purchased from Echelon Biosciences Inc. and used
for quantification of protein-PIP binding. Each row of a 96-well plate is coated with
phosphoinositol or one of the seven phosphoinositides at a concentration of 20 pmols
per well.
In a first step, 100 µl of buffer with protein was incubated for one hour, while
shaking at room temperature. Afterwards, wells were washed three times with buffer.
The first antibody (anti-GST or anti-Hsv2) was incubated for one hour, shaking at room
temperature. Before the secondary antibody was added in the same way, the wells were
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washed again with buffer. The secondary antibody against GST was a goat anti-mouse
antibody, anti-Hsv2 requires a goat anti-rabbit secondary antibody. Again the wells
were washed with buffer.
Different buffers were tested to determine the best conditions. Here, PBS or TBS
were tested with and without Tween 20 and either with or without MgCl2. As blocking
reagent milk and BSA were tested at different concentrations as specified in section
4.2.2.1.
Detection was performed by adding 100 µl/well TMB (3,3’,5,5’ - tetramethylben-
zidine) substrate solution, while incubating the solution onto the secondary HRP-
conjugated antibody the solution turns blue. When a good visibility was reached
(usually after 30 min) the reaction was stopped with 100 µl of 0.16 M sulfuric acid.
The color turns yellow. Absorbance was measured at 450 nm with the TECAN Genios
Pro and its corresponding software.
2.2.6.10 Analytical gel filtration
Analytical gel filtration was used to analyze protein-protein interaction with a Su-
perdex 200 10/300 GL gel filtration column. The masses of protein complexes can be
determined from a calibration curve using molecular weight standards provided in the
Gel Filtration Molecular Weight Markers (12,400 - 200,000) kit from Sigma. This kit
contains seven proteins of known molecular weight:
• Cytochrom c (from horse heart): 12.4 kDa
• Carbonic Anhydrase (from bovine erythrocytes): 29 kDa
• Albumin, Bovine Serum: 66 kDa
• Alcohol Dehydrogenase (from yeast): 150 kDa
• β-Amylase (from sweet potato): 200 kDa
• Blue Dextran: 2,000 kDa
The size of unknown proteins is determined by comparing the ratios of Ve/Vo. Here
Ve is the elution volume of the protein from the gel filtration column and Vo is the void
volume of the column, representing the elution of high molecular weight compounds
which are too big to interact with the matrix of the column and therefore are quickly
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Figure 2.1: Standard curve for analytical gel filtration
(A) Gel filtration runs of molecular weight standards using the Superdex 200 10/300 GL detected with
UV280. (B) Half logarithmic plot of the molecular weight of protein standards versus their respective
Ve/Vo.
over the column. The logarithms of their molecular weight were plotted versus their
Ve/Vo. Connection of these points resulted in a linear curve (see fig. 2.1).
In order to determine the void volume of the analytical gel filtration Blue Dextran
was resuspended in the supplied buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl) sup-
plemented with 5 % glycerol to a concentration of 2 mg/ml. 250 µl of blue dextran was
run over the column loaded with a 0.5 ml loop at 0.5 ml/min using 50 mM Tris-HCl
pH 7.5, 100 mM NaCl as buffer. Fractions of 1 ml volume were collected, additionally
UV280 was detected during all runs. Next, cytochrom c (4 mg/ml) and β-amylase (8
mg/ml) were mixed and 250 µl were applied onto the column. Also carbonic anhydrase
(6 mg/ml) and alcohol dehydrogenase (10 mg/ml) were mixed and run together, then
250 µl albumin (10 mg/ml) was loaded. Albumin elutes in two peaks (monomer and
dimer) which can be both used for the standard curve.
Sample protein was dialyzed into the same buffer and 250 µl were applied onto the
column to calculate its Ve/Vo and using the standard curve the mass of the protein can
be determined.
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2.2.7 Crystallization and structure determination
2.2.7.1 Crystallization screen setup
First screening experiments for crystallization were set up in 96-well sitting drop
plates (MRC, Hampton Research), where two drops of different protein concentration
were pipetted for each buffer condition. The Cartesian Microsys (Cartesian Dispensing
Systems) robot was employed for setting drops. It dispensed 100 nl drops of protein
per well and then added 100 nl screening buffer (reservoir solution).
Quickly after the robot finished the plate was covered with a transparent sealing
tape to avoid drying in of the drops. Crystal plates were stored at 20 ◦C or at 4 ◦C
in an automated Formulatrix crystallization imager. This took pictures of each single
condition at programmed imaging times with the RockImager software (Formulatrix).
Images were checked with the Rockmaker main Application software (Formulatrix).
Different companies supply crystallization screens including Hampton Research (SaltRx
screen), Qiagen (AmSO4, Anions, Cations, ClassicLite, Classics I+II, Compas, JCSG+,
PACT, PEGI+II, pHclearI+II, ProComplex screens) or Emerald Biosystems (Wiz1+2,
Wiz3+4 screens).
When initial crystallization conditions were optimized 24-well Linbro hanging
drop plates (Jena Bioscience) were used. Here, screening buffers were self made and
for each well 1 ml of reservoir solution were prepared. Then each well was greased with
Bayer medium viscosity silicon grease (Jena Bioscience). 1 µl protein and 1 µl reservoir
buffer were pipetted together on a siliconized cover slip (22 mm diameter), up to 4 drops
were fitted on one slide. Afterwards the slide was flipped upside down onto the greased
well to seal it air tight.
Another way of crystallization optimization was achieved by using the Additive
or Silver bullet screens. For this the same reservoir solution was pipetted in all 96
wells. Crystal drops were pipetted as described before with the robot. As an additional
step 20 µl Additive or Silver bullet screen solution was added to 100 nl protein and 100
nl buffer drop.
A third way for optimization are 96-well plate refinement grid screens. These
screens were prepared using the Tecan robot. The robot was used to pipette new
optimized conditions from stock solutions into 1 ml 96-well master blocks. From these
96-well MRC plates for crystallization were pipetted.
Streak seeding of crystals was used for optimization of crystal growth, size, form
and diffraction. For this, a crystal was crushed with an acupuncture needle. Then the
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needle was streaked through a newly set up drop in similar buffer conditions. Crystal
fragments left in the new drop serve as seeds for crystal growth.
Molecularly imprinted polymers (MIP) can be used as nucleation sites [59] and
were added with a acupuncture needle to the freshly set up hanging drops. They were
prepared by mixing 54 mg acrylamide with 6 mg N,N+-methylenebisacrylamide in a
15 ml Falcon tube and the powder was dissolved in 1 ml water. For each MIP 90 µl
acrylamide mix were added to 10 µl of template protein (6 mg/ml) in a 1.5 ml test tube.
Then 2 µl of 10 % APS were added and the mixture degassed with nitrogen for 5 min. 2
µl of 5 % (v/v) TEMED were added and the test tubes stored at RT for polymerization
(approximately 18 hours). Afterwards the obtained gels were pressed through a 75-µm
sieve (diameter of 10 cm; Endecotts Limited). A 50 ml Falcon tube was placed under
the sieve to collect the gel pieces. Sterile water was added onto the sieve to wash down
left gel pieces. The falcon tube with gel pieces were spun at 2000 g for 3 min at RT in
a Sigma centrifuge. Thereafter, 0.5 ml of 10 % (w/v) SDS dissolved in acetic acid were
added to extract the protein from the gel pieces (SDS/acetic acid was put in the micro
wave for dissolving). Finally, the samples were spun twice in a Sigma centrifuge (2000
g, RT, 3 min) and the supernatant discarded. The MIPs were stored at 4 ◦C.
2.2.7.2 Flash cooling of crystals
Cryoprectants were used for flash cooling of crystals to prevent ice formation around
the crystal. For this cryoprotactants like ethylene glycol, xylitol, sucrose or PEG 400
were prepared with the same buffer as reservoir solution (mother liquor) in which crys-
tals grew. When crystals were fished they were first put in fresh mother liquor, then
transferred into a mixture of 1:1 mother liquor and cryoprotectant and finally in cry-
oprotectant. Crystals were fished out of the cryoprotectant and quickly flash frozen in
liquid nitrogen.

3 Project I: Reconstitution of
mammalian Atg12 and MAP1LC3
conjugation pathways
3.1 Introduction
3.1.1 Ubiquitin-like conjugation systems in autophagy
Two ubiquitin-like conjugation systems are involved in autophagy, namely Atg12
and MAP1LC3, the mammalian homolog of Atg8. These two systems are essential
for autophagosomal membrane expansion [60, 61, 62]. Like in the canonical ubiquitin
conjugation system, the ubiquitin-like (ubl) modifiers are conjugated to their targets by
E1- and E2-like enzymes (see figure 3.1).
The Atg12 conjugation system requires Atg7, Atg10 and Atg5. Atg12 is activated
at its C-terminal glycine by the E2-like enzyme Atg7 under consumption of ATP [63].
In a second step, Atg12 is transferred by the E2-like enzyme Atg10 to its final target
Atg5. Conjugation of Atg12 to Atg5 takes place at Lys130 of Atg5 [23]. Furthermore
Atg5 interacts with the N-terminus of Atg16 [64, 65], which oligomerizes and an Atg12-
Atg5˜Atg16 oligomer is formed. In contrast to yeast Atg16, the mammalian homolog
contains a WD40 repeat domain at its C-terminus in addition to the N-terminal domain
required for Atg5 binding and the coiled coil domain.
Both MAP1LC3 (LC3) and Atg12 conjugation systems share the E1-like enzyme
Atg7. However, before LC3 is activated, its C-terminal amino acid needs to be cleaved by
Atg4. Exposure of its C-terminal glycine after cleavage is essential for the conjugation to
its target phosphatidylethanolamine, which is catalyzed by Atg7 and the E2-like enzyme
Atg3 [66]. While Atg5-Atg12 conjugation is irreversible LC3 can be delipidated by
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Figure 3.1: Ubiquitin-like conjugation systems involved in autophagy.
The complexes contain two ubiquitin-like proteins namely Atg12 and Atg8 (MAP1LC3), which are
covalently linked to their targets Atg5 and PE, respectively. In both conjugation reactions E1- and
E2-like enzymes are involved. Atg7 (E1-like) is activating the ubl proteins under consumption of ATP
and then Atg3/Atg10 (E2-like) are linking the ubl protein to their targets. The Atg12-Atg5 conjugate
binds to Atg16, which mediates oligomerization of the entire Atg12-Atg5˜Atg16 complex.
cleavage of Atg4 [67]. Lipidation of LC3 renders its cytosolic localization to membrane
bound.
The C-terminal exposed glycines of both Atg12 and MAP1LC3 form thioester bonds
with the active site cysteins of the E1- and E2-like enzymes and amide bonds with its
final conjugation targets [68].
Between both conjugation systems cross talk has been reported. Atg12-Atg5˜Atg16
acts as an E3-like ligase for LC3 lipidation [69] and specifies the site of LC3 lipidation
to PE [70]. Furthermore, Atg12 can also be conjugated to Atg3 and this conjugate is in-
volved in mitophagy, mitochondrial-mediated cell death, and mitochondrial homeostasis
[71].
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3.1.2 Structure and function of Atg12
Figure 3.2: Structure of Atg12 from A. thaliana
A ribbon diagram of AtAtg12 is shown colored from N-terminus in blue to C-terminus in red. Two
molecules of AtAtg12 were found in the asymmetric unit of the crystal. Each molecule revealing a
ubiquitin-fold. PDB code: 1WZ3.
Atg12 was the first ubiquitin-like modifier identified in autophagy [23]. The structure
of Atg12 from A. thaliana was determined [31] and revealed a ubiquitin-fold region
although it shares no significant sequence homology with ubiquitin (see figure 3.4).
The asymmetric unit of the crystal contained two AtAtg12 molecules that forms an
intertwinned dimer (see figure 3.2) but it is most likely that the monomeric form of
AtAtg12 is biological relevant. The monomeric structure consists of four β-strands
enclosed by two α-helices. The C-terminus of the protein is exposed at the surface.
In complex with Atg16 Atg5-Atg12 is localized to the PAS (pre-autophagosomal
structure) and there it mediates Atg8/LC3 lipidation in an E3 ligase like manner. Re-
cently an additional function of this complex in membrane tethering was reported [72].
3.1.3 Atg8 and its human homologs
Atg8 is crucial for membrane elongation and hemifusion processes in yeast [73].
MAP1LC3B (referred to as LC3) is the most studied mammalian Atg8 homolog. Besides
LC3B seven additional homologs are present in higher eukaryotes, namely LC3A which
has two alternative splicing forms, LC3C, GABARAP, GABARAPL1, GABARAPL2
(GATE-16) and GABARAPL3. These homologs are classified in the LC3 and the
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Figure 3.3: Structure of LC3 from R. norvegicus
Ribbon diagram of rat MAP1LC3 colored from N-termius in blue to C-terminus in red. Like AtAtg12
a ubiquitin-fold was determined for LC3. PDB code: 1UGM.
GABARAP/GATE-16 subfamily [74, 75]. LC3 is localized to autophagosomal mem-
branes and recruits ubiquitinated cargo for degradation via the receptors p62 and NBR1
[76, 77]. GABARAP and GATE-16 were first described as intra-cellular trafficking fac-
tors [78, 79] and localize at autophagosomes which were induced by starvation [80].
Structures of rat LC3 (see figure 3.3) [27], GATE-16 [81], human GABARAPL1
(Structural Genomics Consortium) and yeast Atg8 [82, 83] are known. All contain the
ubiquitin-fold comprising a core of two α-helices and five β-strands and an additional
N-terminal α-helix (see figure 3.4).
3.1.4 Aims
The Atg12-Atg5˜Atg16 and Atg8-PE (MAP1LC3II) conjugation systems are re-
cruited to the phagophore and essential for autophagosome formation [60, 61]. The
complexes contain the two ubiquitin-like proteins namely Atg12 and Atg8, which are
covalently linked to their targets Atg5 and PE, respectively [23, 66]. In addition the
covalently linked Atg12-Atg5 complex interacts via Atg5 with the N-terminus of Atg16
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Figure 3.4: Ubiquitin, LC3 and Atg12 share a ubiquitin fold
In comparison (A) ubiquitin (B) murine MAP1LC3 (LC3) and (C) A. thaliana Atg12 are shown. LC3
and Atg12 show low sequence homology to ubquitin, but the structures reveal a shared ubiquitin fold.
The C-terminus necessary for conjugation is exposed at the surface.
[64, 65]. The structure of yeast Atg5 in complex with the N-terminus of Atg16 has
been described already [84]. Up to now no structure of conjugated Atg5-Atg12 is pub-
lished. However, the underlying molecular function of the ternary complex could not
be elucidated from this structure.
The aim was the generation of mg amounts of lipidated LC3 and the Atg5-Atg12
conjugate either alone or in complex with Atg16 for structural studies. For this purpose
the components of the two mammalian conjugation systems were co-expressed in insect
cells and products were analyzed by mass spectrometry.
3.2 Results
3.2.1 Setting up the insect cell system for co-expression
Expression of large mammalian complexes are very challenging since the bacterial
expression machinery is not constructed for huge proteins. So a different expression
system needs to be chosen. On average, bacterial proteins (average of 317 aa) are much
smaller than eukaryotic proteins (average of 510 aa in human) and hence the expression
machinery is limiting [85]. Therefore, the insect cell expression system was chosen.
Advantages of this system are the implementation of post-translational modifications
and proper folding is more likely compared to bacteria [86]. An expression system for
insect cells developed by I. Berger and colleagues [45] was employed. This system was
optimized for expression of complexes using novel vectors, which can be combined by
recombination and are expressed in insect cells together from a bacmid.
















































with E. coli DH10  
Expression in 
insect cells 
Figure 3.5: Cloning strategy for expression of complexes in insect cells
A set of acceptor and donor plasmids is generated for co-expression. With a Cre/loxP reaction those
plasmids are fused. The expression cassettes are enclosed by Tn7 transposition sites which are used for
integration of the cassette into the MultiBac baculovirus bacmid. Transfection and infection efficiencies
of insect cells can be observed by co-expression of YFP from the bacmid.
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The MultiBac baculovirus over-expression system used in this study consists of a
set of acceptor and donor plasmids with each comprising two multiple cloning sites (see
figure 3.5). Both plasmids share the loxP imperfect inverted repeat which was used
for Cre recombination of acceptor with the donor plasmid. In addition the multiple
cloning sites and the site for recombination of the acceptor plasmid are enclosed by
the right and left termini of the Tn7 transposition sequences. Complementary Tn7
sequences are located within the lacZ gene encoded by the bacmid. Once the final
acceptor plasmid was transformed with E. coli DH10 cells containing the MultiBac, the
plasmid integrates via the Tn7 sites into the lacZ gene, which will be interrupted and
can be used for subsequent blue-white screening of positive clones. The bacmid was
extracted from E. coli cells (see section 2.2.2.2) and used for transfection of insect cells
(see section 2.2.2.3). As a control of virus expression and therefore for the genes of
interest, YFP is co-expressed from the bacmid and can be detected with a fluorescence
microscope. In addition, YFP correlates with the expression levels of genes expressed
under late-stage viral promoters as the genes of interest are (see section 2.2.2.5). The
strong p10 and polyhedrin promoters are used for late-stage expression.
Before the genes of the human conjugation systems were cloned into the MultiBac
vectors, the canonical hAtg7 isoform 1 and full length hAtg16 needed to be generated.
Atg7 was in our lab only available as isoform 2 missing amino acids 626 to 652. In
order to get isoform 1 the missing base pairs were added with PCR. In a first PCR
step two fragments were amplified using primers RB13/RB5 and RB6/RB14 (see table
2.8), whereas primers RB5 and RB6 contain a overhang, adding the missing base pairs.
Atg7 isoform 2 was used as template. The second PCR was performed using both
obtained fragments as template, which overlap each other for 23 base pairs, and primers
RB13/RB14 (see table 2.8) were used. In a similar manner the missing 81 base pairs at
the 5’ site of hatg16 were added. Two steps of PCR were done with first RB39/RB41
as primers and then RB40/RB41 as primer pair (see table 2.8). After this all necessary
human genes for the expression of the complexes were available.
Genes required for both conjugation systems were cloned into either the pFL ac-
ceptor plasmid or pUCDM donor plasmid (see figure 3.6). Here, the E1- and E2-like
enzymes were inserted in the pUCDM donor plasmid and the ubiquitin-like modifiers
MAP1LC3 and Atg12 with its target Atg5 were cloned into the pFL acceptor plasmid.
MAP1LC3 and Atg12 were prepared in a way that they were expressed as a recombi-
nant protein carrying an N-terminal 10x His-tag and a TEV cleavage site, in addition
it was important that MAP1LC3 presents the glycine needed for conjugation to PE at
its C-terminus. Therefore the truncated form comprising residues 1-120 was used. Atg5



























Figure 3.6: Cloning strategy for expression of complexes in insect cells
Restriction digestion check of successful cloning for co-expression of the proteins involved in the conju-
gation systems. Atg5-Atg12 and LC3 were cloned into the acceptor vector pFL, which consists of two
multiple cloning sites (pFL-atg5-atg12 and pFL-LC3). The E1- and E2-like enzymes Atg7, Atg3 and
Atg10, which catalyze the reactions, were cloned into the donor vector pUCDM (pUCDM-atg7-atg3
and pUCDM-atg7-atg10). The arrow is indicating the size of 3 kb.
was expressed with an N-terminal StrepII-tag and a TEV cleavage site. Atg3, Atg10
and Atg7 were not supposed to get purified and therefore kept untagged.
Besides, two viruses were generated expressing Atg16 either with an N-terminal 6x
His-tag or a StrepII-tag both also containing a TEV cleavage site.
3.2.2 Expression and purification of modified human autophagy pro-
teins
3.2.2.1 The Atg12-Atg5 conjugate
Expression of the genes required for the Atg12-Atg5 conjugation system was done
using the MultiBac expression system for insect cells. In order to express this pro-
tein complex the proteins of interest were cloned into the acceptor vector pFL, which
consists of two multiple cloning sites (pFL-atg5/atg12). The E1- and E2-like en-
zymes Atg7 and Atg10, which catalyze the reaction, were cloned into the donor vector
pUCDM (pUCDM-atg7-atg10). Multigene transfer vectors were created by in vitro
fusion of the acceptor and the respective donor vector by using Cre recombinase (pFL-
atg5/atg12/atg7/atg10). Next, the expression cassette, which is located in-between Tn7
transposition sequences, was integrated into the MultiBac baculovirus genome.
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Extracted bacmid was then transfected into highly viable Sf21 or Sf9 insect cells,
which were routinely checked for viability, cell density and diameter with a cell counter.
60 hours after transfection the cells were checked for YFP expression under a fluo-
rescence microscope. Yellow fluorescent cells indicated transfected cells. If most cells
fluoresce medium containing the virus (V0) was harvested. Ff necessary up to 72 hours
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Figure 3.7: Expression of Atg5 and Atg12 in insect cells
Expression of YFP in High5 insect cells was monitored after day of proliferation arrest (DPA). YFP
expression correlates with expression of Atg5-Atg12. Samples taken after the indicated time were
analyzed by SDS-PAGE and Western blotting.
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Higher virus titer and more volume of virus was produced by infection of Sf9/21 cells
with (V0). From the obtained V1 generation High5 expression cells were infected and
virus for later experiments was stored. High5 insect cells were used for expression and
purification of the proteins since they are bigger in volume and therefore more protein
can be expressed. While High5 cells were infected with virus the day of proliferation
arrest (DPA) was determined by cell counting every 12 hours. When DPA was reached
intracellular YFP levels were measured regularly every 12 hours (see figure 3.7). Along
with this an expression profile of uninfected cells, DPA plus 24 hours, 36 hours and
48 hours was compiled. Here whole cell extract (CE), supernatant (S) and pellet (P)
of all time points were checked by SDS-PAGE analysis. At the point of highest YFP
expression High5 cells were harvested.
Figure 3.7 also shows detection of expressed StrepII-Atg5 and His-Atg12 after im-
munoblotting. Both proteins were detected around 100 kDa (expected size ≈ 60 kDa)
indicating the conjugated complex. Only Atg12 was observed as unconjugated form
below the 35 kDa marker band (expected size ≈ 20 kDa including the tag and TEV
cleavage site).
Atg5-Atg12 was then purified from freshly harvested High5 insect cells using Ni2+-
sepharose beads. With the protocol described in caption 2.2.3.2 the Atg5-Atg12 conju-
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Figure 3.8: Purification of Atg5-Atg12 from insect cells
Ni2+-sepharose beads were used for purification of Atg5-Atg12 from High5 insect cells. Samples taken
from different purification steps as cell extract (CE), supernatant (S), pellet (P), flow through (FT),
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Figure 3.9: Detergent test to increase Atg5-Atg12 solubility
Insoluble membrane fractions of High5 cells expressing Atg5-Atg12 conjugate were treated with
the Ni-NTA membrane protein kit containing seven different detergents namely octyl-b-D-
glucopyranoside (DG), n-dodecyl-β-D-maltopyranoside (DM), N, N-Dimethyldodecylamine-N-oxide
(lauryldimethylamine-N-oxide, LDAO), n-dodecyl-β-D-maltoside (DDM), Cymal 6 (Cy6), n-Nonyl-β-
D-glucopyranoside (NG) and FOS-choline-16 (FOS). Soluble protein fraction received after this treat-
ment were analyzed by immunoblotting with a penta-His antibody.
Atg5-Atg12 was reported to associate with the autophagosomal membrane [60].
Membrane bound or associated proteins usually display large hydrophobic patches which
make them insoluble and therefore difficult to purify. Also here Atg5-Atg12 was detected
mainly in the pellet fraction (see figure 3.8). Membrane proteins can be solubilized with
detergents. Detergents are polar molecules which interact with the hydrophobic parts
of the protein, thus solubilizing it. In addition to Triton X-100 which was already used
for purification, different detergents can have variable effects on protein solubilization.
Therefore a detergent screen was performed (see section 2.2.3.3).
Shown in figure 3.9 are soluble protein fractions after treatment with indicated
detergents. A clear increase in soluble Atg5-Atg12 conjugate was detected when the
membrane fraction was treated with DDM and Cy6 detergent. Also NG and FOS
treated samples showed an increase although not as strong as DDM and Cy6.
For further optimization of the purification the results obtained from the detergent
screen should be taken into consideration.
3.2.2.2 Atg16 expression and purification from insect cells
Atg5 the target of Atg12 conjugation also interacts with Atg16 [64]. In order to
obtain the whole complex for crystallization, human Atg16 was expressed using the
MultiBac baculovirus expression system for insect cells. After purification Atg5-Atg12
60Project I: Reconstitution of mammalian Atg12 and MAP1LC3 conjugation pathways
















































+ 24 h 
DPA  
+ 36 h 
DPA  
+ 48 h 
Figure 3.10: Expression of Atg16 in insect cells
Expression profile of human Atg16 in High5 insect cells. YFP expression was monitored over time and
cell extract (CE), supernatant (S) and pellet (P) samples were analyzed by Coomassie stained SDS
gels and Western blots.
and Atg16 will be pooled and further analyzed as well as subjected to crystallization
screens. For this, Atg16 was cloned into the pFL-6x His and pFL-StrepII vector. Bacmid
preparation and virus generation was done as described above. For final expression
High5 insect cells were infected. The day of proliferation arrest was determined and
then frequently YFP expression was monitored (see figure 3.10). Samples taken for YFP
measurement were also analyzed with SDS-PAGE and subsequent Western blotting.
For Atg16 the strongest expression was detected after 36 hours. When High5 insect
cells were incubated for additional 12 hours of expression their viability dropped and
along with this expression of YFP decreased. Nevertheless, expression rates for Atg16
still increased as shown on a Coomassie stained SDS gel and with immunoblotting.
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Comparisons of expression profiles with His-tagged or StrepII-tagged Atg16 revealed
stronger expression of His-Atg16. Differences in virus titer and quality might be the
reason. However, unfortunately Atg16 was detected exclusively in the insoluble protein
and membrane fraction.
Several purification trials of Atg16 with either Ni2+-sepharose beads or Streptactin-
sepharose beads failed. Addition of Triton X-100 did not alter solubility, also buffers
at pH 7.5 or pH 8.0 were tested. Since it is known that proteins in complex formation
might change their solubility, Atg16 cell extract was pooled with cell extract containing
Atg5-Atg12. But still Atg16 could not be co-purified.
3.2.2.3 MAP1LC3II expression in insect cells
MAP1LC3 is the second ubiquitin-like modifier involved in autophagy [66]. Conju-
gation of LC3 to its target PE employes the E1- and E2-like enzymes Atg7 and Atg10,
respectively. For expression of lipidated LC3 (LC3II) multigene transfer vectors were
generated. LC3 was cloned into the acceptor vector pFL. In addition Atg7 and Atg10
were inserted into the two multiple cloning site of the donor vector pUCDM. Both vec-
tors were combined in a Cre/loxP reaction followed by integration of the expression
cassette into the MultiBac bacmid. Virus maintainance was done as described above.
Infected High5 insect cells were monitored regarding their viability, cell diameter and
YFP expression levels (see figure 3.11). YFP expression correlates with the expression
of the complex proteins and was detected at its highest level after DPA plus 36 h to
48 h. Furthermore expression of LC3 in insect cells was analyzed with SDS-PAGE and
Western blot. The Coomassie stained SDS gel showed a band around 20 kDa coming
up after DPA plus 36 hours. Also in immunoblotting this band was detected as well
as a second band just below. The second band consists of lipidated LC3 (LC3II) as it
was shown before that LC3II is shifted to lower molecular weight in SDS gel analysis
compared to unlipidated LC3 [87]. LC3 seemed to be more soluble compared to LC3II
as more LC3 was detected in the supernatant fraction.
Purification of LC3 and LC3II from High5 insect cells was done using Ni2+-sepharose
beads. As solubility can be increased by treatment of the cells with 2 % Triton X-100
was reported before detergent was included in the purification protocol [87]. LC3 was
obtained in high yields from insect cells as shown in figure 3.12. Elution fractions (E1
to E4) and protein still bound to the beads (B) were checked on Coomassie stained SDS
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Figure 3.11: Expression of MAP1LC3 in insect cells
Monitoring of expression was done by measuring YFP levels over time. Cell extract (CE), supernatant
(S) and pellet (P) of insect cells expressing LC3 were analyzed with Coomassie stained SDS gels and
Western blotting.
gels and with Western blotting. Here some of the lipidated LC3 was found still bound
to the beads.
Most of the LC3 expressed in insect cells was unlipidated. In order to purify sufficient
amounts of lipidated LC3 the lipidation rate needs to be improved.
Unlipidated LC3 was also obtained in high yields expressed in bacteria. The purified
protein obtained from E. coli was subjected to Thermofluor analysis for optimization of
purification conditions (experiment was performed by our internship student S. Puranik
under my supervision). Here a temperature shift was applied to the protein which was
supplemented with Sypro Orange and 88 different solutions contained in the Addit
screen. Dequenching of Sypro Orange fluorescence correlates with unfolding of the
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Figure 3.12: Purification of MAP1LC3 from insect cells
Purification of LC3 and lipidated LC3 was checked by testing different steps of purification on Coomassie
stained SDS gels. Cell extract (CE), supernatant (S), pellet (P), flow through (FT), washing steps (W1-
W4), elution fractions (E1-E4) and protein still bound to beads (B) were checked. Western blot analysis
of bead bound fraction (WB) was done with a penta-His antibody.
Increase of Sypro Orange fluorescence was shifted towards higher temperatures in
conditions with ammonium sulfate, potassium citrate, diaminopentane and polyvinylpyrroli-
done (see figure 3.13). These substances increase the stability of LC3 and could be sup-
plemented to the protein during purification to increase the yields of purified proteins.
3.2.3 Analyses of conjugated protein complexes
Western blot analysis with a penta-His and a StrepII specific antibody of the purified
Atg5-Atg12 complex revealed two bands in the high molecular weight region. One
band in the expected size for the conjugate of approximately 60 kDa and a second
prominent band of almost 100 kDa. To assure the purification of the right complex
and identification of all proteins represented by this band, the band was cut from an
SDS gel, subjected to in gel tryptic digestion and then analyzed by mass spectrometry.
This resulted that both bands contained the conjugated complex. In addition mass
spectrometry analysis the exact conjugation site of Atg12 to Atg5 was identified. The
C-terminal glycine of Atg12 is conjugated to Lys130 of Atg5. This showed clearly
that the proteins expressed in insect cells are active and Atg12 conjugated to Atg5.
Furthermore ubiquitin was also found to be conjugated to Atg5.
Also both bands of LC3 and LC3II were analyzed by mass spectrometry. Indeed
both bands contained LC3, but also Atg3 was detected. Some Atg3 must have been
co-purified with LC3 and stuck to the protein even during SDS gel separation.
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Figure 3.13: Thermofluor analysis of MAP1LC3 purified from E. coli BL21 (DE) cells
Sypro Orange dequenching correlates with unfolding of LC3 in solution. 88 different additives were
tested supplemented ot LC3 in purification buffer. Indicated additives shifted unfolding of LC3 towards
higher temperatures signifying stabilizing abilities of these substances. Experiment carried out by S.
Puranik
Mass spectrometric analysis was done by M. Raabe and H.-H. Hsiao from the Bio-
analytical Mass Spectrometry research group, MPI for Biophysical Chemistry.
3.2.4 Influence of Atg12-Atg5-Atg16 on MAP1LC3 lipidation
The yields of lipidated LC3 expressed from insect cells were quite low. Since LC3
and its E1- and E2-like enzymes are over-expressed, probably a lack of available amounts
of PE might be the reason for low conjugation. In order to provide reasonable amounts
of PE, we added PE to cell extract prepared from insect cells expressing the conjugation
machinery.
We assumed from former purifications that 1 l insect cells express approximately 3
mg LC3 and added commercially available PE purified from brain in excess of an 1:2
ratio. PE was resuspended in buffer used for insect cell resuspension supplemented with
3 % OG. Furthermore along with PE 1 mM final concentration of ATP was added to the
cell extract and incubated for 3 hours at RT. Atg12-Atg5˜Atg16 complex was reported
to function as an E3 ligase on LC3 conjugation [69]. Therefore, also cell extract from























Figure 3.14: Western blot analysis of the Atg5-Atg12 complex
(A) In immunoblotting of cell extract (CE), supernatant (S) and pellet (P) from High5 insect cells
expressing Atg5 and Atg12, both proteins alone in their expected size were detected with either His or
StrepII antibody and the complex of 60 kDa. In addition another prominent band was detected around
100 kDa. (B) Coomassie stained SDS gel with purified Atg5-Atg12 complex. The band of 100 kDa
molecular weight was cut from the gel and analyzed by mass spectrometry.
cell extract and PE and incubated. Afterwards, soluble and insoluble fractions were
separated and both analyzed in SDS-PAGE and Western blotting.
Figure 3.15 shows that only addition of external PE is not sufficient to increase
LC3II yields. Even dialysis against buffer, to decrease the OG amounts in the cell
extract did not increase lipidation clearly. However addition of Atg5-Atg12 enhanced
the lipidation rate independently upon supplementation of PE.
Taken these results together it was shown that the Atg12-Atg5 complex is required
for efficient LC3 lipidation.
3.3 Discussion
Here, I show the in vivo reconstitution of full length human Atg12 and LC3 conju-
gation systems. Atg12-Atg5 conjugate was purified from insect cells after infection with
the MultiBac baculovirus carrying the genes of human atg5, atg10, atg7 and atg12 for
co-expression. Correct conjugation of the C-terminal glycine of Atg12 to the Lys130 of
Atg5 was confirmed by mass spectrometric analysis. In addition LC3 was expressed and
purified from insect cells and low yields of lipidated LC3 were obtained. The presence
of the E1- and E2-like enzymes Atg7 and Atg3 were not sufficient for efficient lipida-
tion. Addition of the Atg5-Atg12 conjugate was required to increase the lipidation rate







M       S        P       S       P       S        P       S       S       P 
LC3/Atg3/Atg7:               +       +       +      +       +       +      +       +       + 
PE in OG:              –       –       +      +       +       +      –       +       + 
Atg5/Atg12/Atg10/Atg7:  –       –       –      –       –       –      +       +       + 
dialyzed:              –       –       –      –       +       +      –       –       – 
Figure 3.15: In vitro lipidation of LC3
Different conditions were tested to increase the yields of lipidated LC3. The first two lanes of
the Coomassie stained SDS gel and Western blot show supernatant (S) and pellet (P) fraction of
High5 cells expressing the proteins of the LC3 conjugation complex. In lane 3 and 4 external phos-
phatidylethanolamine PE was added. Next two lanes show S and P dialyzed against buffer to reduce
OG detergent amounts. Lane 7 shows pooled fractions of LC3 and Atg12 complex expressing High5
cells. The last two lanes represent a mixture of both complexes together with addition of PE.
whereas addition of PE alone was not enough to increase lipidation of LC3. It has been
reported, that the Atg5-Atg12 complex is sufficient as E3-like ligase [69].
In vitro reconstitution systems have already been described as from Fujioka et al.
[22]. Here the conjugation system of Atg8 and Atg12 from A. thaliana were recon-
stituted using purified recombinant proteins from bacteria. By pooling these purified
proteins low amounts of Atg5-Atg12 conjugate could be obtained, but the reaction was
not as efficient as in vivo conjugation. In another in vitro reconstitution of mammalian
Atg5-Atg12 expressed in bacteria addition of ribonucleic acid increased the conjugation
yield [88]. Noda et al. [89] reported from co-expression of truncated forms of yeast
Atg12 and Atg5 in bacteria together with Atg7 and Atg10. This truncated conjugation
complex was then mixed with the N-terminus of Atg16 required for Atg5 interaction.
They obtained crystals from this construct but no structure was published up to now.
In order to receive the conjugated proteins in the quantity required for crystallization
and properly folded, an eukaryotic expression system was used here.
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Only lipidated yeast Atg8 was obtained in decent yields using an in vitro recon-
stitution system [90]. Here Atg8-II was reconstituted on liposomes containing 70 %
PE and 30 % PC. Reported in vitro reconstitution of LC3II showed low efficiency [91].
These results indicate the requirement of the E3 activity of Atg5-Atg12. This activity
has been reported for yeast [61], mammals [92] and plant [69] indicating that this func-
tion is evolutionarily conserved. However, neither Atg12 nor Atg5 alone promote this
reaction. Also excess amounts of Atg5-Atg12 inhibits LC3 lipidation [93].
Structural analysis of these complexes is required to gain further insight into the
molecular function of these complexes. Despite their essential role in autophagosome
formation, the mechanism of their activity is poorly understood. From structural anal-
ysis also further insights on their biochemical activity could be gained. Since these
complexes are part of the core autophagy machinery and deletion of a single protein
leads to breakdown of the whole autophagy machinery, some open questions are left to
be answered on their molecular interplay.
3.4 Outlook
Purification of Atg12-Atg5 can be further optimized by implementation of the results
from the detergent screen to increase soluble Atg5-Atg12 yields. Subsequently additional
Thermofluor experiments should be performed to determine stabilizing conditions for
this protein complex. By addition of identified stabilizing substances crystallization
probability might be increased and crystal screens will be set up for the conjugate.
Furthermore Atg16 might be solubilized by using another detergent than Triton X-
100, which needs to be determined using the detergent screen. Probably solubility of
Atg16 could be increased by infection of one High5 insect cell culture with viruses for
Atg16 and Atg5-Atg12 expression. Co-expression of all proteins in one culture might
enhance Atg16 solubility. Another possibility of expressing Atg16 with the Atg5-Atg12
complex is cloning of Atg16 into an additional donor vector, which can be integrated
via the loxP site into the acceptor vector. Then all five proteins belonging to the Atg12
conjugation system will be co-expressed from one bacmid. Even so, the aim is to purify
full length proteins the N-terminal part of Atg16 needed for interaction with Atg5 could
be purified and used co-crystallized instead.
When a complex of Atg12-Atg5˜Atg16 will be purified the oligomerization state of
this complex will be tested using analytical gel filtration or MALLS analysis. So far there
seems to be a discrepancy between dimerization of this complex observed in the crystal
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structure of Atg16 coiled coil domain reported by Fujioka et al. [33] and large molecular
weight Atg12-Atg5˜Atg16 complexes purified from both yeast and mouse, which would
correspond to tetramers in yeast [94] or octamers in mouse [65], respectively.
Lipidation of LC3 in vitro by addition of the Atg5-Atg12 cell extract will be further
optimized. Then the detergent screen will be employed to increase the solubility of
LC3-PE. When LC3II is purified buffer optimization will be done with Thermofluor
experiments. Additionally, purified LC3II will be subjected to crystallization screens.
In case of purification of both complexes they can be pooled and biochemically
analyzed. Also unlipidated LC3 is sufficient to investigate how the Atg12-Atg5˜Atg16
complex interacts with LC3 and how this complex acts as an E3-like ubiquitin ligase on
LC3 [69].
4 Project II: Insights into
membrane binding of PROPPINs
4.1 Introduction
4.1.1 The autophagosomal membrane
For some decades it has been thought that autophagosomes are formed de novo
unlike the formation of other vesicles in the cell, which are generated by budding off
from existing membranes. The source of lipids for the growing isolation membrane (or
phagophore) has been under debate. To our surprise, several membrane compartments
were recently identified to provide membrane precursors. In higher eukaryotes most
autophagosomes were reported to be generated close to the endoplasmatic reticulum
(ER) and EM images showed direct connections between early isolation membrane and
ER [95, 96, 97]. However, also mitochondria [98], the plasma membrane [99, 100]
and Golgi [101, 102, 103, 104, 105] have been reported to give rise to autophagosomal
membrane precursors.
Most autophagy protein complexes described are involved in early stages of au-
tophagosome formation and membrane expansion, including the kinase-containing Atg1
complex (in mammals ULK1 complex) [106, 18, 107, 108, 109], the class III phos-
phatidylinositol 3-kinase complex Vps34 [19, 20], the Atg12 and Atg8 (LC3) conjugation
systems [23, 33, 22, 92, 80], the transmembrane protein Atg9 [110, 111] and phospho-
inositide binding proteins as Atg18 [112]. These complexes are well known but their
molecular interplay has been less studied.
Recruitment of these complexes to the autophagosomal structure and therefore hubs
of autophagosomes are less understood. Among a few others, one protein group is of
special interest to build the connection between the autophagosomal membrane and
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recruitment of other proteins to isolation membranes. This group of β-propeller proteins
that bind polyphosphoinositides (PROPPINs) comprises three yeast homologs, namely
Atg18, Atg21 and Hsv2 (in mammals: WIPI1-4). The PROPPIN family members bind
PI3P.
Production of the phosphoinositide PI3P is essential for autophagosome formation
and induced upon starvation. PI3P is generated by the Vps34 kinase complex [113,
114, 115]. Yeast isolation membranes are enriched with PI3P [116]. Recently it was also
shown that dephosphorylation of PI3P is necessary for final fusion of the autophagosome
with the vacuole since Atg proteins stay associated to the membrane [117].
4.1.2 Phosphoinositide effectors
The seven natural phosphoinositides are enriched in specific membrane compart-
ments. PI(4,5)P2 is localized to the plasma membrane, PI3P and PI(3,5)P2 are present
on early and late endosomes, respectively and PI4P is mainly found at the Golgi com-
plex [118]. A distinctive property of the PIPs is their fast rate of appearance and
disappearance in the membrane. The PI-metabolizing enzymes rapidly synthesize them
upon induction where and when they are required, and they are also rapidly consumed.
This fact makes them ideal determinants for dynamic processes, such as membrane
trafficking and recruitment.
A range of PI effector domains are known and their structures were described (see
figure 4.1). First, the pleckstrin homology (PH) domain was reported to recognize
phosphoinositides [119, 120, 121]. Since then number of domains were found including
the ANTH (AP180 N-terminal homology) [122, 123, 124], C2 (conserved region-2 of
protein kinase C) [125], ENTH (epsin N-terminal homology) [126], FERM (4.1, ezrin,
radixin, moiesin) [127], FYVE (Fab1, YOTB, Vac1 and EEA1) [128, 129], GOLPH3
(Golgi phosphoprotein 3) [130, 131], PDZ (postsynaptic density 95, disk large, zonula
occludens) [132], PROPPINs (β-propellers that bind PIs) [133], PTB (phosphotyrosine
binding) [121], PX (Phox homology) [134, 135, 136] and Tubby modules [137, 138].
Recently the first PROPPIN structures were solved [24, 25, 26]. These effectors show
high specificity to one or two phosphoinositides, in contrast two domains PX and PH
were shown to bind several phosphoinositides.
Many of these phosphoinositide binding motifs have a low affinity and make use of
different mechanisms to increase affinities. One mechanism used is domain oligomer-
ization as reported for the FYVE and PH domain. Some proteins comprise two of
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FYVE: PI3P GOLPH3: PI4P ANTH: PI(4,5)P2 ENTH: PI(4,5)P2 
FERM: PI(4,5)P2 PDZ: PI(4,5)P2 Tubby: PI(4,5)P2 
C2: PI(4,5)P2, PI(3,4,5)P3 PTB: PI4P, PI(4,5)P2 PROPPIN: PI3P, PI(3,5)P2 
PX: PI3P, PI4P, 
PI(3,4)P2, PI(4,5)P2, 
PI(3,4,5)P3 
PH: PI3P, PI4P, 
PI(3,4)P2, PI(3,5)P2 
PI(4,5)P2, PI(3,4,5)P3 
Figure 4.1: Overview of phosphoinositide binding motifs and their structure
Shown here are the known domains binding phosphoinositides. Different domains bind different phos-
phoinositides as indicated. Some show specificity to only one kind of phosphoinositides, some to two
phosphoinositides or like the PX and PH domain to a range of different phosphoinositides. Domains
are colored from the N-terminus in blue to C-terminus in red.
these phosphoinositide effector domains. The C2, PH and PX domains were also found
to bind other lipids as phosphatidylserin or phosphatidic acid in addition to phospho-
inositides. In addition, proteins carrying a phosphoinositide binding domain might also
interact with a membrane protein to get into proximity of the membrane. Furthermore,
partial membrane insertion of the domain is quite common as e.g. described for the
FYVE, PX and ENTH domain. [139].
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4.1.3 Phosphoinositide effectors involved in autophagy
PI3P signaling is crucial for autophagy initiation and is generated by two complexes
in yeast, the Vps34 PI3-kinase complex I comprising Vps34, Vps15, Vps30 (in yeast
also: Atg6, in mammals: Beclin 1) and Atg14 (in mammals: Barkor) and complex II in
which Atg14 is replaced by Vps38 [19]. Complex I functions in autophagy and the Cvt
(cytoplasm-to-vacuole-targeting) pathway, whereas complex II is involved in vacuolar
sorting of carboxypeptidase Y. Followed by the generation of PI3P at the PAS a string
of PI effectors are recruited to the autophagosomal membrane.
Atg14 binds to PI3P and PI(4,5)P2 and recruits the class III phosphatidylinositol
3-kinase I to the early autophagosomal structure [140]. The PX domain harboring
proteins Atg20 and Atg24 bind PI3P and function in the Cvt pathway [141, 142].
The PROPPIN family comprises the three yeast homologs Atg18, Atg21 and Hsv2.
Atg18 is recruited to the PAS and forms a complex with Atg2 and mediates cycling of
Atg9 between a peripheral compartment and the PAS [142]. Furthermore, Atg18 regu-
lates the Fab1/PI(3,5)P2 synthesizing complex [143]. Atg18 is also involved in vesicular
transport from the vacuoles to the Golgi [133]. Atg21 is needed for proper localization
of Atg8-PE to the autophagosomal membrane and is involved in the Cvt pathway [144].
Also Hsv2 binds both phosphoinositides and is required for efficient piecemeal micronu-
cleophagy [112]. The pexophagy (degradation of peroxisomes) specific protein Atg26
binds specifically to PI4P through its GRAM domain [145, 146, 147]. The PI3P effector
protein Atg27 (Etf1) is also involved in the Cvt pathway [148].
Further PI effectors were shown to be involved in autophagy, including ALFY (au-
tophagy linked FYVE protein) [149], FYCO1 (a novel FYVE and coiled-coil domain-
containing protein) [150] and mammalian DFCP1 (double FYVE-containing protein 1)
[95].
4.1.4 PROPPINs and their role in autophagy
β-propellers that bind polyphosphoinositides (PROPPINs) comprise a WD-40 re-
peat containing domain that forms a seven bladed β-propeller [133, 24, 25, 26]. Within
this domain the highly conserved FRRG motif is located, which has been shown to
be essential for phosphoinositide binding [144, 133, 151]. The three yeast PROPPINs
Atg18, Atg21 and Hsv2 are highly conserved. The mammalian PROPPIN homologs are
denoted as WIPI (WD40 repeat containing proteins that interacts with PtdIns) pro-
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teins [152]. Four WIPI homologs have been identified. WIPI1 and WIPI2 are othologs
of Atg18 [153].
Atg18 is part of the core autophagy machinery and involved in macroautophagy, Cvt-
pathway and piecemeal microautophagy of the nucleus (PMN) [154, 155, 151]. PI3P
is necessary for recruitment of Atg18 in early stages of the autophagosomal membrane
formation [142]. In complex with Atg2 it mediates cycling of Atg9 to and from the PAS
[21]. Beside PI3P Atg18 binds to PI(3,5)P2 and localizes to the vacuole where it is a
regulator of the PI3P 5-kinase Fab1 complex [143].
The function of Atg21 is restricted to the Cvt pathway and PMN [156, 144, 112].
Atg21 was reported to act upstream of the Atg8 conjugation system and is involved in
its proper localization to the growing membrane [156, 155].
Hsv2 is the least studied PROPPIN and its function is still unclear, so far it was
only described to be involved in PMN [112].
4.1.5 WD40 repeat containing proteins in autophagy
Among the ten most abundant domains across eukaryotes is the WD40 repeat con-
taining domain which is also present in prokaryotes [157, 158]. A single WD40 repeat
has a length of 44 to 60 residues. Characteristic features of a WD repeat are a con-
served GH dipeptide 11 to 24 residues after the beginning of the motif and a second
conserved WD dipeptide at its C-terminus. Caused by the low sequence conservation
of only two dipeptides it is difficult to predict WD40 repeat containing proteins in the
genome [157, 159, 160, 161, 162]. WD40 repeat containing proteins fold as β-propellers.
They consist of four to eight blades. However, most so far described structures of WD40
containing proteins fold into a seven bladed β-propeller.
Providing a platform for protein-protein and also protein-nucleic acid interactions,
WD40 proteins were reported to play a role in central biological processes as hubs in
cellular networks. WD40 proteins function in signal transduction, cell division, cy-
toskeleton assembly, chemotaxis and RNA processing. Up to date no WD40 containing
protein has been identified with catalytic activity [157, 159, 163, 164].
The β-propeller structure represents a scaffold for interactions and for this reason
WD40 proteins form hubs for huge molecular machineries. Three different interaction
sites are provided on the propeller, the top and bottom region of the propeller and its
circumference, in addition some interactions include the entry site of the central channel
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of the β-propeller [157]. Besides interaction with other proteins, WD40 domains can
interact with each other and therefore provide a platform for complex formation.
A whole range of WD40 repeat containing proteins are known to be involved in the
ubiquitin-proteasome pathway, in which they mediate substrate specificity and recruit
cargo to the ubiquitination machinery. Besides recruiting proteins for ubiquitination
WD40 proteins were also shown to provide a binding site for ubiquitin itself [165, 166].
Autophagy involves several WD40 repeat containing proteins like the proteins con-
taining to the PROPPIN subfamily, Atg16, ALFY, EPG-6 and Ambra-1. Atg16 is part
of the Atg12 conjugation system and only Atg16L homologs of higher eukaryotes contain
the C-terminal WD40 domain. So far Atg16 was reported to be involved in oligomer-
ization of the Atg12-Atg5-Atg16L complex, but this interaction is not dependent on
the WD40 domain and no other interaction partner was identified for this domain, yet
[65]. In selective autophagy the multidomain protein ALFY links p62 labeled cargo
by interaction with its C-terminal BEACH domain to the autophagic machinery. It is
interacting with Atg5 via its WD40 domain and with PI3P containing membranes using
its FYVE domain [167, 149]. EPG-6 an autophagy protein found in C. elegans contains
a WD40 domain and was shown to directly interact with Atg2 and is a homolog of
WIPI4 [168]. Ambra-1 a highly conserved vertebrate WD40 repeat containing protein
is involved in Beclin1/Vps34 activation of autophagy [169, 170].
4.1.6 Structure of Hsv2
During the time course of this thesis the structure of K. lactis Hsv2 [24, 25] and
K. marxianus Hsv2 [26] were published by us and others. Crystals of KlHsv2 grown
diffracted up 3.0 Å [24]. The structure was solved by SAD (single-wavelength anomalous
diffraction phasing) using selenomethionine labeled protein.
The structure of KlHsv2 revealed a seven bladed β-propeller (see figure 4.2). Each
blade comprises four antiparallel β-strands. Unlike most other β-propeller structures,
KlHsv2 shows a non-velcro like closure. Here the last blade is formed completely by
the C-terminus. In other structures containing a velcro-like closure the final blade is
partially formed by the N-terminus [171, 159].
Loop regions connect each β-strand within the β-propeller. These loops are quite
unconserved among PROPPINs and differ in their lengths. KlHsv2 possesses quite
short loops compared to S. cerevisiae Hsv2. Besides one long loop connecting strand


















Figure 4.2: Structure of the PROPPIN KlHsv2
(A) KlHsv2 forms a seven bladed β-propeller (indicated by numbersAtg16L homologs), each propeller
comprises four β-strands (indicated by letters). The loop connecting strand C and D of blade 6 is
especially long and disordered. (B) Shows a 90◦ rotation of the structure to demonstrate the orientation
of the two arginines pointing into opposite directions. PDB code: 4AV8 (See also [24])
electron densities caused by its high flexibility. Due to its flexibility part of the loop
was disordered in the 3.0 Å crystal structure. However, we also determined a 3.3
Å crystal structure where the complete loop could be built [24].
Interestingly the two arginines of the FRRG motif (Arg119 and Arg120), located in
blade 5 strand D and reported to be essential in phosphoinositide binding, did not form
a single phosphoinositide binding pocket as expected. Rather they point into opposite
directions indicating two potential binding sites. To exclude crystal packing constrains
causing the arginines sticking to their observed positions, molecular dynamics simula-
tions were carried out resulting in the confirmation of the position of both arginines
towards opposite directions. Furthermore each of the indicated potential phospho-
inositide binding pockets were occupied by sulfate ions originating from crystallization
conditions. Before it was already reported that sulfate and phosphate ions indicate
potential phosphoinositide binding pockets [172, 173, 174].
Therefore we speculate that PROPPINs contain two possible phosphoinositide bind-
ing sites.
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4.1.7 Aims
Atg18, Atg21 and Hsv2 are PROPPINs involved in autophagy. They are highly
conserved among each other but adopt different functions in autophagy.
How they act in concert with other proteins and how they interact with membranes
is still not well understood. Their structures were of great interest, since WD40 repeat
containing proteins are often a scaffold for protein-protein interactions [157, 159] mak-
ing PROPPINs to candidates for the recruitment of other proteins to autophagosomal
membranes. How do PROPPINs consisting of a single domain combine binding of other
proteins and additional binding to membranes?
The aim of this project was to express, purify and crystallize the autophagic yeast
PROPPINs Atg18, Atg21 and Hsv2. In addition, their membrane binding should be
further characterized using biochemical and biophysical approaches based on our Hsv2
structure (see figure 4.3).
4.2 Results
4.2.1 Expression and purification of yeast PROPPINs
4.2.1.1 Expression and purification of yeast PROPPINs in insect cells
Earlier expression studies revealed that expression of S. cerevisiae Atg18 and Atg21
(hereafter ScAtg18 and ScAtg21) in E. coli gives very small yields of purified protein or
the protein is localized in inclusion bodies and therefore found in the insoluble fraction
during purification. For this reason, I used the insect cell expression system to obtain
soluble ScAtg18 and ScAtg21 [45]. An advantage of this system is, that it is an eu-
karyotic expression system and if the protein needs post translational modifications i.e.
glycolysation, those modifications will be made in the insect cells.
For insect cell expression ScAtg18 and ScAtg21 were amplified for Gateway pENTR/D-
TOPO cloning. During this step a Kozak sequence, 10x His-tag and a TEV cleavage
site were added to the N-terminus of the genes. Furthermore, in an LR recombinase re-
action the genes were transferred from the pENTR vector to the pDEST8 vector, which
is suitable for the integration of the genes into the bacmid. Then, competent E. coli
DH10 MultiBac cells were transformed with pDEST8 vector carrying either ScAtg18 or
ScAtg21 genes. The genes integrate into the bacmid via Tn7 sites, which are located in
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Figure 4.3: Approach for the characterization of PROPPINs.
Flow chart to illustrate the approach for project II. Starting out with two different expression sys-
tems the main goal is the characterization of PROPPINS through X-ray crystallographic structure
determination and biochemical methods.
the lacZ gene and this was used for blue-white screening. Thereafter, for transfection
of Sf21 insect cells the bacmids were extracted from E. coli DH10 cells (see section
2.2.2.2).
Purified bacmid was transfected into Sf21 insect cells for virus generation. It is very
important to ensure high viability of insect cells. If this is the case a high transfection
efficiency can be reached. Therefore, Sf21 cells were checked under the microscope
after Trypan blue addition to stain dead cells. In addition, cell number and viability
was measured using a cell counter. Viability of these cells should be at least 92 % for
efficient transfection (see section 2.2.2.3). The transfection rate can be monitored under
a fluorescence microscope within 48 hours to 60 hours due to expression of YFP from
the bacmid. As a result, virus (v0) should be released to the media in 60 hours to 72
hours and was harvested in this time frame.
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Figure 4.4: Expression of ScAtg18 and ScAtg21 from insect cells.
(A) Measurements of YFP expression in Sf21 insect cells. Samples taken 24 h, 36 h and 48 h after day
of proliferation arrest (DPA). Comparison of YFP expression in ScAtg18 and ScAtg21 co-expressing
cells. (B) Pull down experiment of ScAtg18 and ScAtg21 expressing insect cells. Loaded on 12 %
SDS-PAGE gels are whole cell extract (CE), supernatant (S) and fraction after pull down (PD) from
two different clones of both ScAtg18 and ScAtg21. Expression of the PROPPINs was confirmed in
Western blotting analysis using an antibody against His-tag. (C) YFP determination from infected
High5 insect cells. Samples taken 24 h, 36 h and 48 h after DPA. (D) Following expression of ScAtg18
(upper gel) and ScAtg21 (lower gel) over the time. Shown are whole cell extract (CE), supernatant (S)
and pellet (P) after DPA + 24 h, + 36 h and + 48 hours. (E) Purification of ScAtg18 and ScAtg21
using an 1 ml His-Trap FF column. 12 % SDS-PAGE and Western blotting analysis with anti-His
antibody show whole cell extract (CE), pellet (P), supernatant (S), flow through (FT) and elution
fractions (fraction No.).
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Large scale production of virus in Sf21 cells was necessary to reach a higher virus
titer and to store virus for several expression experiments. For this purpose, 3 ml of
virus was added to 25 ml Sf21 cell suspension. Infection of Sf21 cells with the virus
was determined by measuring cell density. Stagnation of cell devision indicates the day
of proliferation arrest (DPA). In addition, to follow expression of genes encoded by the
bacmid, YFP expression was measured (see section 2.2.2.5) every 12 hours starting after
the DPA (see figure 4.4 A). YFP expression over time increases as expected and is a
direct indicator for late expressed virus genes, since it is regulated by a late stage viral
promoter like ScAtg18 and ScAtg21 genes. In a next step, a test purification of ScAtg18
and ScAtg21 using Ni2+-sepharose beads (see section 2.2.2.4) was carried out with the
same samples taken for YFP measurement (see figure 4.4 B). In fractions containing
proteins enriched with Ni2+-sepharose beads (PD) a prominent band close to 70 kDa
is visible. This band was confirmed to contain a His-tag in Western blot analysis and
consequently represents expressed ScAtg18 and ScAtg21, respectively. Between 60 to
72 hours virus (v1) was harvested again by centrifugation of the cell suspension at 1,000
rpm for 20 min, 4 ◦C.
High5 insect cells were used for large scale expression of the PROPPINs. These cells
are bigger in diameter and therefore more suitable to express higher protein amounts.
After infection of two times 400 ml with v1 virus cell density, viability and diameter
was monitored as well as expressed YFP amounts (see figure 4.4 C). YFP expression
increase stronger in High5 cells than in Sf21 cells. Also the cell diameter increased more
drastic in High5 cells (from 19 µm up to 24.5 µm) than in Sf21 cells (from 17.5 µm up to
20 µm). When the day of proliferation arrest was determined by measuring cell density
High5 cells were harvested at DPA plus 48 hours, since this time point was determined
by YFP measurement as point of highest protein expression. In figure 4.4 D whole cell
extract, supernatant and pellet of DPA plus 24 h, 36 h and 48 h are shown. ScAtg18 is
expressed in very low amounts and hardly visible as a band around 70 kDa. In contrast,
ScAtg21 is expressed in high amounts but most of the protein is present in the pellet
fraction.
During different purification trials the purification protocol for these proteins (see
section 2.2.4.2) were optimized. One of the obstacles to overcome was the problem that
insect cells have much higher chromosomal DNA amounts than i.e. bacteria. Since
adding DNaseI to the cell extract is not sufficient, chromosomal DNA was precipitated
with streptomycin sulfate and pelleted during centrifugation. Another problem was the
high insolubility of ScAtg21, for this reason cell extract was treated with Triton X-100
to disrupt membranes and inclusion bodies. Also an additional purification step was
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Figure 4.5: Purification of ScAtg18 from High5 insect cells with optimized protocol
(A) Purification of ScAtg18 with Ni2+-sepharose beads. The Coomassie stained SDS gel shows fractions
to follow the purification steps and efficiency. (B+C) Purification of ScAtg18 with 1 ml His-Trap FF
column. Fractions taken during purification were checked in SDS-PAGE and by UV280 detection.
(D+E) Final purification of ScAtg18 using size exclusion chromatography with a gel filtration S200
HR 10/30 column.
4.2 Results 81
included. As a first purification step Ni2+-sepharose beads were used for affinity purifi-
cation. Second step was a complementary 1 ml His-Trap FF column purification with
an Äkta to increase purity of the elution fractions. Gel filtration chromatography was
employed as final step to reach protein purity applicable for crystallization. Following
this optimized protocol small amounts of ScAtg18 were purified (see figure 4.5).
4.2.1.2 Bacterial expression and purification of yeast PROPPINs
Expression of ScAtg18 and ScAtg21 from insect cells yielded low amounts of puri-
fied proteins or protein remained insoluble. For this reason, I tried to find homologs
for Atg18, Atg21 and Hsv2 from other yeast species. Criteria for selection were for
example the length of loops which connect the blades of the propeller. Since the loops
are unstructured and highly flexible, proteins with shorter loops are more suitable for
crystallization and solubility of the proteins might be increased. Another indication
for crystallization suitability gave the online tool TarO (Target Optimisation Utility;
http://www.compbio.dundee.ac.uk/taro). This tool combines a broad range of bioinfor-
matic techniques to calculate different protein properties. Besides, it gives an overview
of protein characteristics. Another factor for our decision was the prediction of the
crystallization propensity of the proteins (see table 4.1). Based on these facts I decided
to order synthetic genes optimized for bacterial expression of the following homologs:
• Schizosaccharomyces pombe: Atg18, Atg21 and Hsv2
• Pichia angusta: Atg18 and Atg21
• Kluyveromyces lactis : Atg21
• Caenorhabditis elegans : Atg18
• Drosophila melanogaster : Atg18
S. pombe homologs and D. melanogaster Atg18 are especially short proteins. Here,
unstructured loop regions that might inhibit crystallization are very short and the overall
prediction of disordered regions are quite low (compare table 4.1). P. angusta, C. elegans
and K. lactis Atg18 and Atg21 have a higher potential to crystallize (high score or
amenable) in agreement with TarO.
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Table 4.1: PROPPIN homologs analyzed by TarO
PROPPIN Species Crystallization Sequence Molecular Disorder Glycosy- Phosphory-
propensity length weight prediction lation lation
prediction [aa] [Da] sites sites
Atg18 S. cerevisiae recalcitrant 500 55,102 0.17 1 34
S. pombe recalcitrant 373 41,109 0.11 16
P. angusta high score 525 57,936 0.25 36
C. elegans high score 412 45,274 0.17 25
D. melanogaster recalcitrant 377 41,739 0.03 1 20
Atg21 S. cerevisiae recalcitrant 496 55,198 0.25 1 27
S. pombe recalcitrant 335 37,108 0.05 20
P. angusta amenable 388 42,854 0.10 20
K. lactis amenable 500 43,555 0.05 21
Hsv2 S. cerevisiae recalcitrant 448 51,237 0.16 2 20
K. lactis amenable 339 39,167 0.00 10
S. pombe amenable 364 41,011 0.09 16
Atg18 is part of the core autophagy machinery and highly conserved throughout
eukaryotes. In order to determine the structure of Atg18, I ordered synthetic genes of
its homologs from S. pombe, P. angusta, C. elegans and D. melanogaster. Homologs
of Atg21 were ordered from S. pombe, P. angusta and K. lactis. For crystallization of
Hsv2 I used the S. pombe homolog. These genes were optimized for bacterial expression,
by the algorithms of the company Mr. Gene GmbH. KlHsv2 was also ordered and the
sequence optimized for bacterial expression, I used this protein for biochemical analysis
together with ScHsv2.
The ordered genes were cloned into the pET28a expression vector and first expression
trials were done in E. coli BL21(DE3) cells.
Expression of SpAtg18 and SpAtg21 was tested in different medias, including LB
media, TB + salt media and autoinducible media. In addition, E. coli Rosetta(DE3)
cells were tested as an expression strain for these homologs. Detection of expression
could not be confirmed neither on Coomassie stained SDS-PAGE gels nor in Western
blot analysis. Another approach was it, to co-express these genes with each other or
with SpHsv2 from the pET-Duet1 vector. However, this did not lead to expression of
SpAtg18 or SpAtg21. Sequencing verified the correct insertion of these genes in the
expression vectors. Therefore, work with SpAtg18 and SpAtg21 was stopped at this
point.
The expression of PaAtg18, CeAtg18, DmAtg18, PaAtg21 and KlAtg21 was opti-
mized using E. coli BL21(DE3) cells cultured in different media. First, LB media was
tested as media and expression was induced by IPTG addition. None of the proteins
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Figure 4.6: Purification of PaAtg18 from E. coli BL21(DE3) cells
Chromatograms and SDS-PAGE gels of PaAtg18 purified by (A) affinity chromatography using a
His-Trap FF column followed by (B) gel filtration with HiLoad 16/60 Superdex S75 column.
showed a distinct over expression band (see suppl. figure 5.1 A). Therefore, autoin-
ducible media was tested. In order to check the over expression of the protein homologs,
batch purification using Ni2+-sepharose beads was done and analyzed on SDS gels to-
gether with cell extract and supernatant (see suppl. figure 5.1 B). Over expression of
PaAtg18 and KlAtg21 was observed. Therefore, autoinducible media was chosen for
large scale purification of these proteins.
All five homologs were expressed in 9 l autoinducible media from E. coli BL21(DE3).
Expression was done for three hours at 37 ◦C and then shifted for over night incubation
to 22 ◦C. After 24 hours of culturing the cells were harvested and after lysis, proteins
were purified by affinity chromatography using a His-Trap FF column followed by size
exclusion chromatography. Protein purity and obtained protein yields were tested by
loading cell extract (CE), supernatant (S), pellet (P) and elution fractions on an SDS
gel, which was thereafter stained with Coomassie.
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Figure 4.7: Purification of KlAtg21 from E. coli BL21(DE3) cells
Chromatograms and SDS-PAGE gels of KlAtg21 purified by (A) affinity chromatography using a
His-Trap FF column followed by (B) gel filtration with HiLoad 16/60 Superdex S75 column.
P. angusta Atg18 was purified in high yields and purity after gel filtration purifica-
tion was of good quality (see figure 4.6). PaAtg18 was also purified from minimal media
with selenomethionine as supplement. The same purification protocol was followed. The
protein was stored for crystallization trials in conditions were native protein crystallized.
In contrast, Atg18 from C. elegans was obtained in small yields from His-Trap purifica-
tion, but after gel filtration CeAtg18 could not be enriched or purity improved, instead
the protein seems to be very instable and precipitated or got degraded (see suppl. fig-
ure 5.2). DmAtg18 was not expressed in high levels and with affinity purification the
protein could not be enriched. Gel filtration purification yielded two bands of purified
protein, like CeAtg18 this protein could not be purified sufficiently for crystallization
trials (see figure 4.6).
Next, KlAtg21 was expressed at high levels. Its purification check on SDS gel showed
a double band and the lower band did not disappear after size exclusion chromatogra-
phy. Most likely, the second band represents a smaller, stable fragment of the protein
(see figure 4.7). In addition, selenomethionine labeled KlAtg21 was purified for crys-
tallization. In small yields PaAtg21 was purified, the protein was of good purity (see
suppl. figure 5.4).
Optimal expression conditions were tested for SpHsv2. For this purpose, LB media
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Figure 4.8: Purification of SpHsv2 from E. coli BL21(DE3) cells
(A) Purification of SpHsv2 with 1 ml His-Trap column and analysis of fraction with SDS-PAGE. (B)
Followed by size exclusion chromatography. (C)+(D) Chromatograms of SpHsv2 purification with 1
ml His-Trap FF column (C) and analytical gel filtration with a Superdex 200 10/300 GL column (D)
using an Äkta purifier.
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was first incubated at 37 ◦C until an OD of 0.6. At this time point the expression was
induced by addition of IPTG and then samples were taken from the culture after every
hour. Furthermore, a second culture was shifted to 25 ◦C after IPTG was added. Here,
the last sample was taken after over night incubation. Samples of the supernatant were
checked on Coomassie stained SDS gels. Over-expression of SpHsv2 was observed for
the over night incubated culture (see suppl. figure 5.5). This condition was used for
large scale expression of SpHsv2. Already after His-Trap purification the protein was
almost pure and high yields could be obtained (see figure 4.8 A and C). However, size
exclusion purification of SpHsv2 displayed two peaks, which were both analyzed with
SDS-PAGE (see figure 4.8 B and D). Only one protein band was detected on SDS gels,
suggesting that SpHsv2 might form a dimer.
For biochemical analysis of Hsv2, I purified ScHsv2, which can be obtained in high
yields from bacterial expression. In addition, biochemical studies on PROPPINs mem-
brane binding were done with KlHsv2. The structure of KlHsv2 was solved by Dr. K.
Kühnel in our lab and based on the structure mutagenesis studies were planned.
ScHsv2 was expressed from pGEX-4T3 vector with an N-terminal GST-tag. E. coli
BL21(DE3) cells were used for expression of this construct in autoinducible media. Af-
ter over night incubation at 22 ◦C the cells were harvested and ScHsv2 purified with a
GSTrap FF column. On SDS gels co-purification of high yields of free GST was ob-
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Figure 4.9: Purification of ScHsv2 from E. coli BL21(DE3) cells
(A) GSTrap purification, (B) second GSTrap run after thrombin cleavage followed by (C) gel filtration
with a HiLoad 16/60 Superdex S75 column. Analysis of (D) GSTrap run one and two (E) and gel
filtration on SDS-PAGE. Cell extract (CE), supernatant (S), pellet (P), elution fractions (F), thrombin
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Figure 4.10: Purification of KlHsv2 from E. coli BL21(DE3) cells
Chromatograms and SDS-PAGE gels of KlHsv2 purified by (A) affinity chromatography using a His
Trap FF column followed by (B) gel filtration with HiLoad 16/60 Superdex S200 column.
served (see figure 4.9 A and D). Since the GST-tag is known to dimerize and might
influence with biochemical analysis, the tag was cleaved by thrombin treatment of the
purified protein. After this a second GSTrap run was performed. Here, the flow through
was collected, which contained the cleaved protein. Free GST and uncleaved protein
remained bound to the column (see figure 4.9 B and D). In size exclusion chromatogra-
phy the protein purity was further improved (see figure 4.9 C and E). High amounts of
KlHsv2 were obtained after expression from E. coli BL21(DE3) cells in autoinducible
media. His-Trap purification of this cell extract yielded almost pure protein in high
amounts. An additional gel filtration run was performed (see figure 4.10). Mutants of
ScHsv2 and KlHsv2 for biochemical experiments were purified in the same way as wild
type proteins.
Wild type KlHsv2, used for crystallization, KlHsv2GSlinker, KlHsv2Q274E , KlHsv2Q274D
and KlHsv2Y 272A/F273A were cloned and purified by Dr. K. Kühnel.
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4.2.1.3 Characterization of purified PROPPINs
During protein purification thermal shift assays were performed for the PROPPIN
homologs PaAtg18, CeAtg18, DmAtg18, KlAtg21, PaAtg21 and SpHsv2. In this Ther-
mofluor experiments 88 different buffer compositions (pHat screen) or additives (Addit
screen) were tested. Purified proteins mixed either with different buffers or additives
were supplemented with Sypro Orange. This fluorescent dye is quenched in aqueous
conditions. However, during the thermal shift from 25 ◦C to 95 ◦C the proteins unfold.
During this unfolding hydrophobic patches of the protein are exposed and Sypro Or-
ange can bind and Sypro Orange gets dequenched. An increase in fluorescence indicates
unfolding of the protein. Therefore, fluorescence changes correlate to unfolding of the
protein. With this method the melting temperature of a protein can be determined.
Different buffer conditions and additives can influence protein stability. A more stable
protein will unfold at higher temperature. As a control the protein in its purifica-
tion buffer was used. The crystallization probability of a protein increases, when the
protein is more stable. For this reason Thermofluor experiments were performed and
purification protocols were optimized based on these results.
The pHat screen was generally done after affinity purification of a new protein. A
buffer condition, which increases the melting temperature of this protein the most was
used for gel filtration purification of the protein and was therefore dialyzed into this
buffer overnight. After gel filtration the protein was subjected to the Additive screen.
Initial purifications of these PROPPINs were done in sodium phosphate buffer (50 mM
NaH2PO4 pH 7.5, 300 mM NaCl). Protein in this buffer was used as a reference in the
assay.
A clear shift of the melting temperature towards higher temperatures was observed
for PaAtg18 in sodium lactate buffer at pH 4.0 (see figure 4.11 A). In addition, different
other acidic buffers such as MES pH 5.0 and pH 5.4, sodium acetate pH 4.6 and sodium
lactate pH 4.4 increased the melting temperature. The Addit screen revealed some
salts (ammonium sulfate, potassium citrate, sodium malonate), spermine, PIPES and
imidazole as stabilizing additives (see figure 4.11 B). CeAtg18 was the only protein
preferring only basic buffers of all PROPPINs. Its stability was slightly increased in
buffers from pH 7.4 up to pH 8.8 (see suppl. figure 5.6 A). For further purification I
dialyzed the protein in CHES pH 8.0. Both CeAtg18 and DmAtg18 had an overall low
melting temperatures and the buffer conditions tested with the pHat screen did not




Figure 4.11: Thermofluor analysis of PaAtg18
Thermofluor experiments for PaAtg18 using the (A) pHat and the (B) Addit screen. Sypro Orange
fluorescence was monitored and dequenching indicates unfolding of the proteins. Temperature was
shifted from 25 ◦C to 95 ◦C. Shown conditions increased protein stability in comparison to protein
reference.
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Figure 4.12: Thermofluor analysis of KlAtg21
Thermofluor experiments using the (A) pHat and the (B) Addit screen. Dequenching of Sypro Or-
ange correlates with unfolding of the protein. Temperature was shifted from 25 ◦C to 95 ◦C. Shown




Figure 4.13: Thermofluor analysis of PaAtg21
Thermofluor experiments using the (A) pHat and the (B) Addit screen. Dequenching of Sypro Or-
ange correlates with unfolding of the protein. Temperature was shifted from 25 ◦C to 95 ◦C. Shown
conditions increased protein stability in comparison to protein reference.
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pH 5.2 (see suppl. figure 5.6 B). Different buffers in a pH range between 5.0 and 7.0
were identified for KlAtg21 to show the same curve as the reference curve or shifted the
fluorescence slightly towards higher temperatures (see figure 4.12 A). Therefore, MES
buffer pH 5.8 was chosen for further purification. Stronger effects on stability were
observed for some additives including the salts ammonium sulfate, potassium citrate
and sodium malonate as well as the polymer PEG 4,000 (see figure 4.12 B). In contrast
to the other PROPPINs PaAtg21 showed higher stability, since an increase in the Sypro
Orange fluorescence was detected at higher temperatures. From buffers tested in figure
4.13 A, MES pH 5.8 was selected for further PaAtg21 purification. The additives tested
with the Addit screen did not further increase the stability of PaAtg21. Ammonium
sulfate, sodium malonate and trifluoroethanol had small increasing effects on PaAtg21
stability (see figure 4.13 B). Also the purification protocol for SpHsv2 was optimized
using Thermofluor experiments. Here, citric acid buffer pH 5.5 supplemented with 500
mM NaCl were found to stabilize the protein.
After successful purification of PaAtg18, KlAtg21, PaAtg21 and SpHsv2, their CD
spectra in far UV were monitored in order to analyze their secondary structures. These
measurements were carried out in NaF buffer. These proteins are predicted to fold as
β-propellers therefore the typical spectrum of a protein consisting of β-strands was ex-
pected. CD spectra from 190 nm to 260 nm were measured for PaAtg18 and PaAtg21
(see suppl. figure 5.7 A) as well as KlAtg21 and SpHsv2 (see suppl. figure 5.7 B). All
spectra showed a minimum around 216 nm. This minimum indicates the secondary
structure of these proteins consists of mainly β-strands. In addition, stability of these
proteins was investigated with far UV. Stability of proteins is important for their crystal-
lization, since it can take weeks or even months before a protein crystallizes. Therefore,
I recorded the thermal unfolding curves of these PROPPINs between 20 ◦C and 90 ◦C
at 216 nm (see suppl. figure 5.7 C and D). All proteins were stable and their unfolding
occurred in a single transition. SpHsv2 and PaAtg21 had their transition midpoints
around 65 ◦C, PaAtg18 and KlAtg21 had their midpoint around 52 ◦C.
In order to determine stable fragments of PaAtg18, KlAtg21 and PaAtg21 suitable
for crystallization, proteolytic digestions of these proteins were performed with twelve
different proteases each. Smaller fragments are usually more compact and less disor-
dered and therefore crystallization probability increases. Limited proteolysis was done
for different time frames either 5 min, 10 min, 15 min or 30 min and for comparison undi-
gested protein was also loaded onto the gel. For PaAtg18 no stable fragment comprising
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Figure 4.14: Limited proteolysis of PaAtg18
Purified protein was cleaved with the indicated proteases for a time course up to 30 min at RT. Samples
were analyzed with Coomassie stained SDS gels.
protein very quickly. Treatment of all other proteases resulted the uncleaved protein
band (see figure 4.14).
KlAtg21 showed already after purification a double band and with proteolytic di-
gestion I wanted to check in addition, whether the second smaller band corresponds to
a stable fragment. Indeed, treatment of purified KlAtg21 thermolysin and actinase re-
sulted in digestion of the larger molecular weight band whereas the smaller band stayed
unchanged (see figure 4.15). Furthermore subtilisin and proteinase K again completely
digested the protein. Only the before observed band of 35 kDa could be identified as
stable fragment of KlAtg21. This band was isolated and analyzed by N-terminal protein
sequencing. The N-terminal His-tag was detected with this method, consequently the
C-terminus was cleaved. In limited proteolysis of PaAtg21 only very small fragments of
less than 15 kDa were observed after treatment with trypsin, clostripain and bromelain
(see suppl. figure 5.8).
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Figure 4.15: Limited proteolysis of KlAtg21
Purified protein was cleaved with the indicated proteases for a time course up to 30 min at RT. Samples
were analyzed with Coomassie stained SDS gels.
During purification of SpHsv2 over the gel filtration column the protein was eluted in
two peaks (see figure 4.16 A). In order to investigate whether SpHsv2 forms an oligomer
I performed an analytical gel filtration experiment to determine the molecular weight
of the protein in both peaks. Standards of molecular weight markers were run on the
column and a standard curve was determined by plotting the ratio between elution
volume and void volume (Ve/Vo) versus their molecular weights (see figure 4.16 B).
SpHsv2 peak I eluted after 14 ml and the molecular weight of this complex is 82
kDa. The second peak was observed after 16 ml and corresponds to 41 kDa. These
results indicate, that SpHsv2 peak I contain a SpHsv2 dimer and peak II to a monomer.
However, dimerization of PROPPINs has not been described so far and complex forma-
tion can also be induced by oxidation of cysteine residues. SpHsv2 contains cysteines
and therefore I tested in a next step, whether a reducing agent can prevent dimeriza-
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Figure 4.16: Analytical gel filtration analysis of SpHsv2
(A) In analytical gel filtration peak I eluted after 14 ml and peak II after 16 ml. (B) Comparison
of the Ve/Vo to protein standards revealed that peak I represents a dimerized of 82 kDa and peak II
corresponds to a monomer of 41 kDa. (C) Addition of the reducing agent TCEP reduced dimerization.
in analytical gel filtration (see figure 4.16 C). This peak contained the monomeric form
of SpHsv2. In addition, other reagents like DTT and β-mercaptoethanol reduced the
dimer formation of SpHsv2.
4.2.1.4 Crystallization of PROPPINs
One major aim of this project was to crystallize Atg18, Atg21 or alternatively Hsv2.
Therefore, I purified several proteins from different species of either Atg18, Atg21 or
Hsv2. The buffer conditions were optimized in a way, that the proteins were most stable
and their secondary structures were checked. In a next step, ScAtg18, PaAtg18, KlAtg21
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and SpHsv2 were subjected to crystallization screens in order to get first crystallization
hits, then improving these conditions and finally obtaining well diffracting crystals were
the goal.
ScAtg18 was purified from High5 insect cells in a buffer containing 50 mM NaH2PO4
at pH 8.5 and 500 mM NaCl. This protein was obtained in very small yields and could
be concentrated up to 5 mg/ml. This was used to set up a crystal screen with one
drop per condition and incubate at 20 ◦C. The RockImager took frequently images
of each single condition, so that possible crystal growth was monitored. From this
crystallization screen two conditions yielded spherulites (see figure 4.17 A and table
4.2). In order to check these pre-crystalline structures for their protein content, a dye
was added to the crystallization condition. After some time, the dye was taken up by
the spherulites, indicating that these consists of protein and not salt. Due to low protein
yields, working with ScAtg18 was stopped and no further optimization was done.
Furthermore, SpHsv2 was subjected to crystallization screens. Purified in 30 mM
citric acid pH 5.5 and 500 mM NaCl, crystal plates for SpHsv2 were set up separately
with protein from dimer (peak I) and monomer fraction (peak II) as well as with protein
treated with DTT. Different protein concentrations of 30 mg/ml, 20 mg/ml, 15 mg/ml
and 10 mg/ml were tested. From these screens I found a few conditions in which pre-
crystalline structures were formed (see figure 4.17 B and table 4.2). Protein involvement
in these structures were confirmed by staining with a dye. In further optimization
screens 1 µl protein drops were mixed with 1 µl mother liquor of crystallization buffer.
Here, also different protein concentrations of 30 mg/ml, 20 mg/ml and 10 mg/ml were
tested. However, none of the optimization screens yielded crystals.
Moreover, KlAtg21 was purified and dialyzed into different buffers before it was
subjected to crystallization screens. For membrane proteins it was reported, that their
binding specificity can be improved by addition of MgCl2 [133]. Probably due to effects
on changed protein packing. Therefore, one buffer used for crystallization trials of
KlAtg21 contained 30 mM MES pH 5.8, 300 mM NaCl, 5 mM MgCl2 and 1 mM DTT. If
MgCl2 has an influence on a tighter packing of the protein, the crystallization probability
would be increased. Crystallization trials set up with KlAtg21 in a concentration range
from 10 mg/ml to 30 mg/ml also yielded in spherulites (see figure 4.17 C and table 4.2).
Protein content was again confirmed by staining. Subsequently, optimization screens
were set up in 24 well format with 1:1 µl drops and in the 96 well format. Here, also the
stability improving additives found with the Addit screen in Thermofluor analysis were
implemented. Crystallization conditions containing PEG 4,000 and sodium malonate






Figure 4.17: Spherulites resulting from PROPPIN crystallization
Spherulites obtained from crystallization trials of (A) ScAtg18 (No. 2) (B) SpHsv2 (No. 9) (C)
KlAtg21 (No. 5) and (D) PaAtg18 (No. 3). The number correspond to the crystallisation conditions
in table 4.2.
crystal packing. These crystals were sent to the synchrotron for X-ray data collection.
Unfortunately, all crystals showed the typical diffraction pattern of salt crystals. In
addition, buffer consisting of 10 mM MES pH 5.8, 300 mM NaCl and 1 mM DTT was
used. The buffer concentration was reduced and MgCl2 was taken out to minimize salt
crystal formation. Protein in the concentration of 38 mg/ml and 18.8 mg/ml was used
for new screens. So far, no additional potential crystallization conditions were identified.
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Table 4.2: Initial crystallization conditions for PROPPINs
No. PROPPIN Concentration Condition Drop set up Temp.
1 ScAtg18 5 mg/ml 0.1 M Tris pH 8.5
1 M Lithium sulfate monohydrate
0.01 M Nickel-II-chloride hexahydrate
100:100 nl 20 ◦C
2 ScAtg18 5 mg/ml 0.1 M Hepes pH 7.5
1.5 M Lithium sulfate monohydrate
100:100 nl 20 ◦C
3 PaAtg18 6.5 mg/ml 0.1 M Tris pH 8.5
20 % (w/v) PEG MME 2,000
200 mM Trimethylamine-N-oxide
100:100 nl 20 ◦C
4 KlAtg21 20 mg/ml 0.1 M MES monohydrate pH 6.5
0.6 M Sodium fluoride
100:100 nl 20 ◦C
5 KlAtg21 30 mg/ml 0.1 M MES monohydrate pH 6.0
0.9 M Sodium fluoride
100:100 nl 20 ◦C
6 KlAtg21 15 mg/ml 0.1 M MES monohydrate pH 6.0
15 % (v/v) PEG 400
0.1 M Calcium acetate hydrate
100:100 nl 20 ◦C
7 KlAtg21 30 mg/ml 0.1 M tri-Sodium citrate dihydrate pH 5.6
1 M Ammonium phosphate monobasic
100:100 nl 20 ◦C
8 KlAtg21 20 mg/ml 0.1 M Hepes pH 7.5
2.4 M Sodium malonate
100:100 nl 20 ◦C
9 SpHsv2 30+15 mg/ml 0.1 M Tris pH 7.5
20 % (v/v) Ethanol
100:100 nl 20 ◦C
10 SpHsv2 30+15 mg/ml 0.1 M Sodium cacodylate trihydrate pH 6.5
18 % (w/v) PEG 8,000
0.2 M Calcium acetate hysdrate
100:100 nl 20 ◦C
11 SpHsv2 10 mg/ml
(dimer)
Citric acid anhydrous pH 4.0
3 M Sodium chloride
100:100 nl 20 ◦C
Crystallization screens were also set up for PaAtg18. For first screens I used protein
purified in 30 mM sodium lactate pH 4.0, 300 mM NaCl and 1 mM DTT buffer. The
protein was used at a concentration of 30 mg/ml, 15 mg/ml, 12 mg/ml and 6 mg/ml.
In addition, protein at a concentration of 13 mg/ml, 6.5 mg/ml, 3 mg/ml and 1 mg/ml
purified in 10 mM sodium lactate pH 4.0, 300 mM NaCl and 1 mM DTT was used.
Since for long time no initial crystal hits were observed, crystallization screens were set
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up at 20 ◦C and 4 ◦C. Recently microcrystals were observed and optimization screens
were carried out, but further optimization is needed (see figure 4.17 D and table 4.2).
A recent paper reported from crystallization initiation and crystal diffraction im-
provement using molecularly imprinted polymers (MIP) [59]. These polymers were
added to crystallization screens and can function as nucleation sites. I prepared these
MIPs for KlAtg21, PaAtg18 and KlHsv2. Crystallization conditions were in the mean-
while optimized, therefore I used KlHsv2 as a control to see, whether crystallization
is influenced. These MIPs were added to the hanging drops of 24 well plates. So far,
no further initial crystallization conditions could be identified for neither KlAtg21 nor
PaAtg18. However, crystals were obtained for KlHsv2 and sent to the synchrotron.
The taken diffraction data sets showed, that the crystals diffracted up to 3 Å. Crystal
diffraction in this case was not improved to the previously determined KlHsv2 struc-
ture, but MIPs also did not disturb crystal growth. Molecular printed polymers can be
implemented again, when initial crystal hits are identified.
4.2.2 Functional analysis of PROPPINs
4.2.2.1 Optimization of methods to analyze protein-lipid interaction
In order to study protein-lipid interaction of PROPPINs I first needed to establish
conditions where no non-specific membrane lipid interactions occurred [175]. So far,
PROPPIN membrane binding was mainly investigated using protein-lipid overlay assays
[144, 133, 151]. For this reason, I wanted to use this method first to probe lipid binding,
of the ScHsv2 mutants with PIP strips to study the involvement of these residues in PIP
binding. Therefore, I started first to optimize the buffer and blocking solutions for PIP
strips to find optimal conditions for comparison of all mutants. BSA and milk powder
are commonly used blocking reagents, in addition PBS, TBS or 50 mM Tris-HCl pH 7.5
were tested (see figure 4.18 A). The buffer was additionally substituted with 0.5 mM
MgCl2, which was reported to increase the specificity of PROPPIN phosphoinositide
binding [133]. Here, PBS-T, 0.5 mM MgCl2 and 2 % BSA were found to give best
results with a low background. The protein concentration used was 1 µg/ml. After the
buffer conditions were optimized, ScHsv2 mutants with GST-tag and also free GST as
a control were analyzed with PIP strips. However, in some repetitions free GST bound
to PI3P. Also, testing the mutants with these PIP strips did not give conclusive results.
Thereafter, for quantitative analysis of ScHsv2 mutants, I analyzed the mutants with
Cova PIP specificity plates. Here, TMB (3,3’,5,5’ - tetramethylbenzidine) is provided
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Figure 4.18: Optimization of PIP strips and Cova PIP plate
(A) Buffer optimization for PIP strip analysis using either BSA or milk as blocking reagent dissolved
in PBS, TBS or 50 mM Tris-HCl pH 7.5. 0.5 mM MgCl2 was added to the buffer. Protein was tested at
different concentrations of 1 µg/ml and 0.1 µg/ml. (B) Cova PIP specificity plate used for quantitative
analysis of PIP specificity of ScHsv2.
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as a substrate for HRP (horse radish peroxidase) which can then be monitored by
absorbance measurements. I also tried different buffer conditions for the Cova PIP
specificity plate, but wild type ScHsv2 did not show any binding specificity for a certain
PIP. For free GST, wild type ScHsv2 and ScHsv2FTTG similar absorbances were detected
(see figure 4.18 B).
Since GST alone bound to PIP strips and dimerization of GST-tagged protein might
also affect binding, I then cleaved the GST-tag from all proteins with thrombin and used
untagged ScHsv2 protein for further analysis. Thrombin cleavage was more efficient in
Hepes buffer pH 7.0 compared to citric acid pH 5.5 buffer, which was previously used
to purify ScHsv2 (see suppl. figure 5.9 A). For removal of free GST and uncleaved
GST-tagged ScHsv2 a second GSTrap run followed by a final gel filtration step was
performed. In order to detect free ScHsv2 two rabbit serums with antibodies raised
against the C-terminus of ScHsv2 were tested (provided by Prof. M. Thumm). For
this purpose, purified protein was spotted onto a nitrocellulose membrane. Wild type
ScHsv2, GST and ScHsv2FTTG mutant were tested in different concentrations and also
the anibodies were used in two concentrations (1:1000 and 1:2000). The antibodies
specifically detected ScHsv2 wild type and FTTG mutant, but not GST (see suppl.
figure 5.9 B). In a next step, purified ScHsv2 protein without GST-tag was checked
for its stability. Here, the protein was subjected to an analytical gel filtration run to
exclude aggregation of the protein. ScHsv2 eluted in a single peak from the column,
an additional peak was observed in the molecular weight range of thrombin (see suppl.
figure 5.10). SDS gel check of the eluted peak showed pure ScHsv2 with small amounts of
thrombin contamination. Thrombin cleaved ScHsv2 mutant proteins were again used to
probe PIP strips and the Cova PIP specificity plates using different buffer conditions and
with or without addition of MgCl2. Data were not reproducible similar to the situation
with GST-tagged protein. Freezing and thawing might also influence phosphoinositide
binding of Hsv2. In order to avoid this problem the mutant proteins were purified using
GST SpinTrap columns, which allowed the “fresh” purification of several mutants at the
same time (see suppl. figure 5.11). Wild type and mutant proteins were again cleaved
with thrombin and a second GST SpinTrap purification step was performed. The fresh
purified protein was then directly used for PIP strip analysis. However, also PIP strip
experiments performed with non-thawed proteins did not give conclusive results (see
suppl. figure 5.12).
Taken these results together, PIP strip experiments and quantification using the PIP
specificity plate were not reproducible and did not give conclusive results for mutagenesis
studies of ScHsv2.
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Figure 4.19: Optimization of lipid composition for flotation assay
(A) ScHsv2wildtype and ScHsv2FTTG were found to bind non specifically to liposomes containing 20
% or 10 % PS. Neutral liposomes consisting of 75 % PC, 23 % PE and 2 % Texas Red-PE were not
bound by both ScHsv2 proteins. (B) Upon addition of different amounts of PI3P restored liposome
binding was investigated. 1 % and 2 % PI3P in neutral liposomes were found to be bound by wild
typre ScHsv2. In 5 % and 10 % containing liposomes unspecific binding of ScHsv2FTTG was observed.
(Busse et al., submitted)
Another approach to probe protein-lipid interactions are liposome co-flotation as-
says. Here, the protein is incubated with liposomes before the mixture is put at the
bottom of a non-continuous Nycodenz gradient. If the protein interacts with the li-
posomes, it floats with the liposomes to the top of the gradient during centrifugation.
After centrifugation aliquots are taken and checked in Western blot analysis. First, I
identified conditions where no unspecific protein-lipid binding was observed. To start
with I prepared commonly used small unilamellar vesicles (SUVs) containing PC, PS,
PE, PI3P and Texas Red-PE for visualization. This experiment was performed with
wild type ScHsv2 and the FTTG mutant as a negative control. Strong binding of both
wild type and ScHsv2FTTG was observed in the presence of either 10 % PS or 20 %
PS. Therefore, I continued to optimize the liposome lipid composition in a way, that
binding of the FTTG mutant was diminished. Since negatively charged lipids are often
involved in unspecific binding, PS was left out. Only liposomes without any PS showed
no interaction with the tested proteins (see figure 4.19 A). In a next step, different
PI3P concentrations were added to the liposomes in order to observe liposome binding
of wild type ScHsv2 but no binding of ScHsv2FTTG upon PI3P. Here, 2 % PI3P was
found to be sufficient for interaction of wild type ScHsv2, but the FTTG mutant did
not bind (see figure 4.19 B). ScHsv2wildtype protein also bound to 1 % PI3P contain-
ing liposomes. When 5 % or 10 % PI3P was added, also ScHsv2FTTG bound to the
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liposomes. Binding of ScHsv2FTTG was likely due to non-specific ionic interactions at
higher PI3P concentrations.
Presence of the liposomes in the low density region of the gradient after centrifu-
gation was confirmed by fluorescence measurements of an SDS gel. Fluorescence of
Texas Red was scanned with 532 nm excitation and 670 nm emission wavelength. The
liposomes were detected in the upper two fractions, corresponding to the low density
part of the gradient (see suppl. figure 5.13).
2 % PI3P, 73 % PC, 23 % PE and 2 % Texas Red-PE containing liposomes are
optimal for studying ScHsv2 mutant interaction with liposome flotation assays.
In addition to the identification of residues involved in binding to phosphoinositides,
I also wanted to determine the binding affinities and directly measure the stoichiometry
for PIP binding of PROPPINs. The method of choice for this purpose is isothermal
titration calorimetry (ITC). However, studying protein-lipid interaction by ITC is chal-
lenging. I started to use the water soluble head group of PI3P (PI3P-diC4) for first
titration experiments with purified ScHsv2. For this purpose, PI3P-diC4 was dissolved
at a final concentration of 50 µM in HP150 buffer (20 mM Hepes pH 7.4, 150 mM KCl).
The ligand was stepwise added to 2 µM ScHsv2 in a total of 20 injections, each 15 µl and
a spacing time of 250 sec in between. Measurements were done at 25 ◦C in the VP-ITC
MicroCalorimeter. However, no significant heat changes were observed (see figure 4.20
A). Also changes in concentrations and titrating ScHsv2 into the ligand instead did not
give any indication for binding.
In another experiment I used PaAtg18 for titration analysis, this protein can be
purified also in high yields and showed strong binding to PI(3,5)P2 in PIP strip analysis.
The soluble analogue of PI(3,5)P2 (PI(3,5)P2-diC6) was dissolved in 20 mM Hepes
and 300 mM NaCl buffer. Different concentrations of 100 µM and 50 µM for the
ligand were tested and titrated in 1 mM PaAtg18. These experiments were done in
an ITC200 MicroCalorimeter, since here the needed volumes are much smaller. Even
upon addition of 0.5 mM MgCl2 no heat changes were detected. Furthermore, bubble
formation interfered with measurements.
Since no binding of the soluble head groups to either ScHsv2 or PaAtg18 was ob-
served, I next tested PI3P incorporated into liposomes for binding ScHsv2. I prepared
large unilamellar vesicles (LUVs) in HP150 buffer with the extrusion method. The mean
diameter of LUVs was determined by DLS and was 140 nm. LUVs were placed into the
sample cell, of the VP-ITC machine, and ScHsv2 was titrated into the liposomes. The
liposomes consisted of either 2 % or 5 % PI3P, 73 % or 70 % PC, respectively, 23 % PE
and 2 % Texas Red-PE. Different concentrations of ligand in the liposomes (2 % and
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Figure 4.20: Optimization of ITC measurements
(A) Titration of dibutyl-PI3P into ScHsv2 (black line) in comparison to buffer titration (red line). (B)
Titration of ScHsv2 into large unilamellar vesicles containing 2 % PI3P (black line) and the control
buffer titration (red line). (C) Titration of ScHsv2 into small unilamellar vesicles with 2 % PI3P (black
line). Red trace shows the buffer titration. (D)Titration of ScHsv2 into small unilamellar vesicles with
2 % PI(3,5)P2 (black line). Red trace shows the buffer titration.
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5 % PI3P), liposomes (1 mg/ml - 4 mg/ml total lipid) and ScHsv2 (20 µM - 190 µM)
were tested. However, for some measurements a heat change was observed for the first
injections, but all titrations resulted in precipitation of protein with liposomes. That
the liposomes precipitated was visible due to incorporation of Texas Red (see figure
4.20 B). Stirring of the LUVs during the measurements might lead to precipitation,
even when the slowest stirring speed was chosen. In addition, the extrusion method
does not prevent micelle formation of some lipids, which might induce aggregation and
precipitation.
Therefore, I prepared small unilamellar vesicles, which were also used for flotation
assays. Liposome formation is done with a Sephadex G50 column, this avoids that
micelles elute together with vesicles like on a size exclusion chromatography. Further-
more, SUVs are smaller in size. Using FFF-MALLS analysis of either 2 % PI3P or
PI(3,5)P2, 73 % PC, 23 % PE and 2 % Texas Red-PE containing liposomes revealled
a mean size distribution of the radii of 18 nm for 2 % PI3P containing liposomes and
21 nm for PI(3,5)P2 containing liposomes (these measurements were done by Dr. J.
M. Hernandez). Total phosphate concentration was determined by the phosphomolyb-
date method and then the PI3P concentration calculated. ITC measurements were
done with an accessible PI3P concentration in the liposomes of 5 µM to 10 µM and
a ScHsv2 concentration ranging from 50 µM to 100 µM. ScHsv2 was titrated into the
liposomes using a VP-ITC machine with a total of 20 injections. The first injection
was done with a volume of 3 µl and the following ones with 15 µl each. The spacing
time was increased to 500 sec to allow recovering of the heat change to the baseline.
Measurements were done at 25 ◦C. During measurements large enthalpy changes were
observed in the beginning, which decreased until saturation was reached (see figure 4.20
C). These measurements were used to determine the binding affinity and stoichiometry
of phosphoinositide binding. Furthermore, liposomes were also prepared with PI(3,5)P2
and similar concentrations for the titration were used. Here, also a titration curve was
observed, that was suitable for characterization of the binding reaction (see figure 4.20
D).
4.2.2.2 PROPPINs binding specificity to phosphoinositides
S. cerevisiae homologs of Atg18 and Atg21 purified from E. coli could only be
obtained in small yields or with tags like GST (glutathione-S-transferase) [133, 151] or
MBP (maltose binding protein) [144]. However, the GST-tag leads to dimerization of
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Figure 4.21: Selective binding of PROPPINs to phosphoinositides
(A) Protein-lipid overlay assay analysis of ScHsv2, KlHsv2, SpHsv2, PaAtg18, KlAtg21 and PaAtg21.
The following lipids were spotted on the membrane - 1: Lysophosphatidic Acid (LPA), 2: Lysophos-
phocholine (LPC), 3: PI, 4: PI(3)P, 5: PI(4)P, 6: PI(5)P, 7: PE, 8: PC, 9: Sphingosine-1-phosphate
(S1P), 10: PI(3,4)P2, 11: PI(3,5)P2, 12: PI(4,5)P2, 13: PI(3,4,5)P3, 14: Phosphatidic Acid, 15: PS,
16: Blank. (B) Flotation assay of ScHsv2, KlHsv2, PaAtg18 and KlAtg21 with liposomes containing
1 % of the indicated phosphoinositide, 74 % PC, 23 % PE and 2 % TR-PE. All conditions were tested
with at least three replicates.
the proteins and Dove et al. [133] reported a 2.5 fold difference in binding affinity of
ScAtg18 in comparison to GST-ScAtg18.
During this study, I purified homologs of Atg18, Atg21 and Hsv2 from other yeast
species, which can be obtained in high amounts, carrying a small 6x His-tag or are stable
without any tag. In a first step, I used PIPstrips to analyze the phosphoinositide binding
specificities of these proteins (see figure 4.21 A). ScHsv2 was detected using the Hsv2-
antibody and showed binding to PI3P and to a small amount to PI(3,4,5)P3. KlHsv2
and SpHsv2, both with His-tag, show binding to PI3P and PI(3,5)P2 and binding was
detected with a penta-His antibody. KlHsv2 seems to have a higher affinity to PI(3,5)P2
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than SpHsv2, which binds stronger to PI3P. PaAtg18 binds strongly to PI(3,5)P2 and
to a lower extent to PI3P and PI(3,4,5)P3. Weak binding to PI3P and PI(3,5)P2 was
detected for both KlAtg21 and PaAtg21.
These PIPstrips were mainly used in literature to investigate phosphoinositide bind-
ing specificity. Here, flotation assays were employed as a second method to characterize
phosphoinositide specificities. Furthermore this method is more reliable since liposomes
are used instead of a plain membrane spotted with concentrated phosphoinositides.
Liposomes containing 74 % PC, 23 % PE, 2 % TR-PE and 1 % of indicated phospho-
inositide were used (see figure 4.21 B). Liposomes were incubated with purified ScHsv2,
KlHsv2, PaAtg18 and KlAtg21, subjected to ultracentrifugation with a nycodenz gra-
dient and fractions were analyzed by immunoblotting. All PROPPINs bound to both
PI3P and PI(3,5)P2, because the proteins were present in the top fractions. When
no binding occurs protein is found in the lower fractions, which corresponds to a high
Nycodenz concentration. Compared to the other PROPPINs PaAtg18 shows weaker
binding to PI3P becuase the protein was detected to the same extent in all 6 lanes.
Taken together, these data show that PROPPINs bind with high specificity to PI3P
and PI(3,5)P2.
4.2.2.3 Characterization of Hsv2 membrane binding sites
The FRRG motif of PROPPINs was reported to be essential for phosphoinositide
binding [151]. Mutagenesis of this motif to FTTG resulted in loss of binding. Our
structure of KlHsv2 revealed that the two arginines of this motif point into opposite
directions. Each indicating a separate potential binding pocket. In the KlHsv2 crystal
structure both potential pockets were occupied by sulfates. A third sulfate was found
on the other side of the β-propeller.
In order to investigate the involvement of amino acids from both potential pockets
in phosphoinositide binding they were mutated to alanines in ScHsv2. For controls, the
FTTG and FAAG mutants were generated as well as the ScHsv2R123A mutant. This
residue was chosen because of its location close to the third sulfate in KlHsv2. Binding
site I includes the Arg264, the first Arg from the FRRG motif. In addition His223,
Ser243, Thr247, Arg250 and Glu262 were mutated to alanines. From the second pocket
the conserved residues Arg265, Lys290, Thr292, His294 and Lys269 were mutated to
alanines.






















Figure 4.22: Characterization of ScHsv2 membrane binding site I and II
Analysis of amino acids involved in phosphoinositide binding by mutagenesis of conserved residues in
ScHsv2. Flotation assays were performed with both control liposomes consisting of 23 % PE, 2 %
TR-PE and 75 % PC and liposomes composed of 2 % PI3P, 23 % PE, 2 % TR-PE and 73 % PC. (A)
Wildtype ScHsv2, FTTG and FAAG mutants were tested as well as ScHsv2H123A as controls. (B)
Amino acids conserved in the potential binding site I were analyzed. (C) Mutated residues of binding
pocket II are shown. In small letters the corresponding amino acids in KlHsv2 are given. At least three
replicates were done for each condition.
Flotation assays with liposomes consisting of 2 % PI3P, 23 % PE, 2 % TR-PE and 73
% PC were done with each alanine mutant. As control liposomes containing 23 % PE,
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2 % TR-PE and 75 % PC were used to show that binding is PI3P specific. Figure 4.22
A shows wild type ScHsv2 and ScHsv2R123A binding to 2 % PI3P containing liposomes
but not to control liposomes lacking PI3P. This shows that the region surrounding the
third sulfate is not involved in membrane binding. ScHsv2FTTG and ScHsv2FAAG do
not bind to liposomes.
In the potential binding site I (see figure 4.22 B) Ser243 and Arg264 mutation
resulted in loss of PI3P binding. These residues are essential for PI3P binding. Mutants
ScHsv2T247A and ScHsv2R250A showed reduced ability to bind to liposomes with PI3P,
suggesting an involvement in binding, but these residues are not essential. ScHsv2H223A
and ScHsv2E262A are not effected in binding to PI3P containing liposomes.
In the second potential phosphoinositide binding site Arg265 and His294 are essential
residues, in addition Lys290 and Thr292 are involved in binding (see figure 4.22 C). In
contrast, mutation of Lys269 showed no effect and behaved like wild type ScHsv2.
The analysis of ScHsv2 mutants with flotation assays identified a set of conserved
amino acids essential or involved in PI3P binding. These results strongly support the
presence of two phosphoinositide binding sites in PROPPINs.
4.2.2.4 Determination of binding affinity and stoichiometry
In order to directly determine the stoichiometry and affinities for PI bining PROP-
PINs ITC measurements were performed.
ITC measurements were done by titrating purified proteins into liposomes containing
23 % PE, 2 % TR-PE, 73 % PC and either 2 % PI3P or 2 % PI(3,5)P2 in HP150 buffer
at pH 7.4. When KlHsv2 was titrated into liposomes with 2 % PI3P a KD of 480
nM was determined (see figure 4.23 A, data summarized in table 4.3) and a three
fold higher binding affinity for PI(3,5)P2 was measured. ScHsv2 (figure 4.23 B) and
PaAtg18 (figure 4.23 C) show similar affinities for PI3P as KlHsv2. Also ScHsv2 is
comparable in PI(3,5)P2 binding to KlHsv2. Interestingly, PaAtg18 has a very high
affinity for PI(3,5)P2 (KD = 70 nM). KlAtg21 has lower affinities to the two tested
phosphoinositides (figure 4.23 D).
ScHsv2 has a binding stoichiometry of 0.5 to PI3P, meaning a 1:2 protein to ligand
ratio. The other tested PROPPINs show a lower stoichiometry between 0.35 and 0.37.
These titrations into PI3P containing liposomes need to be further optimized to obtain
a better curve start and resulting from this a more distinct binding stoichiometry.





KlHsv2 – PI3P KlHsv2 – PI(3,5)P2 ScHsv2 – PI3P ScHsv2 – PI(3,5)P2 
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Figure 4.23: ITC measurements of PROPPINs with liposomes containing PI3P or
PI(3,5)P2
Isothermal titration calorimetry curves are shown from titrations of (A) KlHsv2 (B) ScHsv2 (C)
PaAtg18 (D) KlAtg21 into liposomes consisting of 23 % PE, 2 % TR-PE, 73 % PC and either 2 %
PI3P or 2 % PI(3,5)P2. Data was fitted with a One Set of Sites fitting model.
For PI(3,5)P2 the stoichiometry was in general less than the 1:2 ratio observed for
PI3P (N ≈ 0.6). Which might indicate that not all proteins bind a second ligand, which
might depend on the pH.
I also used flotation assays to study binding affinities. With this method phos-
phoinositide concentrations in liposomes needed for sufficient PROPPIN binding were
determined. A set of liposomes were prepared containing PI3P in a range of 0 % to 10
% (0 %, 0.025 %, 0.05 %, 0.1 %, 0.2 %, 0.3 %, 0.4 %, 0.5 %, 1 %, 2 %, 5 % and 10
%) and the same liposomes were also prepared with PI(3,5)P2, PC amounts in the li-
posomes were adjusted accordingly. ScHsv2 and KlHsv2 were added to these liposomes
and binding was analyzed by immunoblotting followed by quantification of the Western
blots using the AIDA software.
Here, the upper (low density) two fractions from flotation assays were considered
to be liposome bound protein, the lower 4 fractions contain unbound protein. After








































































































Figure 4.24: Local membrane concentration of phosphoinositides needed for Hsv2 binding
Quantification of flotation assays and plotting of bound protein fractions versus % phosphoinositide
concentration for (A) KlHsv2 with PI3P containing liposomes, (B) KlHsv2 on PI(3,5)P2, (C) ScHsv2
with PI3P liposomes and (D) ScHsv2 with liposomes of PI(3,5)P2. Data analysis together with A.
Scacioc.
multiplied with 100 % to get the percentage of bound protein. The bound protein frac-
tion was plotted versus the phosphoinositide concentration in liposomes. All conditions
were measured in four replicates and all data were plotted together for subsequent data
fitting (see figure 4.24). Fitting was performed in order to get KD, minimal KD and
maximal KD. Data are summarized in table 4.4.
Resulting from this a KD of 1.52 % was determined for binding of KlHsv2 to PI3P
(figure 4.24 A) and 0.11 % for PI(3,5)P2 containing liposomes (figure 4.24 B). This
means that a local concentration of 1.5 % of PI3P is needed for 50 % of KlHsv2 to bind.
In contrast, ten times less PI(3,5)P2 is needed. ScHsv2 has a KD of 0.26 % for PI3P
and 0.12 % for PI(3,5)P2. These data were analyzed together with A. Scacioc.
These results are in agreement with the ITC data showing that the affinity of PROP-
PINs is higher to PI(3,5)P2 than to PI3P.
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Table 4.3: Binding affininties and stoichiometries of PROPPINs to phosphoinositides
PROPPIN Phosphoinositide Binding affinity Stoichiometry Number of
KD [µM] N measurements
KlHsv2 PI3P 0.48 ± 0.04 0.35 3
PI(3,5)P2 0.18 ± 0.01 0.58 3
ScHsv2 PI3P 0.67 ± 0.02 0.50 7
PI(3,5)P2 0.22 ± 0.07 0.66 4
PaAtg18 PI3P 0.53 ± 0.09 0.37 3
PI(3,5)P2 0.07 ± 0.012 0.62 3
KlAtg21 PI3P 0.89 ± 0.08 0.37 3
PI(3,5)P2 1.38 ± 0.23 0.39 3
(average ± SEM*)
* Average and SEM was determined from at least three measurements.
Table 4.4: Determination of binding affinity KD based on %-bound protein versus % phosphoinositide
in liposomes
PROPPIN Phosphoinositide KD [%] KDmin [%] KDmax [%]
KlHsv2 PI3P 1.52 1.02 2.32
PI(3,5)P2 0.11 0.07 0.14
ScHsv2 PI3P 0.26 0.17 0.31
PI(3,5)P2 0.12 0.10 0.17
4.2.2.5 pH dependency of phosphoinositide binding for Hsv2
Docking of PI3P and PI(3,5)P2 into KlHsv2 binding sites I and II were performed
by A. Scacioc [24]. Interestingly docking of PI(3,5)P2 could only be performed when
KlHsv2 His178 of binding site I and His294 of binding pocket II were protonated. ScHsv2
contains an additional histidine in binding site II. Considering the stoichiometry of
PROPPINs to PI(3,5)P2 of ≈ 0.6 we speculated that protonation of these histidines
might influence the stoichiometry of PI(3,5)P2 binding. Furthermore it is well known
that acidification of e.g. endosomes and lysosomes/vacuole is needed for subsequent
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Figure 4.25: Involvement of ScHsv2 histidines from binding sites 1 and 2 on phospho-
inositide binding
Flotation assays with ScHsv2H223A and ScHsv2H294A mutants on control liposomes of 75 % PC; 23 %
PE and 2 % TR-PE. In addition liposomes with either 2 % PI3P or 2 % PI(3,5)P2, 23 % PE, 2 %
TR-PE and 73 % PC were used.
cellular functions [176, 177]. Whereas the overall intracellular cytoplasmic pH in yeast
is 7.0 to 7.2, but i.e upon glucose starvation the pH decreases [178].
Hence, the effect of mutated ScHsv2 His223 (KlHsv2 His178) and His294 (KlHsv2
His249) was tested on PI(3,5)P2 in addition to the measurements with PI3P shown in
figure 4.22. Flotation assays with liposomes consisting of 2 % PI(3,5)P2, 23 % PE, 2
% TR-PE and 73 % PC were done with the ScHsv2H223A and ScHsv2H294A mutants
in HP150 buffer at pH 7.4. Figure 4.25 shows that His223 in pocket I has no effect
on phosphoinositide binding. In contrast His294 mutation abolished binding to PI3P
containing liposomes and reduced binding to PI(3,5)P2.
In order to address a potential underlying pH dependence of binding, isothermal
titration calorimetry measurements were performed at different pHs with KlHsv2 and
ScHsv2 using liposomes containing either 2 % PI3P or 2 % PI(3,5)P2, 23 % PE, 2 %
TR-PE and 73 % PC. As buffers 20 mM BisTris pH 6.5, 20 mM Hepes pH 7.4 or 20 mM
Tris pH 8.0, all containing 150 mM KCl, were used for titrations. Figure 4.26 shows the
titration of ScHsv2 and KlHsv2 into 2 % PI(3,5)P2 containing liposomes, data obtained
for PI3P and PI(3,5)P2 are summarized in table 4.5.
KlHsv2 shows no pH effect on binding affinity or stoichiometry when titrated into
PI3P containing liposomes. Also no effect was observed for the stoichiometry when
titrated into liposomes with PI(3,5)P2 (see figure 4.26 A and table 4.5). Compared
to pH 7.4 the KD at pH 6.5 and 8.0 increased 2.5 to 3 fold in PI(3,5)P2 containing
liposomes. ScHsv2 shows higher affinities to both phosphoinositide liposomes at pH 6.5
(see figure 4.26 B and table 4.5). Interestingly, when ScHsv2 is titrated into PI(3,5)P2
the KD and stoichiometry increases dependent on the pH. In pH 8.0 stoichiometry
reaches nearly a 1:1 ratio, suggesting that only one of the two binding sites seems to
bind PI(3,5)P2.
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Figure 4.26: ITC measurements of KlHsv2 and ScHsv2 with PI(3,5)P2 liposomes in dif-
ferent pHs
(A) KlHsv2 and (B) ScHsv2 were titrated into either 2 % PI3P or 2 % PI(3,5)P2, 23 % PE, 2 %
TR-PE and 73 % PC containing liposomes at different pHs. BisTris buffer at pH 6.5, Hepes pH 7.4 and
Tris pH 8.0 were tested, all containing 150 mM KCl. (C) Diagrams showing the negative logarithm of
KAs plotted versus pH for KlHsv2 (right panel) and ScHsv2 (left panel).
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Visualization of affinity changes depending on pH were done by plotting the negative
logarithm of KA versus pH (see figure 4.26 C). KlHsv2 data points lie on a horizontal
line. Linear regression analysis of the data points for ScHsv2 showed an increase in
PI3P and PI(3,5)P2 affinity depending on the pH. Supporting the fact of an underlying
pH switch.
Taken these results together a pH switch was observed for ScHsv2 when titrated
into PI(3,5)P2 and to a smaller extent for PI3P containing liposomes. For KlHsv2 no
clear effect was observed.
Table 4.5: Binding affininties and stoichiometries of Hsv2 in different pHs
PROPPIN Phosphoinositide pH Binding affinity Stoichiometry
KD [µM] N
KlHsv2 PI3P 6.5 0.38 ± 0.02 0.30
7.4 0.48 ± 0.04 0.35
8.0 0.30 ± 0.02 0.38
PI(3,5)P2 6.5 0.49 ± 0.08 0.64
7.4 0.18 ± 0.01 0.58
8.0 0.61 ± 0.01 0.50**
ScHsv2 PI3P 6.5 0.23 ± 0.03 0.39
7.4 0.67 ± 0.02 0.50
8.0 0.87 ± 0.12 0.27
PI(3,5)P2 6.5 0.05 ± 0.02 0.57
7.4 0.22 ± 0.07 0.66
8.0 0.35 ± 0.02 0.93
(average ± SEM*)
* Average and SEM was determined from at least three (**two) measurements.
Whether the proteins are stable in the used pHs was investigated by Thermofluor
experiments. Here, proteins were subjected to a temperature gradient from 25 ◦C to
95 ◦C and Sypro Orange fluorescence was measured. An increase in fluorescence corre-
lates with protein unfolding. KlHsv2 shows almost the same stability in all buffers with
a small increase in stability for BisTris buffer at pH 6.5, indicated by the shift of the
curve towards higher temperatures (see figure 4.27 A). ScHsv2 is more stable in Hepes
buffer at pH 7.4 and BisTris buffer pH 6.5. In comparison ScHsv2 starts to unfold at
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Figure 4.27: Stability of KlHsv2 and ScHsv2 in different pHs
Thermofluor analysis of (A) KlHsv2 and (B) ScHsv2 in BisTris pH 6.5, Hepes pH 7.4 and Tris pH 8.0
buffer all supplemented with 150 mM KCl.
lower temperatures in Tris pH 8.0 (see figure 4.27 B). Both proteins are stable and
folded in all buffers and at the temperature used for ITC measurements.
4.2.2.6 Role of loop 6CD for membrane binding
The structure of KlHsv2 adopts a seven bladed β-propeller, whose blades and β-
strands are connected by loops. Interestingly, blade 6 contains a long loop sticking out
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Figure 4.28: The impact of loop 6CD on membrane binding
Flotation assays using 10 % PS, 2 % PI3P and 2 % PI(3,5)P2 containing liposomes and control lipo-
somes consisting of 75 % PC, 23 % PE and 2 % Texas Red-PE only. (A) Showing KlHsv2wildtype
and KlHsv2GSlinker subjected on the liposomes. (B) KlHsv2loopchimera, ScHsv2loopchimera and wild
type ScHsv2 after flotation analysis. (C) Shows KlHsv2 loop mutants KlHsv2K260E/R261D/H262D,
KlHsv2Y 272D/F273D, KlHsv2Y 272D, KlHsv2F273D and KlHsv2Y 272A/F273A
of the β-propeller structure. This loop connects strand C and D of blade 6 and is in
close proximity to the FRRG motif in blade 5, which is essential for PIP binding. This
close proximity led us raise the question, if this loop is involved in membrane binding.
To address this question flotation assays were performed using wild type KlHsv2
and a GS linker construct in which the loop 6CD (amino acids 258 to 274) was replaced
by a (GS)4G motif. Liposomes containing 10 % PS, 65 % PC, 23 % PE and 2 % TR-PE
were used. These negatively charged liposomes were used to test unspecific membrane
binding. Control liposomes, which are known that wild type KlHsv2 does not bind,
and liposomes consisting either 2 % PI3P or 2 % PI(3,5)P2, 23 % PE, 2 % TR-PE and
73 % PC were used. Figure 4.28 A shows binding of wildtype KlHsv2 to liposomes
with 10 % PS, but not to liposomes without PS or phosphoinositide (control). Binding
occurs to liposomes containing either 2 % PI3P or 2 % PI(3,5)P2. When the loop 6CD
was replaced by the GS linker motif no binding was detected to any of the liposomes.
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These data show that besides the two PIP binding sites also the loop 6CD is required
for membrane binding.
In a next step, I tested whether the loop 6CD region from KlHsv2 and ScHsv2
can replace each other and therefore recover membrane binding. This loop region is
disordered and less conserved throughout PROPPINs, e.g. the loop in ScHsv2 is longer
compared to KlHsv2 (suppl. figure 5.15). I used synthetic loop chimera constructs to
analyze this binding with flotation assays. Here, KlHsv2loopchimera showed wild type-
like liposome binding, suggesting that the binding ability is completely recovered. Also
ScHsv2loopchimera and wild type ScHsv2 bind the same liposomes. These results show
that the loop regions can substitute for each other.
How loop 6CD insertion into the membrane occurs was next investigated. First we
analyzed loop 6CD by alignment of this region in different PROPPINs. The human Hsv2
homologs WIPI3 and WIPI4, Hsv2 from A. thaliana, Y. lipolytica, A. gossypii and C.
glabrata as well as ScHsv2 and KlHsv2 were aligned (suppl. figure 5.16). The alignment
was manually modified by A. Scacioc according to properties like hydrophobicity and
charges. This loop is not conserved, but in the middle region of the loop is a small patch
of positively charged amino acids (amino acids with red background) and at the end of
the loop aromatic amino acids (Tyr, Phe) are located. KlHsv2 was used for mutagenesis
studies of the positively charged patch. Here, Lys260, Arg261 and His262 were mutated
into negatively charged amino acids K260E/R261D/H262D. Furthermore, the aromatic
residues Tyr272 and Phe273 were exchanged, here the double mutants Y272D/F273D
and Y272A/F273A were generated as well as single Asp mutants of both residues.
In flotation assay analysis the KlHsv2K260E/R261D/H262D triple mutant showed nei-
ther binding to 10 % PS containing liposomes nor to 2 % PI3P. Its binding was reduced
on 2 % PI(3,5)P2 liposomes (see figure 4.28). The two double mutants KlHsv2Y 272D/F273D
and KlHsv2Y 272A/F273A were diminished in binding to 10 % PS and 2 % PI(3,5)P2 con-
taining liposomes. PI3P binding was completely abolished. Binding to all liposomes was
lost in KlHsv2Y 272D and KlHsv2F273D mutants. In conclusion these results show that
membrane binding of loop 6CD occurs through both hydrophobic and ionic interaction
with the membrane lipids.
PIP binding of KlHsv2 and ScHsv2 loop mutants were also tested on PIPstrips
(suppl. figure 5.17). Wild type KlHsv2 and the loop chimera construct were detected
on spots containing PI3P and PI(3,5)P2. ScHsv2 bound PI3P and PI(3,4,5)P3, the
loop chimera of ScHsv2 showed unspecific binding to all 7 phosphoinositides. The GS
linker construct of KlHsv2 showed strongly reduced binding to PI3P and PI(3,5)P2. In
addition, KlHsv2Q274E and KlHsv2Q274D mutants were tested. In these mutants the last
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amino acid of the loop 6CD was mutated. In line with the flotation assays of KlHsv2
loop mutants also these mutants were strongly reduced in binding to PI3P or PI(3,5)P2.
Taken together loop 6CD is important for membrane binding while the two PIP
binding sites coordinate membrane specific binding to the phosphoinositides PI3P and
PI(3,5)P2.
4.2.2.7 Analysis of stability of Hsv2 mutants
Mutants with either single or double mutations in loop 6CD were checked for protein
folding. For this CD spectra were taken and Thermofluor experiments were carried out.
First, CD spectra for wild type ScHsv2 and KlHsv2 were taken from 190 nm to 260
nm (see figure 4.29 A and B). Typical spectra for β-strand containing proteins were
observed with a minimum around 216 nm. Next, ScHsv2FTTG, ScHsv2loopchimera and
KlHsv2loopchimera were analyzed and compared to wild type ScHsv2 (see figure 4.29
B). Both mutants showed also the minimum around 216 nm. In addition, CD spectra
for KlHsv2GSlinker, KlHsv2K260E/R261D/H262D, KlHsv2Y 272D/F273D, KlHsv2Y 272D and
KlHsv2F273D were monitored (see figure 4.29 C). All mutants showed a similar CD
spectrum to wild type KlHsv2. This analysis showed, that folding of the β-sheets were
not influenced by the mutations.
Protein stability was examined by following the behavior of the protein at 216 nm
during a thermal shift from 20 ◦C to 90 ◦C. Here, the protein mutants were compared
to wild type protein (see suppl. figure 5.18). Mutant proteins showed only slight shifts
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Figure 4.29: CD spectra of KlHsv2 and ScHsv2 mutants
CD spectra taken from 260 nm to 190 nm for (A) KlHsv2 (B) ScHsv2wildtype, ScHsv2FTTG,
ScHsv2loopchimera and KlHsv2loopchimera (C) KlHsv2GSlinker, KlHsv2K260E/R261D/H262D,
KlHsv2Y 272D/F273D, KlHsv2Y 272D and KlHsv2F273D.
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of the curves compared to wild type protein, but no unfolding curve changed dramati-
cally towards lower temperatures. Unfolding of all proteins (besides KlHsv2loopchimera)
occurred in one transition.
A second method to monitor protein stability was employed by using Thermofluor
experiments. Unfolding was recorded by following fluorescence changes of Sypro Or-
ange, which is dequenched, when protein unfolds and represents hydrophobic patches for
binding of Sypro Orange. Wild type ScHsv2 and KlHsv2 and their corresponding loop
chimera constructs showed almost the same stability, the transition midpoint was in the
range between 55 ◦C and 58 ◦C (see suppl. figure 5.19 A). On the other hand, the tran-
sition midpoint of KlHsv2GSlinker shifted to 62 ◦C. Indicating, that deletion of the loop
increases protein stability significantly. The mutants KlHsv2Y 272A/F273A, KlHsv2Q274D
and KlHsv2Q274E were only slightly shifted compared to wild type KlHsv2 (see suppl.
figure 5.19 B). Furthermore, a comparison of KlHsv2wildtype, KlHsv2K260E/R261D/H262D,
KlHsv2Y 272D/F273D, KlHsv2Y 272D and KlHsv2F273D in Thermofluor experiments re-
vealed that mutant KlHsv2F273D had an improved protein stability (see suppl. figure
5.19 C). None of the mutant proteins were strongly affected in their stability.
4.2.3 Co-expression and interaction studies of PROPPIN homologs
with Atg8
4.2.3.1 Cloning, expression and purification using the ACEMBL system
In order to test for Atg21 and Hsv2 binding to Atg8, I ordered synthetic genes
of KlAtg8 and PaAtg8 with a C-terminal One-STrEP-tag, optimized for bacterial ex-
pression and cloned them together with either KlAtg21, PaAtg21 or KlHsv2 into the
ACEMBL system for bacterial complex expression [46].
The multi protein expression system for E. coli employs a set of acceptor and donor
vectors similar to the MultiBac baculovirus system for insect cell expression. Both ac-
ceptor and donor vectors contain the loxP imperfect inverted repeat for Cre recombina-
tion and different antibiotic resistances for plasmid screening. An important difference
between acceptor and donor vectors is their origin of replication. Acceptor vectors con-
tain the ColE1 origin of replication whereas the donor vectors possess the conditional
origin of replication derived from R6Kγ. This origin is dependent on a host strain
expressing the pir gene like in E. coli BW23474 cells.
The Atg8 homologs were cloned with a C-terminal One-STrEP-tag into both the
pACE acceptor and the pDK donor vector for single and complex expression. The genes
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coding for KlAtg21, PaAtg21 and KlHsv2 were cloned into the pACE-His acceptor vec-
tor. Multi gene expression cassettes were generated by the Cre/loxP reaction. Verified
expression vectors were then transformed with E. coli BL21(DE3) cells for expression.
The three complexes of KlAtg21/KlAtg8, KlHsv2/KlAtg8 and PaAtg21/PaAtg8 were
expressed in autoinducible media for three hours at 37 ◦C and then shifted to 22 ◦C
for overnight incubation. The cultures were harvested, cell extracts were prepared and
the soluble protein fraction subjected to affinity purification with an 1 ml His-Trap FF
column for co-purification of the complexes in 30 mM Hepes pH 7.0 and 300 mM NaCl
buffer. However, the His-tagged PROPPINs were purified, but no Atg8 co-eluted from
the column. Therefore, cultures were grown again and this time subjected to a Strep-
Trap column. Here, the Atg8 homologs were purified, but the co-expressed proteins
again did not co-elute. In a next approach, the proteins were expressed separately and
their interaction was analyzed.
4.2.3.2 Purification of K. lactis and P. angusta Atg8
KlAtg8 and PaAtg8 were expressed from E. coli BL21(DE3) in autoinducible media.
The proteins were purified in 30 mM Hepes pH 7.0 supplemented with 300 mM NaCl
buffer. Soluble protein fraction derived from cell extract was subjected to a 5 ml Strep-
Trap column. Both proteins were obtained in high yields after elution with 2.5 mM
desthiobiotin (see figure 4.30 A and C). The peak fractions were checked with SDS-
PAGE. Afterwards, the protein fractions were pooled and loaded onto a Superdex S75
column (see figure 4.30 B and D). The peak fractions were loaded on an SDS gel again,
the protein concentrated and snap frozen in liquid nitrogen. Storage of the protein was
done at -80 ◦C.
The purified proteins were analyzed for their secondary structure and stability using
CD spectroscopy. NaF buffer was used for measurements. CD spectra of both KlAtg8
and PaAtg8 were taken from 190 nm to 260 nm at 20 ◦C. Here, both Atg8 homologs
showed the typical minimum of an α-helix containing protein at 208 nm (see figure 4.31
A). The second minimum of α-helix containing proteins is reduced due to the proteins
additional β-strands. This confirms the expected secondary structure of Atg8. The
X-ray crystallographic structures of S. cerevisiae Atg8 and its mammalian homolog
MAP1LC3 revealed a ubiquitin-like fold consisting of two α-helices enclosing four β-
strands in its core.
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Figure 4.30: Purification of KlAtg8 and PaAtg8 from E. coli BL21(DE3) cells
(A) Affinity purification of KlAtg8 using a 5 ml Strep-Trap column followed by (B) gel filtration with
a HiLoad 16/60 Superdex 75 column. (C) Affinity purification of PaAtg8 with a 5 ml Strep-Trap






















Figure 4.31: CD spectra and melting curve of KlAtg8 and PaAtg8
(A) CD spectra of KlAtg8 and PaAtg8 were measured from 160 nm to 190 nm. (B) Melting curves of
KlAtg8 and PaAtg8 were taken at 208 nm from 20 ◦C to 90 ◦C
In addition, stability of purified KlAtg8 and PaAtg8 was investigated by recording
the minimum at 208 nm along a thermal gradient from 20 ◦C to 90 ◦C. Both proteins
unfolded in a single transition curve, thereby PaAtg8 started to unfold at higher tem-
peratures compared to KlAtg8 (see figure 4.31 B). The transition midpoint of PaAtg8
was at 48 ◦C and for KlAtg8 at 40 ◦C. These results showed that both proteins are
stable and folded.
4.2.3.3 Biochemical analysis of interactions
Investigation of the interaction of Atg21 and Hsv2 with Atg8 was done using different
approaches. First, the separately purified proteins were subjected to analytical gel
filtration and their elution profile was monitored. Then KlAtg21 and KlAtg8 were
mixed and loaded together onto the column. Here, the recording of UV280 showed that
the protein eluted in two peaks (see figure 4.32 A). Both peaks correspond to the peaks
monitored for each protein alone. In addition, the peak fractions of KlAtg21-KlAtg8
were analyzed on an SDS gel. This showed that both proteins were present in different
elution fractions. The interaction of KlAtg21 with KlAtg8 could not be confirmed with
analytical gel filtration analysis.
The same result was observed for PaAtg21 and PaAtg8. In addition, KlHsv2 and
KlAtg8 were combined and run over the analytical gel filtration column. Interestingly,
the peak of the potential complex eluted in between the peaks of the single proteins (see
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Figure 4.32: Interaction studies on KlHsv2 and KlAtg8
(A) Analytical gel filtration of KlAtg21, KlAtg8 and KlAtg21-KlAtg8 in complex. (B) Analytical gel
filtration of KlHsv2, KlAtg8 and KlHsv2-KlAtg8 in complex. (C) Titration of 250 µM ScHsv2 in 20
µM KlAtg8. (D) Titration of 150 µM KlAtg8 into 25 µM KlHsv2. (E) Co-flotation analysis of KlHsv2
and KlAtg8 with liposomes containing 2 % PI3P, 73 % PC, 23 % PE and 2 % Texas Red-PE.
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figure 4.32 B). Therefore, the peak fractions were analyzed with Coomassie stained SDS
gels. Here, both proteins were observed in the same fractions, indicating that KlHsv2
and KlAtg8 might form a complex.
Further analysis of the KlHsv2 and KlAtg8 interaction was done with ITC measure-
ments. This method is highly sensible and allows detection of weak interactions. ITC
measurements were performed in Hepes buffer (30 mM Hepes pH 7.0, 300 mM NaCl).
First, 250 µM KlHsv2 was titrated into 20 µM KlAtg8. The titration was done with
20 injections of each 15 µl at 25 ◦C. For this measurement no significant heat change
was observed (see figure 4.32 C). Therefore, the titration was also done the other way
around and 150 µM KlAtg8 was titrated into 25 µM KlHsv2. However, no heat change
was detected (see figure 4.32 D). Taken the ITC results together, no interaction was
observed for KlHsv2 and KlAtg8.
KlHsv2 binds to phosphoinositides. This binding might cause structural changes in
the protein and affect its affinity to interaction partners. Therefore, flotation assays
were performed to test for protein-protein interaction. Liposomes containing 2 % PI3P,
73 % PC, 23 % PE and 2 % Texas Red-PE were prepared and mixed with KlHsv2
and KlAtg8. This mixture was overlaid with a Nycodenz gradient and centrifuged
at high speed. Fractions taken after centrifugation were analyzed by immunoblotting
using a penta-His antibody to detect KlHsv2 and a Strep-tag II antibody for KlAtg8-
OneSTrEP. KlHsv2 was found in the low density fractions indicating its co-flotation
with the liposomes, whereas KlAtg8 was present in the high density fractions indicating
no binding to KlHsv2.
Different approaches for probing the Atg21-Atg8 and Hsv2-Atg8 interactions were
tried, but no binding was detected with these methods. High ionic strength buffer (300
mM NaCl) might prevent binding in the analytical gel filtration and ITC experiments.
4.2.3.4 Co-expression of ScAtg21 and ScAtg8 in insect cells
Interaction of PROPPINs with Atg8 was identified in S. cerevisiae. In order to
investigate binding of ScAtg21 and ScAtg8, I co-expressed both proteins in insect cells
using the MultiBac baculovirus expression system. Therefore, I cloned ScAtg8-StrepII
into the second multiple cloning site of the pFL vector carrying the gene for His-ScAtg21
expression. This expression vector was transformed with E. coli DH10 cells carrying the
MultiBac bacmid. The expression cassette integrates into the bacmid via Tn7 transpo-
sition sites. The bacmid was extracted from E. coli cells and transfected into Sf9 insect
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Figure 4.33: Coexpression of ScAtg21 and ScAtg8 in insect cells
(A) Expression profile of ScAtg21 and ScAtg8 in High5 insect cells. Samples taken at indicated time
points were checked on SDS gels. (B) Western blot analysis of cell extract from ScAtg21 and ScAtg8
co-expressing insect cells. ScAtg21 was detected with a penta-His antibody and ScAtg8 with a Strep-
MAB-Classic HRP conjugated antibody. (C) Show the coomassie stained SDS-PAGE of ScAtg21 and
ScAtg8 co-purification from insect cells.
cells. The virus was generated and harvested after approximately 60 hours. An addi-
tional virus generation was produced by infection of Sf9 cells. Here, generally the virus
titer increased and larger High5 insect cell cultures could be infected at once. During
infection of High5 insect cells the day of proliferation arrest (DPA) was monitored by
counting the cells per ml culture. When the DPA was reached samples were taken every
12 hours until DPA + 48 hours. From the samples cell extract, supernatant and pellet
fraction were prepared and analyzed on SDS gels. Here, a band appeared after DPA
+ 24 hours in the size of 70 kDa (see figure 4.33 A). The expected size of ScAtg21
corresponds to 70 kDa. An additional band for ScAtg8 was not observed. Therefore,
the expression was also tested with Western blotting. The cell extract of High5 insect
cells was checked with a penta-His antibody for detection of ScAtg21 and a Strep-tag II
antibody for ScAtg8. Western blot analysis showed that both proteins were expressed
in insect cells. The band of 70 kDa was recognized by the His antibody, for ScAtg8 a
band around 15 kDa was detected (see figure 4.33 B).
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Next, I tried to co-purify ScAtg21 and ScAtg8 from the insect cells. For this purpose,
High5 insect cells were harvested after DPA + 48 hours and cell extract was prepared
using Hepes buffer (30 mM Hepes pH 7.0, 300 mM NaCl, 30 mM imidazole). The
soluble protein fraction was loaded onto 2 ml Ni2+-sepharose beads. The beads were
incubated for three hours with the supernatant, then washed and bound protein was
eluted with Hepes buffer and 500 mM imidazole. Samples taken during the purification
were analyzed with SDS-PAGE. Coomassie staining showed that ScAtg21 was purified
using the Ni2+-sepharose beads (see figure 4.33 C). No band corresponding to ScAtg8
was observed on the SDS gel. In contrast, when ScAtg21 was expressed alone in insect
cells it was not soluble.
Taken together these results did not confirm the interaction of ScAtg21 and ScAtg8.
The fact that co-expression of both proteins led to increased solubility of ScAtg21
however suggests that both proteins have an effect on each other.
4.2.3.5 Crystal soaking for KlHsv2 with Atg8 peptide
Analytical gel filtration analysis of the KlHsv2 and KlAtg8 suggested a potential
interaction of both proteins. Although in ITC measurements binding could not be
confirmed. In our lab KlHsv2 was crystallized and its structure determined (work from
Dr. K. Kühnel). These crystals can be used for soaking experiments with an Atg8
peptide. In addition, co-crystallization of KlHsv2 and KlAtg8 can be tried.
In a first step, I wanted to co-crystallize full length KlAtg8 with KlHsv2. Therefore,
I mixed both separately purified proteins in a 1:1 molar ratio and subjected them to
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Figure 4.34: Gel filtration purification of KlHsv2 and KlAtg8
Both proteins were mixed in a 1:1 molar ratio (in), concentrated (conc) and purified with size exclusion
chromatography.
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and analysis of the peak fractions confirmed the presence of both proteins in the same
elution fractions (see figure 4.34).
In order to optimize the buffer conditions for the protein complex, Thermofluor
experiments were performed using the pHat and the Addit screen. Sodium lactate pH
5.2 and MES buffers in the range of pH 6.2 to 7.0 shifted the fluorescence curve towards
higher temperatures and increased stability of the complex. Therefore, KlHsv2 and
KlAtg8 were dialyzed in MES buffer pH 6.5 and 300 mM NaCl. Next, the Addit screen
was performed. Caesium chloride, samarium bromid and DMSO increase stability (see
figure 4.35).
Crystal screens were set up with KlHsv2-KlAtg8 in Hepes buffer with low ionic
strength (30 mM Hepes pH 7.0, 150 mM NaCl) and in MES buffer (30 mM MES pH
6.5, 300 mM NaCl, 5 % DMSO). The protein concentration ranged from 5 mg/ml to 20
mg/ml. Some interesting crystallization conditions were observed, but so far no crystals
or spherulites were grown.
Additionally, to get an insight how the proteins interact, I reproduced KlHsv2 crys-
tals under conditions used for solving its structure and performed soaking experiments.
In those experiments a peptide comprising the N-terminal eight amino acids of ScAtg8
was added to the conditions containing KlHsv2 crystals (see figure 4.36). Also KlHsv2
crystals were seeded into fresh crystallization conditions containing KlHsv2 and the Atg8
Figure 4.35: Thermofluor analysis of KlHsv2 in complex with KlAtg8
Thermofluor experiments using the Addit screen of the KlHsv2-KlAtg8 complex. Sypro Orange fluo-
rescence was monitored, since dequenching correlates with protein unfolding. Out of 88 different tested
conditions indicated additives increased protein stability.
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Figure 4.36: KlHsv2 crystals for Atg8 peptide soaking
Purified KlHsv2 (35 mg/ml protein in 0.2 M NaCl, 30 mM citrate pH 5.5) was subjected to crystal-
lization. (A) In condition with 0.1 M Hepes pH 7.0, 1.5 M MgSO4 and (B) 0.1 M Hepes pH 6.5, 1.5
M MgSO4 crystals of KlHsv2 were reproduced.
peptide. These crystals were sent to the synchrotron and data sets were collected. The
structure was solved using molecular replacement with the KlHsv2 structure. However,
none of the crystals contained the Atg8 peptide. Incorporation of the peptide into the
crystal might be inhibited due to different reasons, e.g. the sequence was not optimized
for K. lactis Atg8, the ionic strength in the crystallization conditions was too high (1.2
- 2 M MgSO4) or the first eight amino acids are not sufficient for binding. Therefore,
in a parallel experiment co-crystallization conditions for KlHsv2 with the peptide were
screened, but yielded no crystals.
4.3 Discussion
Different yeast PROPPIN homologs were purified during this study. Their stabilities
were characterized with Thermofluor experiments and measurements of their melting
curves with CD spectroscopy. Stable fragments were identified by limited proteolysis,
which can be useful for crystallization. Proteolytic digestion of KlAtg21 yielded in a
stable fragment of 35 kDa, which was also observed during purification. Analysis of
this fragment revealed cleavage of a 5 kDa fragment at the C-terminus of KlAtg21.
Secondary structure analysis of this protein with different bioinformatical prediction
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algorithms and IUPRED for disorder prediction showed that KlAtg21 contains an ad-
ditional small α-helix at its C-terminus. Homology modeling of the Atg18 and Atg21
homologs from A. Scacioc revealed that both Atg18 and Atg21 possess this additional
C-terminal α-helix in contrast to Hsv2.
So far, no crystals were obtained from a variety of crystal screens which were set
up with ScAtg18, PaAtg18, KlAtg21 and SpHsv2. However, crystallization conditions
yielding in pre-crystalline structures like spherulites were observed. Microcrystals of
PaAtg18 were obtained in one screen but could not be reproduced.
Previous studies mainly characterized PROPPINs phosphoinositide specificity with
protein-lipid overlay assays using PIP strips. Controversial results for PIP specificities
were reported. GST-tagged ScAtg18 was shown to have a high specificity for PI3P
and PI(3,5)P2 in dot blot assays, but specifically interacted with PI(3,5)P2 containing
membranes in surface plasmon resonance studies [133]. In a different study, high speci-
ficity for PI3P and a weak affinity to PI(3,5)P2 was shown for GST-ScAtg18 with PIP
strips. GST-ScAtg21 in contrast showed strong binding to PI3P and PI(3,5)P2 and
weak interactions with PI4P and PI5P [151].
PIP strip analysis with MBP-tagged proteins revealed strong binding of ScAtg18,
ScAtg21 and ScHsv2 to PI3P but no binding to PI(3,5)P2 [144]. In a previous study
we showed binding of GST-ScHsv2 to PI3P and PI(3,5)P2 and weak interaction with
PI4P, PI5P and PI(3,4)P2 [24].
Flotation assays are a suitable alternative method. However, caution has to be
taken with the lipid composition of liposomes used for flotation assays to avoid binding
due to non-specific electrostatic interactions. Unspecific binding of the protein has to
be tested with control liposomes without the ligand being incorporated. I here used
neutral liposomes as a control, containing only PC, PE and Texas Red-PE. In addition,
the ligand concentration had to be optimized, since concentrations above 5 % (w/w)
PI3P resulted in unspecific binding of the binding incapable FTTG mutant.
In order to answer the question of phosphoinositide binding specificity of the yeast
PROPPINs, I optimized the lipid composition of liposomes for PROPPINs to perform
flotation assays. Using this method I showed a distinct phosphoinositide binding speci-
ficity of Atg18, Atg21 and Hsv2 to PI3P and PI(3,5)P2. The tested liposomes contained
1 % (w/w) phosphoinositide, 74 % (w/w) PC, 23 % (w/w) PE and 2 % (w/w) Texas
Red-PE. An advantage of using liposomes to study membrane binding is the incorpo-
ration of phosphoinositides into membranes at different concentrations whereas pure
phosphoinositides are spotted on a flat membrane on PIP strips. PIP strips can be
used to test whether phosphoinositide binding can be detected at all, but the results
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have to be verified with a second method [175]. Especially for quantification PIP strips
are not reliable, as shown in this study.
In a recent study liposome sedimentation assays were used to study phosphoinositide
specificity of PROPPINs. Here, multilamellar liposomes containing 15 % phosphoinosi-
tides and 30 % PS were used. Co-sedimentation of the protein with the liposomes
indicates liposome binding. KlHsv2, ScHsv2 and the human WIPI1, WIPI3 and WIPI4
were tested and showed binding to PI3P, PI5P and PI(3,5)P2 [25].
The structure of KlHsv2 showed that the two arginines of the FRRG motif, which
is essential for phosphoinositide binding, point into opposite directions, indicating two
potential binding pockets for phosphoinositides. Using flotation assays with 2 % PI3P
containing liposomes I identified a set of conserved residues comprising both pockets.
Thus supporting the hypothesis, that PROPPINs possess two binding pockets for PI3P.
Amino acids Ser243, Thr247, Arg250 and Arg264 from ScHsv2 are part of binding pocket
one, the second pocket comprises ScHsv2 Arg265, Lys290, Thr292 and His294. In vivo
localization studies were performed by Dr. R. Krick in the group of Prof. M. Thumm
with these ScHsv2 mutants and also with the corresponding ScAtg18 mutants. The in
vivo data of Dr. R. Krick are consistent with my in vitro studies. The mutants shown
to be unable to bind to liposomes also showed cytosolic localization compared to the
punctate localization indicating membrane association of wild type ScAtg18 and ScHsv2
[24]. Furthermore, docking studies of PI3P and PI(3,5)P2 into the KlHsv2 structure
were done. These studies are in agreement with the in vitro and in vivo studies because
residues involved in binding in the studies were also shown to be important for binding
in our experiments. Only Thr247 did not show an interaction to PI3P or PI(3,5)P2 [24].
A similar study was published at the same time from Baskaran et al. [25]. The
structure of KlHsv2 was determined as well, leading to the observation of two potential
binding pockets in Hsv2. In contrast to the here used liposome flotation assays, liposome
sedimentation assays were performed to identify residues of KlHsv2 involved in PI3P
binding. All tested mutants of binding site I did not show an effect on PI(3,5)P2.
Like us Arg250 (Kl:205) and Arg264 (Kl:Arg219) were found to interact with PI3P in
binding site I. Arg265 (Kl: Arg220), Lys290 (Kl:Lys245) and His294 (Kl: His249) were
identified in binding site II.
With flotation assays, in vivo localization experiments and computational docking
studies the residues involved in phosphoinositides binding were identified. In order to
further characterize the binding of PROPPINs with PI3P and PI(3,5)P2, binding stoi-
chiometries and affinities were determined using isothermal titration calorimetry. ITC
measurements with the water soluble PI3P-diC4 and PI(3,5)P2-diC6 as well as with
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large unilamellar vesicles (LUVs) did not give any heat changes or resulted in precipi-
tation. Whereas LUVs are quite big and therefore prone to aggregation due to stirring
while the measurements are done, soluble PI3P or PI(3,5)P2 analogs were not suffi-
cient for binding. Incorporation of the phosphoinositides into small unilamellar vesicles
(SUVs) were suitable for these measurements. Furthermore, the method for preparation
of vesicles can be important. SUVs were prepared by size exclusion chromatography
using a Sephadex G50 column. In contrast, LUVs were formed using the extrusion
method. Here, micelle formation can not be avoided, which could drive precipitation of
protein and LUVs during the measurement. For analysis of the ITC data, the precise
concentrations of protein and ligand are needed. Therefore, analysis of liposomes is nec-
essary as described here to calculate the accessible PIP concentration. The phosphate
concentration was measured with the phosphomolybdate method and the size distribu-
tion of SUVs was determined by FFF-MALLS. From the total phosphate concentration,
the phosphoinositide concentration was calculated. Then accessible PIP amounts were
derived by considering a double-layered membrane with a surface area (A = 4πr2).
KlHsv2, ScHsv2, PaAtg18 and KlAtg21 were used for ITC measurements. The two
Hsv2 homologs and PaAtg18 showed a similar KD to PI3P containing liposomes in the
range of 0.5 µM. KlAtg21 in comparison binds with a weaker affinity to PI3P of 0.9
µM. However, its binding affinity to PI(3,5)P2 containing liposomes is even less (KD =
1.4 µM). In contrast, Hsv2 (KD = 0.2 µM) and Atg18 (KD = 0.07 µM) have a stronger
affinity to PI(3,5)P2 compared to PI3P. These differences in binding affinities might be
important for the different functions of the varios PROPPIN homologs in autophagy.
Determination of the binding stoichiometry showed that two PI3P molecules bind to
one ScHsv2 protein. KlHsv2, PaAtg18 and KlAtg21 had an average molar ratio of 0.37.
Binding of PI(3,5)P2 revealed a molar ratio of 0.6 for Hsv2 and Atg18.
Binding affinities of PROPPINs were also determined with reflectrometric interfer-
ence spectroscopy (RIfS). Here, a lipid bilayer was formed on wafers and interference
fringes were detected. Incubation of the membrane with GST-ScHsv2 resulted in a KD
of 1.3 µM [24]. Differences between binding affinities from ITC and RIfS measurements
might be due to using untagged versus GST fusion proteins and differences in membrane
composition. 3 % PI3P were used in RIfS measurements. From FRET measurements
of KlHsv2 affinities in the submicromolar range were estimated, but no precise numbers
were given from Baskaran et al. [25]. Dove et al. [133] obtained a KD of 0.18 µM by
surface plasmon resonance measurements with GST-ScAtg18 to PI(3,5)P2.
Quantification of flotation assays showed that 0.1 % PI(3,5)P2 are required in lipo-
somes for recruitment of 50 % of the present KlHsv2 and ScHsv2. In contrast, ScHsv2
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needs 0.26 % PI3P whereas KlHsv2 requires 1.52 % PI3P in liposomes. These data are
in agreement with the binding affinities derived from ITC measurements, that due to
higher affinity for PI(3,5)P2 less of this phosphoinositide is needed in the liposomes for
recruitment of Hsv2.
In silico docking studies of KlHsv2 with PI(3,5)P2 were only successful, when the
histidines in the binding pockets were protonated. Besides, determination of molar
ratios for the binding of PI(3,5)P2 suggested one or two ligands bound to PROPPINs.
ITC measurements at different pHs showed that ScHsv2 binding to phosphoinositides
is dependent on the pH. Here, the molar ratio in acidic buffers was 0.57, whereas basic
buffers completely disabled one phosphoinositide binding site (N = 0.93). The binding
affinity was increased in acidic buffers. This pH dependency was shown for ScHsv2
binding to either PI3P or PI(3,5)P2. This effect was stronger for PI(3,5)P2. However,
KlHsv2 did not show a difference neither in stoichiometry nor in binding affinity. This
difference between KlHsv2 and ScHsv2 might be caused by the additional histidine in
ScHsv2 binding site II. This histidine is not conserved and KlHsv2 possesses a lysine
at this position instead. The stronger effect of the pH dependency for ScHsv2 binding
to PI(3,5)P2 and PI3P can be explained by the stronger negative charge of PI(3,5)P2
compared to PI3P.
A similar effect was described for FYVE domain containing proteins. Increase of
the pH disrupted binding of the FYVE domain to PI3P, a decrease caused an enhanced
affinity. This pH dependency was due to a pair of conserved histidine residues [129, 179].
I also showed that the loop 6CD is essential for membrane binding. Substitution
of the loop by a GS linker abolished the binding to liposomes. Loop insertion into
the membrane is due to hydrophobic and ionic interactions with membrane lipids. The
involvement of loop 6CD was also described by Baskaran et al. [25]. Here, basic patches
of the protein at the rim of the β-propeller were mutated and loop 6CD substituted with
a GS linker. In sedimentation assays they showed that only deletion of the loop had an
effect on membrane binding. Thus, suggesting an edge on binding of Hsv2 and probably
other PROPPINs towards the membrane. Furthermore, they showed that PROPPIN
homologs with more hydrophobic residues in the loop have a higher binding affinity to
the membrane.
The insertion of a loop to increase membrane affinity was also described for FYVE
domain containing protein like EEA1 and the PX domain of Vam7. The PI3P specific
binding domains alone have a too low affinity to PI3P to allow membrane recruitment
[128]. Dimerization of the FYVE domain and additional loop insertion is required for
FYVE domains to bind sufficiently to membranes. Some residues of the PX domain
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Figure 4.37: Proposed model of Hsv2 membrane binding
Our studies suggest a perpendicular binding of PROPPINs to the membrane. Two PI3P or PI(3,5)P2
molecules are bound one in each of the two binding sites. In addition a long flexible loop inserts into
the membrane to stabilize binding. Figure derived from [24]
have been shown to penetrate into the membrane, deletion of these residues diminished
membrane binding [180].
Taking our in vivo and in vitro data and the computational studies together, we
postulated a binding model for KlHsv2 to the membrane containing PI3P or PI(3,5)P2
(see figure 4.37 [24]). Hsv2 binds with two phosphoinositide binding pockets towards
the membrane in an edge on geometry. This allows penetration of loop 6CD into the
membrane. A similar model was described by Baskaran et al., [25].
Phosphoinositide binding domains often use multidomain cooperativity to increase
their membrane binding affinities. This is achieved either by dimerization of the PIP
binding domain, addition of a loop that inserts into the membrane or interaction with
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additional membrane binding proteins (reviewed in [139]). Here, we showed that PROP-
PINs employ two phosphoinositide binding sites in the β-propeller domain. In addition,
I showed the requirement of loop 6CD in membrane binding.
β-propeller proteins generally form a platform for protein-protein interactions. As
PROPPINs bind in an edge on manner to the membrane the β-propeller sticks out
of the membrane and is accessible for potential interaction partners. Atg18 at the
PAS was shown to bind to Atg2 and mediates cycling of the membrane protein Atg9
[142]. Atg18 in complex with Atg2 is recruited from the cytosol to the membrane [21].
Interaction studies of Atg18 with Atg2 showed that Atg2 binds with blade 2 of Atg18
[26]. Furthermore, Atg18 is part of the PI3P 5-kinase complex including Fab1 at the
vacuolar membrane [181, 143].
Atg21 was shown to be involved in recruitment of Atg8-PE to the PAS [144, 156].
In order to characterize binding of Atg21 to Atg8, I performed different experiments to
confirm a direct interaction between the PROPPINs Atg21 and Hsv2 to Atg8. However,
ITC measurements of Hsv2 with Atg8 did not give any detectable heat change and
analytical gel filtration of Atg21 with Atg8 resulted in elution of two separate peaks
from the column. Soaking experiments of an Atg8 peptide into crystals containing
Hsv2 did not show additional electron density for the Atg8 peptide. In addition, co-
expression experiments did not yield any crystals, yet. Earlier affinity isolation and
yeast two hybrid screens with Atg21 were performed and no interaction was achieved
[144]. Probably the interaction between Atg21 and Atg8 requires additional factors
or posttranslational modifications which are absent when working with recombinant
proteins.
4.4 Outlook
The purification protocols for the investigated PROPPINs are set up and first crys-
tallization screens were done for K. lactis Atg21 and P. angusta Atg18. These screens
yielded in some pre-crystalline structures, which need further optimization. These pro-
teins might be suitable for crystallization, since the disorder prediction of IUPRED
displayed only small stretches of disorder in the N-terminal and C-terminal region. Ho-
mology modeling and secondary structure predictions showed an additional C-terminal
α-helix for Atg18 and Atg21 proteins, which is not present in Hsv2. The importance of
this region can be analyzed by deletion of this region followed by in vivo localization
studies in comparison to wild type protein. Probably this region is involved in protein-
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protein interactions and potential interaction partners can be identified using a yeast
two hybrid screen or co-purification of interaction partners with the tandem affinity
purification (TAP) method.
In addition, to the biochemical analysis of PROPPINs membrane binding, bioinfor-
matic studies are carried out by A. Scacioc to study the role of loop 6CD for membrane
binding of PROPPINs. Starting from the existing coarse-grained model of Hsv2 bind-
ing to the membrane [24] (see figure 4.37), an atomistical model will be derived. This
model allows a more detailed analysis of membrane binding regarding the loop insertion
and identification of which residues go into the membrane. By insertion of the protein
into a membrane and pulling it out of the membrane virtually, binding affinities can be
achieved and compared to the in vitro results.
Furthermore, ITC measurements for KlHsv2, PaAtg18 and KlAtg21 to PI3P con-
taining liposomes and KlAtg21 to PI(3,5)P2 containing liposomes need to be optimized
to achieve a conclusive binding stoichiometry for all tested PROPPINs. Here, adjusting
of the protein concentration might lead to a longer starting phase of the curve, which
is required for optimal fitting and therefore for calculation of the stoichiometry.
Since so far no crystal structure of Atg18 and Atg21 is available, their structures will
be determined on an atomistical scale using homology modeling with the Hsv2 structure
by A. Scacioc. Analysis of their binding sites and modeling of PI3P and PI(3,5)P2 will
be performed to support and validate my in vitro data.
In order to show the importance of loop 6CD, in vivo localization studies are planned
in collaboration with Prof. M. Thumm. The loop mutants of KlHsv2 characterized in
this study will be cloned into a yeast expression plasmid. The recombinant protein
will be tagged with an N-terminal GFP for fluorescence microscopy in S. cerevisiae.
Membrane binding of the loop mutants in comparison to wild type KlHsv2 protein will
be investigated.
Interaction of Atg21 and Hsv2 with Atg8 could not be confirmed with the here used
methods. Further investigations should be done to determine, whether an additional
factor is needed for interaction. Most likely the interaction between PROPPINs and
Atg8 is on an indirect level. Therefore, interaction partners of Atg21 can be identified
using a yeast two hybrid screen.
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5.1 Structures of autophagy-related proteins in the PDB
The following table is ordered by the release date of the structures in PDB.
Table 5.1: Structures of autophagy proteins in PDB (2)
Protein PDB entry Structure type Reference
R. norvegicus LC3 (Atg8) 1UGM X-ray, 2.05 Å Sugawara et al., Genes Cell (2004) [27]
plant Atg12 1WZ3 X-ray, 1.80 Å Suzuki et al., Autophagy (2005) [31]
human Atg4B 2CY7 X-ray, 1.90 Å Sugawara et al., JBC (2005) [28]
human Atg4B 2D1I X-ray, 2.00 Å Kumanomidou et al., J Mol Biol
(2006) [182]
S. cerevisiae Atg5-Atg16(1-46) 2DYM X-ray, 2.20 Å Matsushita et al., JBC (2007) [84]
S. cerevisiae Atg5-Atg16(1-57) 2DYO X-ray, 1.97 Å Matsushita et al., JBC (2007) [84]
S. cerevisiae Atg3 2DYT X-ray, 2.5 Å Yamada et al., JBC (2007) [29]
Bcl-xL/Beclin 1 complex 2P1L X-ray, 2.50 Å Oberstein et al., JBC (2007) [183]
2PON solution NMR Feng et al., J Mol Biol (2007) [184]
human Atg4A 2P82 X-ray, 2.10 Å Walker et al., Structural Genomics
Consortium (2007)
Atg4B-LC3(1-120) 2Z0D, 2Z0E X-ray, 2.10 Å Satoo et al., EMBO J (2009) [185]
human GABARAP1 2R2Q X-ray, 1.65 Å Tempel et al., Structural Genomics
Consortium (2007)
M11/mouse Beclin 1 (106-124) 3BL2 X-ray, 2.30 Å Ku et al., Plos Pathog (2008) [186]
M11/mouse Beclin 1 BH3 domain 3DVU X-ray, 2.50 Å Sinha, Autophagy (2008) [187]
LC3/p62 2ZJD X-ray, 1.56 Å Ichimura et al., JBC (2008) [188]
LC3/p62 2K6Q solution NMR Noda et al., Genes Cell (2008) [189]
MAP1ALC3 3ECI X-ray, 2.65 Å Walker et al., Structural Genomics
Consortium (2008)
S. cerevisiae Atg8-Atg19(412-415) 2ZPN X-ray, 2.70 Å Noda et al., Genes Cell (2008) [189]
human Atg4B(C74S)/LC3(1-124) 2ZZP X-ray, 2.05 Å Satoo et al., EMBO J (2009) [185]
p62 PB1 domain 2KKC solution NMR Yokochi & Inagaki, J Biomol NMR
(2009) [190]
Trypanosoma brucei Atg8 3H9D X-ray, 2.30 Å Koopmann et al., Autophagy (2009)
[191]
S. cerevisiae Atg16 coiled coil do-
main
3A7O X-ray, 2.50 Å Fujioka et al., JBC (2009) [33]
S. cerevisiae Atg16 3A7P X-ray, 2.80 Å Fujioka et al., JBC (2009) [33]
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Keap1 with Sequestosome-1/p62 3ADE X-ray, 2.80 Å Kurokawa & Yamamoto, Nat Cell Biol
(2010) [192]
p62 PB1 dimer 2KTR solution NMR Saio et al., J Biomol NMR (2010) [193]
D. melanogaster Vps34/2-
methyladenine
2X6F X-ray, 3.30 Å Miller et al., Science (2010) [36]
D. melanogaster Vps34 2X6H X-ray, 2.90 Å Miller et al., Science (2010) [36]
D. melanogaster Vps34/PIK-90 2X6J X-ray, 3.50 Å Miller et al., Science (2010) [36]
D. melanogaster Vps34/PI-103 2X6K X-ray, 3.50 Å Miller et al., Science (2010) [36]
Atg8 2KQ7 solution NMR Schwarten et al., Biochem Biophys Res
Commun (2010) [82]
Atg8 2KWC solution NMR Kumeta et al., J Biomol NMR (2010)
[83]
Atg19 α-mannosidase binding mo-
tif
2KZB solution NMR Watanabe et al., JBC (2010) [194]
Atg34 α-mannosidase binding mo-
tif
2KZK solution NMR Watanabe et al., JBC (2010) [194]
Bombyx mori Atg8 3M95 X-ray, 2.40 Å Hu et al., Acta Crystallogr Sect F
(2010) [195]
GABARAPL-1/NBR1-LIR 2L8J solution NMR Rogov et al., J Mol Biol (2011) [196]
p62 UBA domain/ubiquitin 2RRU solution NMR Isogai et al., JBC (2011) [197]
p62 UBA domain/ubiquitin 3B0F X-ray, 1.40 Å Isogai et al., JBC (2011) [197]
S. cerevisiae Atg7 (1-595) 3VH1 X-ray, 3.00 Å Noda et al., Mol Cell (2011) [30]
S. cerevisiae Atg7 (1-613) 3VH2 X-ray, 3.30 Å Noda et al., Mol Cell (2011) [30]
S. cerevisiae Atg7 CTD/Atg8 3VH3 X-ray, 2.00 Å Noda et al., Mol Cell (2011) [30]
S. cerevisiae Atg7 CTD/Atg8
MgATP
3VH4 X-ray, 2.65 Å Noda et al., Mol Cell (2011) [30]
Atg8/Atg7C30 2LI5 solution NMR Noda et al., Mol Cell (2011) [30]
Atg7C/Atg8 3RUI X-ray, 1.91 Å Hong et al., Nat Struct Mol Biol
(2011) [198]
yeast Atg7 N-terminus 3RUJ X-ray, 2.10 Å Hong et al., Nat Struct Mol Biol
(2011) [198]
S. cerevisiae Atg7 (289-630) 3T7E X-ray, 2.25 Å Taherbhoy et al., Mol Cell (2011) [199]
S. cerevisiae Atg7 (1-289) 3T7F X-ray, 1.89 Å Taherbhoy et al., Mol Cell (2011) [199]
S. cerevisiae Atg7 (1-289)/Atg3
(128-144)
3T7G X-ray, 2.08 Å Taherbhoy et al., Mol Cell (2011) [199]
S. cerevisiae Atg7 (1-289) 3T7H X-ray, 1.60 Å Taherbhoy et al., Mol Cell (2011) [199]
Beclin 1 coiled coil domain 3Q8T X-ray, 1.90 Å Li et al., Nat Commun (2012) [34]
Beclin 1 ECD domain 4DDP X-ray, 1.55 Å Huang et al., Cell Res (2012) [35]
Vps30/Atg6 BARA domain 3VP7 X-ray, 1.55 Å Noda et al., JBC (2012) [200]
Kluyveromyces lactis Hsv2 com-
plete loop 6CD
4AV8 X-ray, 3.35 Å Krick et al., PNAS (2012) [24]
Kluyveromyces lactis Hsv2 4AV9 X-ray, 3.00 Å Krick et al., PNAS (2012) [24]
Kluyveromyces marxianus Hsv2 3VU4 X-ray, 2.60 Å Watanabe et al., JBC (2012) [26]
Kluyveromyces lactis Hsv2 4EXV X-ray, 3.00 Å Baskaran et al., Mol Cell (2012) [25]
Kluyveromyces marxianus Atg10 2LPU solution NMR Yamaguchi et al., Structure (2012) [32]
Kluyveromyces marxianus Atg5 3VQI X-ray, 2.50 Å Yamaguchi et al., Structure (2012) [32]
S. cerevisiae Atg8/Atg32 peptide 3VXW X-ray, 3.00 Å Kondo-Okamoto et al., JBC (2012)
[201]
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Figure 5.1: Testexpression of CeAtg18, PaAtg18, PaAtg21 and KlAtg21 in E. coli
BL21(DE3) cells
Cultures were grown (A) in LB media and (B) in autoinducible media. LB culture was induced with
IPTG at OD 0.6. In autoincibale media grown cells were incubated for 3 hours before the temperature
was shifted to 22 ◦C. Also the LB culture was shifted after induction. After another 20 hours samples
were taken of all cultures and subjected to SDS-PAGE analysis. Here cell extract (CE), supernatant
(S) and Ni2+-sepharose beads bound (Ni-B) fractions were checked.
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Figure 5.2: Purification of CeAtg18 from E. coli BL21(DE3) cells
Chromatograms and SDS-PAGE gels of CeAtg18 purified by (A) affinity chromatography using a
His-Trap FF column followed by (B) gel filtration with HiLoad 16/60 Superdex S75 column.
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Figure 5.3: Purification of DmAtg18 from E. coliBL21 (DE3) cells
Chromatograms and SDS-PAGE gels of DmAtg18 purified by (A) affinity chromatography using a
His-Trap FF column followed by (B) gel filtration with HiLoad 16/60 Superdex S200 column.
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Figure 5.4: Purification of PaAtg21 from E. coli BL21(DE3) cells
Chromatograms and SDS-PAGE gels of PaAtg21 purified by (A) affinity chromatography using a
His-Trap FF column followed by (B) gel filtration with HiLoad 16/60 Superdex S75 column.
0 h   1 h   2 h   3 h   4 h        0 h   1 h   2 h   3 h  4 h   o/n 








Figure 5.5: Testexpression of SpHsv2 in E. coli BL21(DE3) cells
Two E. coli cultures with the plasmid for SpHsv2 expression were incubated at 37 ◦C until OD of 0.6
and induced with IPTG (0 h). Then one culture was shifted to 25 ◦C. Samples were taken after each
hour and over night (o/n) and analyzed with SDS-PAGE.
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Figure 5.6: Thermofluor analysis of CeAtg18 and DmAtg18
Thermofluor experiments using the pHat screen of (A) CeAtg18 and (B) DmAtg18. Sypro Orange
fluorescence was monitored and dequenching indicates unfolding of the proteins. Temperature was





Figure 5.7: CD spectra and melting curves of yeast PROPPINs
CD spectra taken from 260 nm to 190 nm for (A) PaAtg18, PaAtg21, (B) SpHsv2 and KlAtg21.
Melting curves of (C) SpHsv2, (D) KlAtg21, PaAtg21 and PaAtg18 were monitored at 216 nm over a
temperature shift from 20 ◦C to 90 ◦C.
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Figure 5.8: Limited proteolysis of PaAtg21
Purified protein was cleaved with the indicated proteases for a time course up to 30 min at RT. Samples
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Figure 5.9: Buffer optimization for thrombin cleavage of ScHsv2 and Hsv2 antibody test
(A) Buffer optimization for thrombin cleavage of wild type ScHsv2 (left) and ScHsv2 FTTG mutant
(right) using Hepes pH 7.0 and citric acid pH 5.5 buffer. (B) ScHsv2 antibodies were tested in 1:1000
and 1:2000 dilutions on wild typre and FTTG mutant of ScHsv2 as well as on purified GST. Proteins









Figure 5.10: Analysis of ScHsv2 after thrombin treatment for stability using an analytical
gel filtration
Purified GST-ScHsv2 was treated over night with thrombin and then GSTrap purified. ScHsv2 without
tag was analyzed with an analytical gel filtration and fractions under the elution peak were tested on
SDS gel.
ScHsv2wild type ScHsv2FAAG 







Figure 5.11: GST SpinTrap purification of ScHsv2 homologs
Samples taken during the purification of wild type ScHsv2 and ScHsv2FAAG with GST SpinTrap
columns were tested on Coomassie stained SDS gels.

































Figure 5.12: PIPstrip analysis of ScHsv2 binding site mutants
PIP strip analysis using 1 µg/ml GST SpinTrap purified protein without GST-tag. 2 % BSA in PBS-T
was used as buffer. The protein was detected using a ScHsv2 antibody and a seconday anti-rabbit
antibody with HRP conjugation at 30 sec exposure time. The following lipids were spotted on the
membrane - 1: Lysophosphatidic Acid (LPA), 2: Lysophosphocholine (LPC), 3: PI, 4: PI(3)P, 5:
PI(4)P, 6: PI(5)P, 7: PE, 8: PC, 9: Sphingosine-1-phosphate (S1P), 10: PI(3,4)P2, 11: PI(3,5)P2, 12:
PI(4,5)P2, 13: PI(3,4,5)P3, 14: Phosphatidic Acid, 15: PS, 16: Blank.
148 Appendix
M   1   2    3    4     5     6     M   1    2    3    4     5     6 
Density 
Fractions 
Figure 5.13: Liposome floating analysis with SDS-PAGE
Floating of the liposomes towards the low density region of a non-continuous Nycodenz gradient during
centrifugation was shown by fluorescence scanning of Texas Red at 532 nm excitation and 670 nm
emission wavelength. Fractions of the gradient were taken from top (1) to bottom (6). 2% Texas
Red-PE, 73 % PC, 23 % PE and 2 % PI3P containing liposomes were used.
Figure 5.14: Determination of liposome size distribution by FFF-MALLS
The number of liposomes of a certain size (Pn) was plotted against their geometric radii (R). 2 %
PI3P and 2 % PI(3,5)P2 containing liposomes were subjected to FFF-MALLS analysis and their size
homogeneity was confirmed. 2 % PI3P liposomes showed an average radius of 18 nm, whereas 2 %
PI(3,5)P2 lipsomes were slightly bigger with a mean of 21 nm in radius.
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A B 
Figure 5.15: Structure of KlHsv2 and homology model of ScHsv2
(A) Homology model of ScHsv2 was derived by using (B) the structure of KlHsv2 as template. Marked
with a red circle is the loop 6CD. Modified figure derived from A. Scacioc.
FRRG 
Loop region 
Figure 5.16: Alignment of the loop 6CD region of different Hsv2 homologs
Shown is the alignment of the human Hsv2 homologs WIPI3 and WIPI4, Hsv2 from A. thaliana, Y.
lipolytica, A. gossypii and C. glabrata as well as ScHsv2 and KlHsv2. Marked is the conserved region


















Figure 5.17: PIPstrip analysis of loop 6CD mutants
Purified proteins were subjected to PIPstrips spotted with the following lipids - 1: Lysophosphatidic
Acid (LPA), 2: Lysophosphocholine (LPC), 3: PI, 4: PI(3)P, 5: PI(4)P, 6: PI(5)P, 7: PE, 8: PC,
9: Sphingosine-1-phosphate (S1P), 10: PI(3,4)P2, 11: PI(3,5)P2, 12: PI(4,5)P2, 13: PI(3,4,5)P3, 14:
Phosphatidic Acid, 15: PS, 16: Blank
A B C 
Figure 5.18: Melting curves of KlHsv2 and ScHsv2 mutants
Melting curves taken at 216 nm 20 ◦C to 90 ◦C for (A) KlHsv2 (B) ScHsv2wildtype, ScHsv2FTTG,
ScHsv2loopchimera and KlHsv2loopchimera (C) KlHsv2GSlinker, KlHsv2K260E/R261D/H262D,
KlHsv2Y 272D/F273D, KlHsv2Y 272D and KlHsv2F273D.




Figure 5.19: Stability analysis of KlHsv2 and ScHsv2 mutants using Thermofluor
Increase of Sypro Orange fluorescence during a thermal shift assay correlates with protein unfolding.
(A) Shows ScHsv2wildtype, ScHsv2loopchimera, KlHsv2wildtype, KlHsv2loopchimera and KlHsv2GSlinker.
In (B) KlHsv2wildtype, KlHsv2Y 272A/F273A, KlHsv2Q274D and KlHsv2Q274E were compared. (C) Shows
KlHsv2wildtype, KlHsv2K260E/R261D/H262D, KlHsv2Y 272D/F273D, KlHsv2Y 272D and KlHsv2F273D. The
temperature was shifted from 25 ◦C to 95 ◦C.
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